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General introduction 
 
 
 
 
 
 
 
 
There are many children like Eric and Jane. 
Asthma and cystic fibrosis (CF) are two well-known illnesses in pediatric care. 
Both are complex diseases which affect the pulmonary system and have a 
chronic course. Asthma is the world’s most common pediatric chronic disease, 
with a prevalence rate of 5-10% in Western societies [1]. Asthma is mainly a 
single-organ disease of the airways, with recurrent unpredictable episodes of 
wheezing, coughing and shortness of breath. CF is less common than asthma, 
but is still the most common lethal autosomal recessive disorder in Caucasians. 
CF is a multi-organ disease, it has a gradual progressive nature and a life 
threatening prognosis. The median life expectancy of patients with CF increased 
dramatically over the last 30 years. Estimated survival for patients with CF in the 
Netherlands to 30 years increased from 6% in the 1950-to-1954 cohort, to 36% 
in the 1970-to-1973 cohort [2]. 
Both diseases pose a high burden on patients, their family (especially 
the caregivers) and society. This is explained by the impairments related to the 
disease itself, but also to its treatment. Both diseases need a complex daily, 
disease management, which increases the burden. Most children with a chronic 
illness and their families adjust to the medical illness and show admirable 
resilience [3]. However, previous research has also shown that children with 
chronic illnesses are at increased risk of developing a broad range of 
psychosocial problems [4]. The same seems to be true for patients with asthma 
Eric, twelve years old, goes to secondary school. He likes to play football 
and likes to hang out with his friends. Eric has cystic fibrosis (CF). Eric 
goes to hospital every three months and is admitted once every year. 
Since last year Eric argues a lot with his parents about doing his 
homework, getting enough sleep, taking his medication and adhering to 
his diet.  
Jane, eight years old, goes to primary school. Jane has asthma. Jane 
avoids activities, she enjoyed before, because she is afraid these 
activities will trigger an asthma attack. She suffers from depressive 
mood and doesn’t feel her medication can help her control her asthma. 
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and CF. In addition, these psychosocial problems contribute to patients and 
caregivers ability to manage the disease. 
This thesis has the aim to gain more insights into the different 
psychosocial factors which are relevant to the care of young patients with 
asthma or CF (both as outcome of the disease and as factors mediating in the 
disease management) and how to measure these factors in clinical care. This 
introductory chapter starts with a brief outline about current insights into the field 
of pediatric psychology. After this short theoretical background and research 
model, in succession the somatic and psychosocial aspects of respectively 
asthma and CF will be briefly discussed. This chapter continues with a short 
overview of the importance and state of the art regarding patient-reported 
outcomes. This chapter ends with the aim and outline of this thesis.  
 
Pediatric psychology and theoretical background 
In the past decades, the number of children growing up with a chronic illness has 
increased tremendously [5]. This increase is a result of decreasing childhood 
mortality due to improvements in pediatric diagnostic and therapeutic 
opportunities. Chronically ill children and adolescents do not only have to meet 
their age-related developmental tasks, but they also experience several 
consequences of their medical illness. These consequences include physical 
symptoms and complaints related to their disease but also burdensome 
consequences of their medical treatment such as following a daily therapeutic 
regime, frequent visits to the hospital or regularly painful procedures. It is now 
recognized that children with chronic illnesses are at higher risk for developing 
emotional and behavior problems than their healthy peers [6, 7]. These 
psychosocial problems may affect health in general but may also negatively 
affect treatment adherence or self-management.  
 
Theoretical models 
Wallander and Varni have done a remarkable job by conceptualizing the impact 
of chronic disease on children and their families in their famous ‘model of child 
adjustment to chronic physical disorders’ of the year 1998 [8]. This model is an 
important framework in the field of pediatric psychology and has guided clinical 
research in recent years [9]. Adjustment or adaptation is conceptualized on 
mental, social and physical domains and is a consequence of how disease 
related factors, functional independence and psychosocial stressors (the so-
called risk factors) are mediated by stress processing factors, personal factors 
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and social-ecological factors (the so-called resistance factors). This model is 
partly based on the stress-vulnerability model (or the stress-appraisal-coping 
model) by Lazarus and Folkman in 1984. In this model Lazarus and Folkman 
show that persons confronted with a stressor (for example a diagnosis of a 
chronic illness) firstly evaluate the potential harm or benefit of the stressor 
(primary appraisal) and secondly decide if they can deal with it (secondary 
appraisal), and then actually deal with the stressor (coping), which leads to 
different outcomes on physical, mental and social domains. The psycho-
physiological perspective extends the model by adding physiological and 
immunological factors as mediators between psychological risk factors and 
disease outcomes [10]. Coping (the way a person deals with a stressor), is one 
of the factors which can mediate disease outcome and could be altered by 
psychological treatment. 
 
Research model  
Our research model (Fig. 1) is based on the adjustment model of Wallander and 
Varni and is divided into three boxes: background characteristics, mediating 
factors and outcome factors. Outcome is subdivided into the three domains of 
health derived from the current WHO definition of health as ‘a state of complete 
physical, mental and social well-being and not merely the absence of disease or 
infirmity’. This definition was already formulated in 1948 and although it has been 
criticized over the past 60 years, especially because of the absoluteness of the 
word ‘complete’, it has never been adapted. Probably, because of its 
groundbreaking breadth due to the inclusion of besides physical also mental and 
social domains [11]. It supports the vision that in clinical care it is insufficient to 
strive for one overall physical outcome measurement but it needs an integration 
of different outcomes from physical, mental and social perspectives. This is in 
line with perspectives on outcomes in childhood chronic diseases where the 
focus on survival (medical outcome) is more and more extended to a broader 
perspective, taking also psychosocial and even spiritual factors into account. As 
already indicated in the first part of the introduction, this is particularly true in 
both childhood asthma and CF. 
In our research model it is important to take into account a 
developmental oriented perspective. In contrast to adults, the cognitive, physical, 
behavioral and verbal capabilities of children develop very fast as they grow 
older and their social surroundings change with them. As a result, every age is 
associated with its own developmental tasks, challenges and risk factors. In 
addition, a system perspective is important since children are depended on 
Chapter 1 
14 
 
adults and caregivers play an important role in their development but also in the 
field of disease-management. This system oriented perspective is highlighted in 
our research model in all three boxes. We will elaborate further on these two 
perspectives in the following paragraph.  
Developmental and system oriented perspective 
We show how a developmental perspective can and should be applied to our 
research model by illustrating this with some examples from clinical care. As 
shown in our model, outcome factors are a sum of risk factors or stressors (the 
so-called background characteristics) which can be mediated by a large variety 
of so-called mediating factors. For example: the way asthma is controlled 
(physical outcome) is not only a result of the severity of this disease (for instead 
the degree of bronchial hyper reactivity as a background variable) but is 
mediated by the way it is treated by patients themselves, their caregivers and the 
health care providers (mediating factors). From a developmental perspective; we 
know that many mediating factors are dependent on the developmental age of a 
patient. For example: infants do not have the cognitive abilities (personal factors) 
to make an association between taking medication and feeling better in the long 
run. Especially with infants, this often leads to problems when babies, who are 
experiencing shortness of breath, need rescue medication by inhalation but 
refuse a mask over their mouth and nose. In this situation, the negative 
relationship between the age of the child (a background or independent variable) 
and the way asthma is controlled (a physical outcome) is mediated by treatment 
(a mediating factor). Adequate parental guidance (mentioned in the group of 
social-ecological mediating factors) might have a positive mediating effect on 
health outcome in this particular case. Another example: the famous ‘terrible 
twos and trees’ in toddlerhood is a normal time period in which tantrums occur 
frequently and many parents struggle with daily activities with their toddler like 
eating, getting dressed, brushing teeth and, not surprisingly, taking medication. 
In most cases these normal challenges in growing up and parenting do not 
account for serious health problems, however in the case of chronic illnesses 
some of these normal ‘hassles’ might hamper treatment or the relationship with 
caregivers (mediating factors) and can lead to serious health problems (on 
physical, mental and social domains). Adolescence is another striking period 
which brings out its own challenges for chronically ill young patients and their 
relatives. Adolescence is a transitional stage of physical and mental personal 
development generally occurring between puberty and adulthood in which 
increased independence usually goes along with less supervision from  
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Fig. 1 Research model 
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caregivers (changing social-ecological mediating factors). This is also the period 
in which young patients tend to test rules and limits, also regarding health issues 
such as self-management. Adolescents are usually capable of greater 
autonomy, however they struggle with themes like independence, self-esteem, 
body-image and peer-relations. They become more aware of their social roles 
and want to be a part of the group compared to younger children. So taking your 
medication in the neighborhood of peers can be an embarrassing situation for 
adolescents which they rather want to avoid. Relationships with parents change 
and discussions and conflicts about rules and responsibilities occur more 
frequently, which sometimes accounts for problems adhering to their therapeutic 
regime. Based on recent insights in the field of developmental psychology we 
know that there is a difference in how quickly children develop [12]. For clinical 
care, this means that it is important that doctors take these differences into 
account, so that they can tailor their medical treatment to the specific needs of 
their minor patients. 
The second perspective to take into account is the system oriented 
perspective: children and adolescents depend (more or less) on people in their 
social surroundings. Moreover, a system-oriented perspective in pediatric 
psychology assumes a reciprocal influence between a child and other individuals 
within the system. Bronfenbrenner’s (1979) social-ecological model of 
development is probably the most famous conceptual model in which four rings 
of systems (microsystem, mesosystem, exosystem and macrosystem) represent 
different influences on the child [13]. In this thesis we will focus primarily on the 
micro and mesosystem with caregivers and medical staff (represented in Box 2 
by social-ecological factors).  
Even before children are born they are exposed to external influences 
(such as maternal smoking or maternal stress). From the start of their life, young 
children totally depend on their primary caregivers. Parents are responsible for 
giving a young baby the basic needs and providing a safe and warm 
environment. When children grow older, they gain more autonomy and 
responsibilities step by step. In adolescence, the role of caregivers shifts from 
caring via managing to supervision, and relationships with peers become more 
important. For clinical care and research this perspective means that it is 
important not only to look at the patient but at the whole system (e.g. caregivers, 
siblings, teachers, peers, medical staff). This perspective is integrated in our 
research model in all three boxes (environmental stressors, social-ecological 
mediating factors and social outcome). Assessing health beliefs and the 
psychosocial wellbeing of caregivers is therefore important because these 
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factors might have an impact on health outcomes. For example, in the situation 
that caregivers are anxious about the possible side-effects of medication, have 
incorrect cognitions about the disease, they are suffering from a burn-out or 
there are many battles with their child, these problems are most likely to have a 
negative effect on disease management (an important mediating factor) [14]. 
When children are younger, caregivers are mainly responsible for the 
management of diseases. Caregivers are usually the ones who have to interpret 
signs of their child when the child is too young to tell his parents he is 
experiencing shortness of breath or is suffering from abdominal cramps. As 
children grow older they gain more cognitive abilities to carry out various 
treatment tasks, but they still need parental supervision and guidance. Assigning 
too much responsibility solely to a child can lead to poor self-management and 
adherence. Another reason why it is important to take into account the 
psychosocial health of caregivers is that mental health of caregivers and the 
parenting styles they use seem to predict the development of psychosocial 
problems in their children [15, 16]. For psychosocial research and clinical care 
this means that it is important to integrate information from more informants than 
just from the patient [17].  
 
Asthma 
Somatic aspects of asthma 
Prevalence rates of childhood asthma have increased remarkably in the last 
decades [18]. In Europe, a prevalence rate of 5-10% is estimated [1]. Asthma is 
described by the Global Initiative for Asthma (GINA) as ‘a chronic inflammatory 
disorder of the airways in which many cells and cellular elements play a role. 
The chronic inflammation is associated with airway hyper responsiveness that 
leads to recurrent episodes of wheezing, breathlessness, chest tightness, and 
coughing, particularly at night or in the early morning. These episodes are 
usually associated with widespread, but variable, airflow obstruction within the 
lung that is often reversible either spontaneously or with treatment’ [19]. The 
diagnosis of asthma is not always easy to make in childhood: there is no single 
‘golden standard or measurement’. A diagnosis is usually based on a 
combination of the child’s symptoms, medical history, physical examination and 
lung function tests. However, children under the age of 5 are usually not capable 
of providing a reliable lung function test and even in the case lung function tests 
are possible, a normal lung function test in a good stable period does not rule out 
asthma. Moreover, there are many other diagnoses in which children might 
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experience symptoms which resemble asthma such as viral wheezing, recurrent 
bronchitis or the so-called somatoform respiratory disorders in children and 
adolescents such as habit cough, vocal cord dysfunction, dysfunctional breathing 
(for example hyperventilation) or panic attacks [20-22]. 
Asthma cannot be cured, but it can be controlled; obtaining optimal asthma 
control is nowadays the major goal of asthma management [23]. According to 
the GINA guidelines, asthma is controlled when patients can (1) avoid 
troublesome symptoms night and day, (2) use little or no reliever medication, (3) 
have productive, physically active lives, (4) have (near) normal lung function and 
(5) avoid serious attacks. The shift from asthma severity to asthma control is in 
line with current views, that especially in a chronically ill population more 
attention should be given on the ability of patients to cope with and self-manage 
their disease [11]. Despite the fact that the GINA-guidelines emphasize that 
asthma control is a combination of different outcome measures, mental health 
outcomes are still neglected in these guidelines. Most of the factors mentioned, 
focus on the more physical domain of health (e.g. medication use, normal lung 
function) or on the social domain (role functioning as in having a productive, 
physically active life).  
Despite the availability of effective therapies, overall asthma control is 
rather low, because of high rates of non-adherence or problems with self-
management [24-26]. As a consequence many children and adolescents with 
poor asthma control continue to have symptoms, lifestyle restrictions, emotional 
problems and require emergency care [27-29].  
Besides the personal burden for patients and their relatives, the 
economic burden for asthma is considerable. The GINA estimated that the cost 
of asthma currently comprises 1 to 2% of total health care expenditures. 
Hospitalization and emergency care due to asthma exacerbations are 
consistently, disproportionately high. This data suggest that extreme excess 
costs are a consequence of poor control and poor disease management [30]. In 
the United States the total annual incremental costs of asthma to society were 
estimated to be $56 billion [31]. In Europe the annual costs involved in asthma 
care for children was estimated to be over € 3.000 million, which is also 1-2 % of 
the total health care costs in Europe [1, 32]. Unfortunately, there is no data 
available of the annual costs of asthma in the Netherlands. On a societal level, 
economic costs are also considered as important outcomes of asthma. 
The GINA guidelines describe four components of care for patients with 
asthma in order to achieve optimal control: (1) develop patient-doctor 
partnership, (2) identify and reduce exposure to risk factors, (3) assess, treat and 
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monitor asthma, and (4) manage exacerbations. As both doctors, caregivers and 
the child itself are involved in these components, it supports the importance of 
the mediating factors in our model (Box 2). The pharmacological treatment of 
asthma usually comprises quick-relief medications used to treat acute symptoms 
(short acting beta2-adrenoceptor agonists) and long-term control medications 
(corticosteroids) for the prevention of exacerbations. In all these components of 
care adequate self-management of patients and caregivers is essential and 
therefore a good working patient-doctor partnership is given special attention in 
the GINA-guidelines.  
 
Psychosocial aspects of asthma 
Almost a century ago, far before the underlying inflammatory basis of asthma 
was discovered, asthma was regarded as a psychosomatic disease. Clinicians 
and researchers recognized that many asthmatic patients also suffered from 
psychological problems such as anxiety or depression. During the 1930s-50s 
many clinicians considered asthma to be purely psychogenic in origin. The 
asthmatic wheeze was interpreted as the child’s suppressed cry for his mother 
and treatment often primarily involved psychoanalysis or other ‘talking cures’ 
[33]. In older medical textbooks asthma was considered a nervous disease and 
was referred to as ‘asthma nervosa’ [34]. Psychological factors were taken into 
account as the most important determinants of the medical outcome. 
Fortunately, this simplistic and erroneous view has been deserted and research 
has shifted to the underlying inflammatory pathophysiology of asthma. 
Nowadays, research focus on a complex, bidirectional integration of genetic, 
immunological, and psychological factors in both the onset and course of asthma 
[35-37].  
As shown in our research model, psychological health is not only an 
important outcome of the disease (represented in Box 3), in addition 
psychosocial factors (Box 1) seem to affect disease outcomes by different 
mediating pathways (represented in Box 2). One pathway is psycho-
immunological or psycho-physiological in nature. By some researchers it is 
proposed that in a proportion of patients emotions and stress (as daily hassles or 
life events in Box 1) are triggers for asthma episodes [38] and that this process is 
mediated by the autonomic nervous system. Increased activity of the vagus 
nerve and stimulation of the parasympathic system might result in 
bronchoconstriction [39]. Other theories hypothesize that more chronic stress 
alters the immune system and increases the inflammatory process [40]. Psycho-
physiological and psycho-immunological mechanisms relating psychosocial 
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stressors to asthma onset and outcome are not completely understood but 
continue to be investigated [41, 42]. These mechanisms are shown in our 
research model as stress processing mediating factors in Box 2. 
Another pathway in which psychosocial factors might influence various health 
outcomes in children with asthma is behavioral in nature: psychosocial problems 
of the patient or within the family may negatively interfere with disease self-
management and adherence to treatment (represented in Box 2) [43]. 
Adherence problems or problems with self-management may lead to poorer 
asthma control with a higher risk of subsequently an increased rate of even more 
psychosocial problems: a vicious circle. As mentioned above, achieving optimal 
asthma control requires a complex daily self-management of patients and/or 
caregivers. Patients (or caregivers) need to know what asthma is, how to 
interpret different physical signs, and how to avoid triggers. Most often they need 
to inhale corticosteroids on a daily basis for a long period of time, they need to 
know what to do in case of acute asthma-attacks and when to seek specialized 
medical care. Adherence to such a complex daily treatment over a long period of 
time is not easy, reflected by the high percentages of non-adherence in this 
population [44-46]. The World Health Organization addressed the issue of poor 
adherence to treatment of chronic diseases as a worldwide problem of striking 
magnitude. In developed countries treatment adherence for chronic illnesses is 
estimated around 50% [30]. In their 2003 report the WHO claimed that 
'Increasing the effectiveness of adherence interventions may have a far greater 
impact on the health of the population than any improvement in specific medical 
treatment'. There is no reason to believe this statement is not true for asthma. 
Adherence is simultaneously influenced by several factors including (but 
not restricted to) patient or caregiver related factors, health care team/system, 
social and economic factors, and characteristics of the disease or therapy [30, 
47]. Examples of patient-related factors associated with non-adherence are 
oppositional behavior, time-management, poor planning capabilities, and 
incorrect health beliefs about medication and illness (represented in Box 1 in our 
research model) [48]. Examples of health care factors (mentioned in our 
research model as social ecological mediating factors) associated with poor 
adherence are little time for consultations, non patient-tailored treatment plans 
and communication problems between health care providers and patients [30]. 
One of the patient-related factors frequently reported to be associated with poor 
adherence in the young asthma population is the presence of psychosocial 
problems in patients [49, 50] and/or within the family or caregivers [14, 48, 51] 
(Box 1). As mentioned before, there is a burst of evidence that children and 
General introduction 
21 
 
adolescents with asthma and their caregivers are at increased risk for mental 
health problems [36, 43, 52-60]. Especially internalizing problems such as 
depressed mood or anxiety occur more often in this population compared to a 
healthy population [61-64].  
This paragraph shows why it is important to pay attention to 
psychosocial aspects of both patients and their caregivers in the field of pediatric 
asthma: not only because psychosocial functioning is an important pillar of 
health in general (as outcome in Box 3) but also because psychosocial factors 
might influence the more physical component of asthma outcomes in various 
ways by interfering with immunological-physiological processes but also with 
disease management). 
 
Cystic fibrosis 
Somatic aspects of CF 
Cystic fibrosis (CF) is the most common lethal genetic disease among the 
Caucasian population. In the Netherlands, the overall birth prevalence was 1 in 
4,750 live births for 1974 to 1994, which is a considerable decrease compared 
with 1961 to 1965 (1 in 3,600 live births) due to genetic counseling and an 
increased number of newborns of non-European descent [2]. Despite advances 
in care and treatment modalities, CF is still a life-threatening disease, involving 
many organs especially the pulmonary, gastrointestinal and reproductive organs. 
CF is an autosomal recessive disorder, caused by genetic mutations in the CF 
transmembrane conductance regulator (CFTR) protein. This protein is 
responsible for the movement of chloride ions through the cell membranes. CF 
affects the secretory glands, including the glands that make mucus and sweat. 
Normally the mucus is a slippery, watery substance, but in patients with CF it is 
thick and sticky. This mucus builds up in the lungs and blocks the airways, which 
make it easier for bacteria to grow. The growth of these bacteria leads to 
repeated serious lung infections which damage the lung tissue and are 
accountable for declining lung function. Over time, permanent damage to the 
lungs can cause severe breathing problems. Respiratory failure is the most 
common cause of death in CF patients. Besides blocking the airways, the thick 
mucus can also block ducts in the pancreas, with the result that the digestive 
enzymes made in the pancreas cannot reach the small intestine. Without these 
enzymes the intestines cannot fully absorb fats and proteins. This can cause 
malnutrition, vitamin deficiency, bulky stools and severe constipation, pain or 
discomfort. CF is also associated with CF-related diabetes, osteoporosis, 
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infertility (in men) and reduced fertility (in women) [2, 65, 66]. The symptoms and 
severity of CF varies from person to person and also over time due to recurrent 
infections. In some patients, serious lung and digestive problems start early in 
life and in others they show up in late adolescence or adulthood. Because of the 
progressive nature of this disease, symptoms and treatments become more 
severe and complex over time.  
Treatment of CF comprises three important pillars or goals: (1) 
preventing and combating respiratory infections, (2) maintenance of general 
fitness and (3) maintenance of nutritional status. Fortunately, life expectancy of 
patients with CF has improved dramatically in recent years due to early 
diagnosis and better treatment options [2]. However, with this increasing life 
expectancy, patients with CF face other issues such as long term disease self-
management, development towards personal autonomy and identity, questions 
concerning family planning and worries about the future. It is now recognized 
that traditional measurements of the physiological status (e.g. lung function and 
body mass index) are inadequate to cover all aspects of the impact of CF on 
daily life and on the broader issues mentioned above [67]. From our research 
model this is understandable because many factors (background characteristics 
and mediating factors) are interrelated and influence health outcomes on 
physical, mental and social domains.  
 
Psychosocial aspects of CF 
CF poses a heavy burden on patients and their families (and especially on the 
caregivers) [68-70]. This burden is not only due to the unpredictable progressive, 
lethal course of the disease but also because of the high treatment burden. To 
achieve the goals mentioned above, patients must adhere to a daily, complex 
time-consuming treatment consisting of: inhalations, antibiotics, vitamins, 
enzymes, special breathing techniques, high calorie intake, exercise or 
physiotherapy, hygiene rules, segregation and, in some situations, antibiotics via 
portable infusion pumps, nocturnal tube feeding, insulin injections and oxygen 
therapy. These treatments take up to several hours per day depending of the 
stage of the disease [71]. Besides these daily treatments, patients are admitted 
to hospital frequently especially when lung capacity declines and infections occur 
more frequently. These examples show the direct link between disease 
characteristics, the mediating complex effect of treatment and different outcome 
measures (Box 1, 2 and 3 in our research model). 
Although increasingly researched, there is still no cure for CF. In 
contrast, patient are faced with more time-consuming treatment options in last 
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decades, making adherence to treatment more complex and more prone to non-
adherence [72]. Non-adherence to treatment can have detrimental effects on 
health outcomes in CF [73]. Treatment adherence rates for children and 
adolescents in CF are dramatically low and vary depending on the type of 
treatment and the method of measurement [74-79].Most of the rates reported 
were based on self-reports and might therefore be even an overestimation of 
actual adherence [74].  
Within this context it becomes more important to gain a better 
understanding about the different factors related to non-adherence. This better 
understanding can be the basis for improving the effectiveness of adherence 
interventions (and subsequently, have a positive effect on health outcomes). As 
discussed in the paragraph about adherence in asthma, reasons for non-
adherence to treatment for CF are also very diverse and differ for each patient. 
As in asthma, in CF, psychosocial problems (Box 1) seem to be one of the 
factors that can hamper adequate disease-management and can have a major 
impact on health outcomes. A number of studies have highlighted the link 
between psychosocial factors in CF and poor treatment adherence or problems 
with self-management [48, 80]. For example, Smith et al. showed that child 
depressive symptoms were significantly associated with lower rates of 
adherence to airway clearance [81]. There is also growing evidence that family 
relationships can have an effect on treatment adherence: In 2004 DeLamboo et 
al. showed an association between observed family relationship quality with 
treatment adherence in older children [82]. Because caregiver mental health is 
known to influence the child’s mental health and adaptation [15] and the fact 
that, especially in younger children, caregivers are responsible for treatment 
adherence it is important to take parental mental health into account. Mental 
health problems of caregivers may have a negative effect on treatment 
adherence and various health outcomes of the child.  
Fortunately, psychosocial research in CF has been given more attention 
in recent years. During the last North American Cystic Fibrosis congress in 
Anaheim (California) 45 abstracts within the psychosocial area were presented. 
However, comparing to asthma, literature on psychosocial factors in CF is still 
scarce. Literature is inconsistent about the prevalence rates of various 
psychosocial risk factors as anxiety or depression [81, 83-91]. Possible 
explanations for this inconsistency may include: the big time-span in which 
studies were performed (the life of a patient with CF 20 years ago is hardly 
comparable to living with CF in the year 2012), the measurement of different 
psychological concepts, different age- ranges of patients and different regions 
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and cultures. In a review of Cruz et al. (2009) it is stated that anxiety and 
depression appear to be more common in patients with CF than in the general 
population [80]. Besier et al. (2011) showed that more than one third of parents 
of young patients with CF showed elevated levels of anxious symptoms and 
significantly more parents reported elevated levels of depressive symptoms 
compared to a community sample [92]. In a study by Bregnballe et al. (2007) the 
children with CF did not differ from the norm group concerning depression, 
disruptive behavior and self-concept. However, young children with CF (7-10 
years) and boys with CF scored significantly higher on anxiety. Low forced 
expiratory volume in one second (a measurement of lung functioning) was 
associated with low self-concept and high anxiety in adolescent patients [93]. 
This paragraph shows that also in the case of CF, although there is no 
reason to assume that psychosocial factors intervene with physical health by 
means of psycho-physiological mechanisms (as seems to be the case in the 
onset and course of asthma), paying attention to psychosocial aspects in 
patients and their caregivers is important for health in general and also as a 
mediator in obtaining a good self-management.  
 
Patient-reported outcomes (PROs) in asthma and CF 
The last decades the care for patients with chronic illnesses has shifted from a 
hierarchical system (in which the doctor decided) to a more patient-doctor 
partnership (with shared decision making). The role of patients in care has 
shifted from a passive role into a more central, active role, in which patients are 
put more in control. The doctor is the expert in medical aspects, but only with the 
information of patients and caregivers about their own health beliefs, cognitions, 
behavior and emotions it is possible to achieve optimal patient-tailored care. This 
is also in line with shift of focus from survival rates to quality of life. 
Because of this paradigm shift, in current guidelines themes like disease 
management, self-management and patient-centeredness have gained 
increasing attention. As shown in our model, these concepts can mediate 
between background characteristics and different health outcomes. Moreover, 
they are not stable over time, but can be altered by means of psychological 
treatment. Parallel to this development, the measurement of how patients think 
and feel about their illness, treatments and different domains of health, is 
becoming increasingly important. Within this context, measuring patient and 
caregiver reported outcomes by standardized questionnaires is of growing 
interest in clinical care, especially in pediatric and adolescent care [94-96]. The 
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first prerequisite in providing individually tailored care is to know the uniqueness 
of the patient and to take these individual strengths and weaknesses into 
account. In asthma and CF, the last decades numerous new questionnaires 
have been specifically designed and evaluated to measure different aspects of 
health status and disease management aspects in these populations [97]. All 
these patient (and/or caregiver) reported outcomes measure different aspects of 
the subjective beliefs, thoughts and feelings of the most important partners in 
care; the patients and their relatives. Patient (and caregiver) reported outcomes 
can assess a wide range of psychosocial or more physical issues such as 
(health or disease-related) quality of life, psychosocial wellbeing and stressors, 
disease control, illness cognitions or barriers to treatment adherence. So, PRO’s 
can be used to gain more insights into all three boxes in our research model. 
Nowadays, for research purposes, patient reported outcomes are 
accepted and valued outcomes. Many studies about new treatments for asthma 
and/or CF use various PROs for measuring primary or secondary outcomes [98-
100]. In contrast to research, in clinical care, PROs have not yet been 
implemented on a wide scale. Many health care providers typically rely on the 
medical history, the physical exam and more or less on physiological parameters 
(such as blood tests, X-rays and scans). The perception about how patients 
and/or caregivers think and feel about their health status is, in most cases, not 
systematically assessed through validated questionnaires. Moreover, although 
many new PROs have been designed, it is difficult to find reliable instruments 
with good validity and adequate reference values for specific populations. 
 
Background and aim of this thesis 
This introduction shows that besides somatic factors, psychological and social 
factors of both young patients and their caregivers seem to play a vital role in the 
course of both asthma and CF. Patients’ and caregivers’ unique psychosocial 
characteristics can be assessed through patient and caregiver reported 
outcomes and may give valuable information which is of indispensable value in 
the care for chronic ill patients. However, assessment of patient reported 
outcomes has still hardly been implemented into clinical care in a systematic 
way. This may be due to several reasons and unanswered questions. Some of 
these questions are; Which factors are relevant to assess? Who should we ask; 
the patient or his caregiver(s)? Is assessing health related quality of life sufficient 
to provide an overall view? How are physiological parameters interrelated with 
patient reported outcomes? Which reference data and cut-off scores are useful? 
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In an attempt to reduce this gap in knowledge, we have conducted several 
studies in children and adolescents with asthma or CF, their caregivers, and 
healthy peers. This research is done with the aim to gain more insights into the 
various psychosocial parameters which are relevant to assess in asthma and 
cystic fibrosis care for young patients, and to answer some of the questions 
mentioned above. Part 1 (chapter 2, 3 and 4) focuses on pediatric asthma and 
part 2 (chapter 5 and 6) focuses on cystic fibrosis in young patients. The specific 
research objectives addressed in this thesis are mentioned in the following 
paragraph. 
 
Outline of the thesis  
Chapter 2 focuses on the psychosocial and environmental background 
characteristics (Figure 1, Box 1) and the physical outcome (Figure 1, Box 3): 
 
In Chapter 2 we review studies that investigate the longitudinal relationships 
between the psychological characteristics of children and adolescents suffering 
from asthma and those of their caregivers and the subsequent onset and course 
of the asthma.  
 
Chapters 3 and 4 focus on how diverse outcomes on the physical, mental and 
social domain are interrelated (Figure 1, Box 3): 
 
Chapter 3 describes a study on the prevalence of psychosocial problems and the 
way children with psychosocial problems are adequately identified by the most 
widely used questionnaire to measure asthma-related quality of life in children 
and adolescents with asthma. 
 
In Chapter 4 a study is presented on how asthma control is associated with 
psychosocial problems and other aspects of health status, such as airway 
inflammation and airway obstruction. This chapter also looks at the agreement 
between reports of adolescents and their caregivers on asthma control and 
psychosocial problems.  
 
Chapter 5 and 6 focus on health outcomes on the three domains of Box 3 and 
partly on the relationship with mediating factors out of Box 2 in our research 
model: 
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Chapter 5 describes various aspects of the psychosocial health of young 
patients with cystic fibrosis and their caregivers. This chapter is based on the 
international TIDES-study (The International Depression/anxiety Epidemiological 
Study).  
 
Chapter 6 focuses on a study in which data of healthy children and adolescents 
is used to increase our understanding of the most widely known CF specific 
health related quality of life instrument for children and adolescents with CF. 
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Abstract 
Objective: To systematically review all available studies that investigated the 
longitudinal relationships between the psychological characteristics of children 
and adolescents suffering from asthma and those of their caregivers, and the 
onset and course of the asthma. 
Methods: Relevant studies were identified using Medline, PubMed, and 
PsychINFO between 1970 and September 2009.  
Results: Twenty studies matching inclusion criteria were reviewed. Six studies 
focused on child-specific psychological characteristics in relation to the onset 
and course of asthma. No compelling evidence was found for an association with 
asthma onset, but there was some evidence that the child’s psychological 
characteristics can contribute to the subsequent course of asthma. Fourteen 
studies considered the effects of the psychological characteristics of the 
caregivers. Eleven studies found significant relationships between the 
psychological problems of caregivers and the subsequent onset and unfavorable 
course of the asthma in the child.  
Conclusion: In pediatric asthma both the psychological characteristics of the 
affected children and their caregivers appear to contribute to the course and 
possibly also to the onset of the condition.  
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Introduction 
With approximately 300 million persons currently suffering from asthma 
worldwide, this condition is one of the most common chronic diseases, especially 
in childhood [1]. Mean worldwide ‘current wheeze’ prevalence rates in the last 12 
months range from 11.6% in 6-7-year age children to 13.7% in 13-14-year-olds, 
according to phase III of the International Study of Asthma and Allergies in 
Children [2]. 
Recent epidemiological studies assessed the effects of psychosocial 
characteristics on the expression of atopic disorders. Besides studies on 
childhood asthma, Chida and colleagues reviewed the research on various other 
atopic disorders (e.g. allergic rhinitis, atopic dermatitis and food allergies) in both 
children and adults. They found robust, positive, and bidirectional associations 
between psychosocial factors and both the onset and prognosis of the conditions 
studied [3]. They, however, did not explicitly address the possible differential role 
that the characteristics of the children and parents or caregivers may play in the 
onset and course of asthma episodes in childhood and adolescence.  
It is important to differentiate between the child’s and caregiver’s 
psychological characteristics, because it is still not known how these factors are 
related which each other in the case of childhood asthma. Moreover, children 
and caregivers tend to have different perceptions of to what constitutes severe 
asthma [4]. In addition, differences between their personal characteristics may 
yield valuable information about the direction interventions should take, i.e., 
whether the treatment should focus more on the child or on the caregiver(s). It is 
also important to differentiate between different aspects of mental health. 
Depression, anxiety or stressful events require other interventions. 
In their meta-analysis of the data of nearly 5000 children suffering from 
asthma, McQuaid et al. found that these children had more psychological 
problems, especially internalizing problems, than their healthy peers [5]. The 
majority of the analyzed studies were cross-sectional, which therefore does not 
allow any conclusions to be drawn about causality. Several theories have been 
proposed to explain the mechanisms that relate psychological characteristics to 
asthma onset. As a result genetic, immunological, neural, endocrine, and 
behavioral pathways have been suggested as linking psychological 
characteristics to asthma onset, severity, and course. These pathways continue 
to be investigated [6-8]. Behavioral pathways include problems with treatment 
adherence and the effects of psychological problems on the perceptions and 
management of asthma by different informants. 
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It is important to ensure that psychological problems are detected early in 
asthmatic children, because there is evidence to suggest that such problems 
negatively affect the children’s treatment adherence, which is already notoriously 
low in this population [9, 10]. This may result in reduced physical and 
psychosocial health, and increased health care utilization and costs.  
Moreover, besides the children’s own psychological characteristics, 
psychological problems of their caregivers also tend to increase the risk of 
asthma onset or have a negative effect on the course of asthma [11-13]. If we 
are to improve psychosocial interventions that help enhance the children’s 
overall health status and reduce the burden of asthma on the patients and their 
families as well as on society, knowledge of the interrelationship between these 
personal characteristics of children and their caretakers and asthma outcome is 
crucial. In order to compile an overview of the insights to date, we conducted a 
systematic review of the available empirical research on the longitudinal 
relationship between specific psychological characteristics of healthy and 
asthmatic children or teenagers and their caregiver(s), and the onset and course 
of asthma. In our report we consider the psychological characteristics of both 
parties in terms of anxiety, depression or exposure to stressful events, which 
also includes parenting stress.  
 
Method  
Selection of relevant studies  
In this systematic review we evaluate reports published in peer-reviewed 
journals in English, German, French, and Dutch. The electronic databases of 
Medline, PubMed, and PsychINFO (between 1970 until the end of September 
2009) were used to identify relevant publications. In order to identify publications 
on the subject of psychological characteristics and asthma in children and 
adolescents, we used the search terms: (asthma) AND (psych* OR emotion* OR 
distress* OR depress* OR mental* OR adjustment* OR anxiety OR behavior* 
OR quality of life). We limited our review to studies that included participants ≤ 
18 years old. Since we were interested in longitudinal relationships between the 
psychological characteristics and the onset and course of asthma, we merely 
considered prospective (longitudinal) studies. We searched the reference lists of 
the studies in order to identify additional relevant studies, which we had not 
found with initial search strategies (snowball method).  
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Assessment of study quality 
Study quality was determined based on the protocols of the Cochrane Database 
of Systematic Reviews [14]. The inclusion criteria were adjusted to fit the 
research questions of our review:  
i. Database: English, German, French or Dutch language full-length 
publication in a peer-reviewed journal and abstract available in an 
electronic database. 
ii. Selection of subjects: the participants in the study should be ≤ 18 years 
old and selected randomly or consecutively. 
iii. Psychological characteristics (in children, adolescents or caregivers) 
such as anxiety, depression, behavior adjustment or general distress 
should be addressed through questionnaires or clinical interviews with 
proven reliability and validity, and should be compared with reference 
populations.  
iv. Outcome measures associated with asthma should concern asthma 
onset or asthma course and assessed by well-expressed child or 
parental reports, physical parameters or physician’s diagnosis.  
v. Study-design: Studies should have a prospective design investigating a 
longitudinal association between psychological characteristics of 
children or caregivers and the subsequent onset and/or course of 
asthma. 
vi. All studies were required to have reported statistics (e.g., means and 
standard deviations, t, F)  
Study inclusion and data extraction were conducted by the first author (MT) and 
verified by the second (CV). 
 
Presentation of the results 
We divided the relevant literature into prospective studies that investigated the 
child’s asthma manifestations in relation to the child’s psychological 
characteristics and those that examined them in relation to the caregiver’s 
characteristics. If one publication addressed both research questions, it was 
considered as two separate studies. 
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Results 
Our search strategy yielded 711 publications that addressed a wide range of 
topics related to psychology and asthma. The first author (MT) initially screened 
the titles and abstracts against the content and methodological criteria for 
review, which resulted in the exclusion of 643 articles. Table 1 shows the 
reasons for exclusion in this first round.  
 
Table 1 
Overview of the grounds on which studies were excluded based on abstract content 
 
   
Reason for exclusion   Total % 
   
Main focus on medical aspects  230 32 
Main focus on other diseases than asthma 128 18 
Main focus on interventions 77 11 
Main focus on sociodemographic, lifestyle or economic/epidemiological 
      aspects  
41 6 
Psychometric properties of questionnaires insufficient 38 5 
Participants older than 18 years 26 4 
Main focus on smoking behavior/exposure 27 4 
Main focus on association asthma and body weight 18 3 
Non-prospective (non-longitudinal) design 12 2 
Review 6 1 
No abstract available or not published in one of the target languages in  
       a peer-reviewed journal 
6 1 
Other (no focus on association between psychological characteristics  
       and asthma) 
34 5 
Potentially relevant articlesa 68 10 
   
Total 711 100 
 
a Publications meeting the criteria for review as based on abstract content 
 
 
The remaining 68 publications (10%) subsequently underwent a more detailed, 
second evaluation of their content and methodologies, after which 53 
publications were excluded. The reasons for this exclusion are detailed in Table 
2. The flowchart in Fig. 1 provides an overview of the inclusion and exclusion 
process. 
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Table 2 
Overview of the reasons for exclusion following the second screening 
 
   
Reason for exclusion Total % 
   
Psychological assessment inadequately defined  
 (no standardized measurements or inappropriate for this review) 
17 25 
Non-prospective 11 16 
No full-length article availablea 11 16 
Asthma outcome inadequately defined 5 7 
Focus on effect of asthma on psychological characteristics 3 4 
Overlapping report 2 3 
Participants older than 18 years 4 6 
Remaining publicationsb 15 22 
   
Total 68 100 
  
a Articles that were not automatically available as full length publications were obtained by 
contacting the first author if possible 
b Publications meeting the criteria for review as based on their content and methodological 
aspects 
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Figure 1. Flowchart showing the selection process of relevant studies and 
publications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ultimately 15 publications were included for review. They addressed 20 separate 
research questions pertaining to the association between psychological 
characteristics and the onset and course of asthma in the child [11-13, 15-26]. 
Different psychological inventories were used to assess various psychological 
characteristics [27-39]. The details of the studies reviewed are summarized in 
Tables 3 and 4 and discussed in the following paragraphs. 
 
Publications included for review (n=15) 
Publications retrieved for more detailed 
evaluation (n=68)  
Publications excluded after detailed scrutiny of 
their contents and methodology (Table 2) 
(n=53) 
Publications excluded on the basis of their titles 
and abstracts (Table 1) (n=643) 
Research questions addressed (n=20): 
- Prospective studies investigating relationships between child-specific 
psychological characteristics and the onset and course of asthma (n=6) 
- Prospective studies investigating relationships between caregiver-
specific psychological characteristics and the onset and course of 
asthma in the child (n=14) 
Potentially relevant publications identified 
and screened for retrieval (n=711) 
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Relationships with the child’s psychological characteristics 
Six studies examined associations between the child’s psychological 
characteristics and the onset and course of their asthma (Table 3) using various 
psychological inventories, with sample sizes ranging from 71 to 3575 and follow-
up times from two weeks to nine years. Psychological factors differed from 
internalizing problems and externalizing problems (such as behavior problems) 
to acute stress in terms of stressful events. Development or diagnosis of 
wheezing/asthma was only assessed by parental reports (no physicians’ 
diagnoses). One study based asthma course on peak-flow diaries [22] and one 
study assessed immune changes in the child’s blood [19]. 
 
Associations with asthma onset 
Three studies focused on the child’s psychological characteristics in relation to 
asthma onset [11, 15, 23]. One was a large-scale study examining 3575 healthy 
5-year olds. It concluded that internalizing problems (as measured by the Child 
Behavior Checklist) were not associated with the onset of asthma nine years 
later [15]. The study recoded internalizing symptoms into normal and abnormal 
symptoms using a cut-off score. The other two studies, which also used cut-off 
scores, concluded that externalizing problems (behavior problems as assessed 
with the Eyberg Child Behavior Inventory and Behavior Screening 
Questionnaire) were associated with the subsequent onset of wheezing or 
asthma [11, 23]. However, both were smaller scale studies with shorter follow-up 
times (18 months and two years, respectively). Assessing 411 healthy children 
Calam et al. found externalizing problems to precede the onset of wheezing with 
an odds ratio of 8.95 [11]. Investigating the effect of externalizing problems in 
265 children with atopic dermatitis Stevenson et al. found a small but significant 
odds ratio (1.15) between initial externalizing problems and the subsequent 
onset of asthma [23]. 
 
Associations with the course of asthma  
Three studies investigated children’s psychological characteristics in relation to 
the course of their asthma. They all concluded that psychological problems and 
exposure to severely stressful events increased asthma severity over time [19, 
22, 24]. One study examined the effects of exposure to acute and chronic stress 
(as measured by the Psychosocial Assessment of Childhood Experiences) on 
asthma severity in the following weeks (as based on peak-flow diaries) in 90 
children (aged 6-13 years) [22]. The combination of high chronic stress with 
acute stress correlated positively with the subsequent increased risk of new 
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asthma attacks. This result is in agreement with the finding of a recent study by 
Marin et al., in which 71 children with asthma (mean age 13 years) were 
included [19]. Children who had higher levels of chronic family stress showed an 
increased production of IL-4, IL-5, and IFN-γ at times when they had 
experienced an acute stressful event in the past 3 months. They also reported 
more asthma symptoms. The third study included 1260 children (aged 4-9 years) 
with asthma. It found that children with psychological problems (internalizing as 
well as externalizing problems as assessed with the Child Behavior Checklist) 
had more days of wheezing and a lower general functional status in the following 
nine months [24]. However, they had fewer hospitalizations than their peers 
without psychological problems and a similar number of unscheduled visits as 
these peers. 
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Relationships with the psychological characteristics of the child’s 
caregiver  
Eleven publications, which together address 14 research questions, reported on 
associations between the psychological characteristics of the child’s principal 
caregiver and the onset or course of asthma (Table 4). Sample sizes ranged 
from 50 to 13,907 children and follow-up times ranged from 6 months to 8 years. 
Different psychological characteristics of the caregivers were assessed: anxiety 
and depression (Center for Epidemiological Studies Depression Scale, Hospital 
Anxiety and Depression Scale and the Crown-Crisp Experiental Index), exposure 
to different types of stress (Perceived Stress Scale and Parenting Risk Scale), 
and more general psychological characteristics (Brief Symptom Inventory, 
physician’s diagnosis based on the International Classification of Diseases, and 
the General Health Questionnaire). 
Half of the studies assessed asthma outcome using parental reports, 
while physicians were involved in five studies and asthma-relevant markers such 
as eosinophil cationic protein (ECP) release and interleukin-4 (IL-4) production 
were examined in the child’s blood were assessed in three studies.  
 
Associations with asthma onset in the child 
Ten research questions (in eight publications) examined the psychological 
characteristics of the caregivers in relation to the onset of asthma in their 
children [11, 12, 17, 18, 20, 21, 25, 26]. Investigating three aspects, Calam et al. 
found that parental or caregiver depression, anxiety and psychiatric disorder 
were not associated with the development of wheezing in 411 healthy 3-year-old 
children two years later [11]. 
With regard to the other seven research questions, the studies in 
question found that caregiver psychological problems were associated with an 
increased risk of wheezing or asthma in the later lives of the children under study 
[12, 17, 18, 20, 21, 25, 26]. In the largest study Kozyrskyj et al. followed 13,907 
healthy 1-year-old children and found that maternal psychological problems from 
birth until the age of seven were associated with an increased risk of developing 
physician-diagnosed asthma with an odds ratio of 1.25 [12]. In a population-
based birth cohort of 5810 children Cookson et al. found that there was a higher 
likelihood of asthma at the age of 7.5 (OR, 1.64) in children of mothers in the 
highest quartile of anxiety scores compared with the lowest quartile of anxiety 
scores at 32 weeks of gestation [17]. Studying a cohort of 2888 children whose 
age was approximately 6 years and 6 months, Milam et al. found that parental 
stress led to more incidents of parent-reported wheezing in their child one year 
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later (approaching significance with an odds ratio of 1.18). In particular amongst 
boys with no parental asthma there was a strong dose-response relationship 
with an odds ratio as high as 2.76 [20]. Others also found that caregiver stress 
was associated with the subsequent onset of asthma in children under the age of 
eight with a family history of asthma [18, 21, 25]. The manuscripts of Mrazek and 
Klinnert report on the same cohort of children, with data from two distinct follow-
up periods. In a later study comprising 215 children with a family history of 
asthma Wright et al. found that caregiver stress in the first six months after birth 
was associated with an increased lymphocyte proliferative response, a higher 
total IgE, and an increased level of cytokine expression (TNF-α) two years later 
[26].  
 
Associations with the course of asthma in the child 
Three publications addressed four research questions pertaining to the 
psychological characteristics of the caregiver in relation to the course of the 
child’s asthma, and all found significant associations [13, 16, 24]. Assessing the 
mothers of 158 8-year-old children with asthma Bartlett et al. found that the 
mothers with depressive symptoms were more likely to take their child to the 
emergency department in the following six months [16]. 
In a large cohort of 1260 asthmatic children (aged 4-9 years) Weil et al. 
observed that psychological problems in caregivers were associated with more 
hospitalizations of the child in the following three to nine months, although the 
frequency of unscheduled visits, days of wheezing or lower general functioning 
status was not higher relative to those reported in the children of untroubled 
caregivers [24]. Wolf et al. found higher levels of parental depression (mean 
child’s age was 13.3, n = 50) to be associated with increased eosinophil cationic 
protein (ECP) release six months later, although the interleukin-4 production had 
not increased. Higher levels of parental stress were associated with both an 
increased ECP release and an increased IL-4 production [13]. 
 
Discussion and conclusion 
Discussion 
In this systematic review we evaluated 15 publications that addressed 20 
research questions pertaining to possible relationships between psychological 
characteristics and the onset or course of childhood asthma. Six of the research 
questions addressed associations with the child’s psychological characteristics. 
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The remaining 14 research questions addressed associations with the 
psychological characteristics of the child’s principal caregiver. 
Our evaluations showed that there was no compelling evidence that 
child psychological problems increased the risk of developing asthma. Results 
were conflicting and differences in the samples, assessment instruments and 
methods, follow-up times, and statistical analyses did not make it possible to 
draw firm conclusions about child characteristics contributing to asthma onset.  
The fact that Alati et al. failed to find any correlations between 
internalizing psychological problems in the child and the onset of asthma is 
somewhat remarkable, in view of the fact that in their large meta-analysis 
McQuaid et al. concluded that children with asthma had in particular more 
internalizing than externalizing disorders [5, 15]. A possible explanation could be 
that children who already suffer from asthma are at risk regarding the 
subsequent development of internalizing problems. Two other smaller studies 
concluded that externalizing problems preceded the onset of wheezing.  
There was some evidence that child-specific psychological 
characteristics contributed to an unfavorable course of the asthma over time. 
Two studies found that the combination of current high chronic stress and acute 
stress correlated positively with the subsequent increased production of immune 
markers and risk of new asthma attacks [19, 22]. Another study found that 
children with more psychological problems (internalizing as well as externalizing 
problems) had more days of wheezing and a lower general functional status in 
the following nine months. However, they also reported that the number of 
hospitalizations was lower with these children than with their untroubled peers, 
while the number of unscheduled health visits was similar [24]. Differences in 
measurements of psychological characteristics and asthma course made it 
impossible to draw a firm overall conclusion. 
The results for the onset of childhood asthma in relation to the 
psychological characteristics of the child’s caregiver were more unambiguous: 
except for one study that investigated three caregiver aspects [11], all other 
studies found significant, positive correlations. The caregiver’s self-reported 
stress and psychological problems appeared to be associated with a higher risk 
of asthma onset both in healthy children with a positive family history of asthma 
and in an overall healthy cohort [12, 17, 18, 20, 21, 25, 26]. In contrast, when 
Calam et al. tried to find associations between parental psychological problems 
and subsequent parent-reported onset of wheezing, they found none [11]. 
With regard to caregiver characteristics and the course of childhood 
asthma, three studies demonstrated that in children with asthma or children at 
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risk of atopy, the caregiver’s psychological problems and stress were associated 
with a higher risk of a less favorable course over time, as reflected in the higher 
number of emergency department visits [16] and elevated inflammatory and 
immunological markers in the children’s peripheral blood [13]. Surprisingly, Weil 
et al. found that, apart from more hospitalizations, the children of caregivers with 
psychological problems did not have more unscheduled health visits, days of 
wheezing or lower general functional status than the children with ‘healthy’ 
caregivers [24]. It was impossible to draw a firm, general conclusion again, 
because of major differences in study designs, psychological instruments, 
children’s ages, follow-up times, controlled covariates, and data analyses the 
various studies addressing caregiver involvement. In particular the fact that the 
assessed psychological characteristics differed completely (in nature, focus, and 
time period), made it impossible to gain insight into which psychological 
characteristics are more or less important in this complex but intriguing 
interaction between asthma and psychology.  
Our review once more shows that asthma is a complex disease of 
multifactorial etiology, subject to a wide range of genetic and environmental 
influences (both biological and psychological), and interactions between these 
factors.  
 
Strengths and weaknesses 
To our knowledge this is the first systematic review to specifically evaluate the 
available evidence of longitudinal relationships between the psychological 
characteristics of healthy and asthmatic children and adolescents, and their 
parents or caregivers and the onset and course of childhood asthma. However, 
given the nature of reviews, a positive publication bias that may have affected 
our conclusions cannot be excluded.  
Another point of concern is a methodological one: nearly all the studies 
we reviewed exclusively derived their information from self-report subjective 
questionnaires. This implies that the psychological problems of parents or 
caregivers may have affected their perceptions of illness and symptoms in the 
child in their care as well as their expectations concerning the child’s health, 
almost certainly in cases where the child was at risk of developing atopy or 
asthma. This does not only apply to the questionnaires inquiring about their own 
psychological characteristics and those of the children, but also to their 
interpretations of respiratory symptoms and diagnoses of asthma. In order to 
overcome this problem, a recent review by Everhart et al. suggests that 
researchers should consider using an informant other than the child’s parent 
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when other parent-report measures are used in their studies. [40]. Moreover, our 
review of the available results was hampered by the substantial differences in 
study designs and parameters. This obviously prevented us from basing a 
theoretical model on the likely underlying mechanisms, i.e. on how and 
especially which psychological characteristics interfere with the onset and course 
of childhood asthma. This means that we presently cannot answer the question 
whether we have to focus more on psychological problems (such as anxiety or 
depression) or on perceived stress. Because of the inconsistent reporting of 
statistics (and the many differences in designs, sample sizes, and parameters) in 
most included studies, we were not able to define effect sizes in an accurate 
way. For future reviews it would be useful to consider effect sizes and 
confidence intervals to strengthen methodological rigor and gain more 
knowledge of the magnitude of relationships between psychological 
characteristics and asthma outcome. 
Finally, our evaluation was one-sided, although we believe that there is 
a reciprocal, bidirectional relationship between psychological characteristics and 
asthma. In order to gain more knowledge of this complex interaction, it is 
therefore important that future research broadens its scope in both directions 
and considers the interrelationships between the child’s features and those of its 
parents or immediate caregivers in one design. 
 
Research recommendations 
Following the first research recommendations mentioned above, we believe 
future research should take the following points into consideration. First of all, 
asthma outcome should be optimized by including physicians’ diagnoses of 
asthma (preferably on the basis of international guidelines). Secondly, reliable 
and validated self-report instruments to monitor asthma control and asthma-
related quality of life should be used with records kept by both the caregiver and 
the child. Thirdly, a wide variety of medical parameters should be assessed 
(medication, unscheduled health, emergency department visits, hospitalizations, 
lung function tests, fractional exhaled nitric oxide or other inflammatory markers, 
and airway hyper responsiveness). In addition, the psychological characteristics 
of children as well as of caregivers should be assessed through standardized, 
validated instruments in sufficiently large samples composed of patients of 
varying ages. The psychological characteristics of the caregivers should be 
clearly subdivided into different concepts such as anxiety versus depression and 
exposure to stress (acute versus chronic). In children it seems important to 
differentiate between internalizing and externalizing problems. Follow-up periods 
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should be prolonged to allow children to be monitored from birth into 
adolescence. The interaction between genetic, biological and psychological 
features should be investigated in closer detail in order to gain a greater insight 
into this complex disease. Finally, associations between psychological 
characteristics and asthma merit reciprocal and bidirectional scrutiny. 
We expect that such sophisticated investigations into childhood asthma 
will enhance our understanding of the complex interrelationship between the 
psychological characteristics of children and their caregiver(s) and the onset and 
course of asthma. Ultimately this will help us to improve holistic interventions to 
reduce the burden of asthma and improve the quality of life of families who have 
children with asthma. 
 
Conclusion 
The reviewed studies strongly suggest that various psychological problems in 
children and their caregivers have an effect on the course of childhood asthma, 
perceived asthmatic symptoms, objective markers of atopy and inflammation, 
and, possibly, also on the onset of asthma.  
 
Practice implications 
Since the underlying mechanisms are unknown as yet and require additional 
research, no practical implications or recommendations can be given at this 
moment. 
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Abstract 
Background: Evidence shows that psychosocial problems among children and 
adolescents with asthma interfere with adherence to treatment and therefore 
need attention in asthma care. It is unknown whether the already frequently 
implemented asthma-related quality of life (QoL) instruments reflect psychosocial 
problems in children with asthma.  
Objectives: The aim of this study was to assess the relationship between 
asthma-related QoL and psychosocial problems and to determine whether an 
asthma-related QoL instrument is able to identify those children and adolescents 
with asthma with major psychosocial problems.  
Methods: In a multicentre study psychosocial problems (Strengths and 
Difficulties Questionnaire) and asthma-related QoL (Pediatric Asthma 
(Caregivers) Quality of Life Questionnaire) were obtained in children and 
adolescents with asthma aged 6-16 years and their caregivers.  
Results: A total of 339 children and adolescents (response rate 95%) from four 
pediatric outpatient clinics in the Netherlands with doctor-diagnosed asthma 
participated. Of the caregivers, 43% reported major or minor psychosocial 
problems in their child or adolescent, which is two times more than in the 
reference group, whereas the percentage of adolescents reporting psychosocial 
problems was comparable to a reference population. Adolescents and 
caregivers reported few impairments in asthma-related QoL (median score 
between 6.2 and 7.0). However, an optimal asthma-related QoL did not rule out 
major psychosocial problems: 10% of the adolescents with an optimal asthma-
related QoL score reported major psychosocial problems. And in one out of 
seven children with an optimal caregiver’s asthma-related QoL score, major 
psychosocial problems were reported.  
Conclusion: The prevalence of psychosocial problems in children and 
adolescents with asthma is considerable. Assessment of asthma-related QoL 
alone is insufficient to identify those children with major psychosocial problems. 
We recommend the implementation of psychosocial screening, besides 
assessment of asthma-related QoL, in routine pediatric asthma care, to improve 
asthma management.  
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Introduction 
In Western societies, 5-10% of children and adolescents have asthma, making 
this disease the most common chronic illness in childhood [1]. Despite growing 
treatment modalities, in a significant proportion of patients, asthma is not well 
controlled and patients continue to have symptoms [2]. In addition, young 
patients with asthma and their caregivers experience reduced quality of life 
(QoL) [3-5]. Furthermore, children and adolescents with asthma have more 
psychosocial problems than healthy peers, especially internalizing behavior 
problems (such as mood and anxiety disorders) [6-8]. Detection of psychosocial 
problems is relevant because it can be associated with reduced adherence to 
inhaled steroids, reduced asthma control, and more health care usage [9-12]. 
Although several studies recommend focusing on psychosocial problems in 
pediatric asthma, assessment of psychosocial problems is still not implemented 
in routine pediatric asthma care or clinical guidelines [13, 14].  
In contrast, measurements of asthma-related QoL have been introduced 
on a large scale as an indicator for treatment success. The most widely used 
asthma-related QoL measurement is Juniper’s Pediatric Asthma (Caregivers) 
Quality of Life Questionnaire, which addresses the evaluation of symptoms, 
limitations in activities, and emotional functioning due to asthma, but does not 
assess psychosocial problems in general [3, 4, 15]. 
A reason that assessment of psychosocial problems is not yet 
implemented in pediatric asthma care could be that pediatricians assume that 
assessment of asthma-related QoL is sufficient to reflect a child’s overall health 
status. We would challenge this assumption because asthma-related QoL 
instruments only focus on asthma related problems and not on general 
problems.  
Previous studies on the relationship between psychosocial problems 
and asthma-related QoL were based on small sample sizes and selected 
samples of patients [16, 17]. In both studies large time-consuming 
questionnaires were used, preventing implementation of the assessment in daily 
clinic practice. In the present study, we aimed to investigate with compact 
validated instruments, in a wide representative sample of children and 
adolescents with doctor- diagnosed asthma, the incidence of psychosocial 
problems in children and adolescents with asthma. In addition, we investigated 
to what extend asthma-related Qol assessment could identify children and 
adolescents with major psychosocial problems. We hypothesized that children 
and adolescents with asthma are at risk for major psychosocial problems 
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compared to a normative sample and that assessments of asthma-related QoL 
only partly succeed in identifying those children and adolescents with major 
psychosocial problems. 
 
Materials en methods 
Participants 
Participants were recruited from four pediatric outpatient clinics in the 
Netherlands, from one tertiary referral asthma center (University Lung Centre 
Dekkerswald, Groesbeek), and three regional hospitals (Canisius Wilhelmina 
Hospital, Nijmegen; Rijnstate Hospital, Arnhem; and Máxima Medical Center, 
Veldhoven). Between September 2007 and November 2008, all patients and 
their parent(s)/caregiver(s) visiting the outpatient clinic who fulfilled the inclusion 
criteria were invited to participate in the study. The inclusion criteria were: 
children and adolescents aged 6-16 years with asthma diagnosed by a 
pediatrician, informed consent of legal caregivers and adolescents and ability to 
understand and read the Dutch language.  
 
Measures 
Psychosocial problems  
Psychosocial problems of children were assessed with the Dutch version of the 
Strengths and Difficulties Questionnaire (SDQ) [18]. The SDQ is used as a valid 
instrument to assess a wide range of psychosocial problems including emotional 
symptoms, conduct problems, hyperactivity-inattention, peer problems and 
prosocial behavior [19, 20]. The questionnaire consists of 25 questions. The 
SDQ has been recommended as a tool in paediatric care to appropriately refer 
children at risk for major psychosocial problems to child mental health services 
[14]. Psychometric properties of the SDQ are comparable to those of the 
Achenbach System of Empirically Based Assessment [18, 21-23]. Caregivers of 
all children aged 6-16 years and adolescents aged 11-16 years were asked to fill 
out the SDQ. The reference data and cut-off scores were based on a general 
population study of 1,288 Dutch adolescents (age 11-16) and 285 caregivers 
[24]. Psychosocial problems between the 80th and 90th percentiles and above the 
90th of the reference group were classified as minor and major psychosocial 
problems, respectively. 
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Asthma-related QoL 
Asthma-related QoL of adolescents (11-16 years) was measured with the self-
report version of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) for 
children [3, 25]. It consists of domains related to emotions, activity, and 
symptoms, which are all equally weighted. Results were expressed by the 
median score per domain as well as by overall asthma-related QoL. The PAQLQ 
has been validated and is the best-established measure of asthma-specific 
health-related quality of life [26]. There are no official cut-off scores for the 
interpretation of the PAQLQ. Scores range from 1 to 7, with seven being 
indicative of optimal quality of life. 
 
Asthma-related QoL of caregivers  
Asthma-related QoL of all caregivers was measured with the Pediatric Asthma 
Caregivers Quality of Life Questionnaire (PACQLQ), which reveals how 
caregivers are limited in their own QoL due to their child’s asthma [4]. The 
domains relate to emotions and activity. Results are expressed by the median 
score per domain as well as by overall asthma-related QoL of caregivers. There 
are no official cut-off scores for the interpretation of the PACQLQ. Scores range 
from 1 to 7, with 7 being indicative of maximum quality of life. 
 
Procedure 
Formal approval was obtained from the medical ethics committee of the 
Radboud Medical Center and from the local medical ethics committees of 
participating hospitals. Written informed consent was obtained from caregivers 
and adolescents. Patients and caregivers filled out the paper-pencil versions of 
the questionnaires after visiting their pediatrician without help. For the children 
aged 6-10 years, only caregivers filled out the questionnaires. From the age of 
11 years both patients and caregivers filled out the questionnaires. 
 
Statistical analysis 
There are no official cut-off scores for the PA(C)QLQ to decide whether a 
specific score is normal or abnormal. For the purpose of this study we 
categorized the PA(C)QLQ scores into two categories: optimal versus 
suboptimal Asthma-related QoL (resp. PA(C)QLQ score = 7 and PA(C)QLQ 
score < 7). One sample t tests were used to assess differences between 
psychosocial problems of the study population group and those of the reference 
group. Spearman correlations were used to assess the correlation between 
psychosocial problems and asthma-related QoL of adolescents and caregivers. 
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All statistical tests used were two-tailed. The level of significance was set at 5% 
or corrected for multiple comparisons when applicable (Bonferroni). Data were 
analyzed with SPSS version 14.0. 
 
Results 
Patient Characteristics 
Informed consent was given for 339 out of 357 children and adolescents, (221 
boys and 118 girls) with a median age of 10 years (range, 6-16 years). There 
were 181 children aged 6-10 years (53%) and 158 adolescents aged 11-16 
years (47%). Eighty-three percent of the caregivers were married or living 
together, and 60% of the families included a parent who attended higher 
education or university. 26% of the children and adolescents visited a tertiary 
pediatric centre and 74% visited a general hospital. As little as 6% of the children 
and adolescents had reliever medication only (short acting β2-agonists), 68% of 
the children used normal doses of inhaled glucocorticosteroids (ICS), whereas 
26% of the children and adolescents used high doses of ICS or ICS with 
additional leukotriene modifiers or long acting inhaled β2-agonists.  
 
Psychosocial problems and asthma-related quality of life scores 
Table 1 and Fig. 1 show the percentages of major and minor psychosocial 
problems in the asthma population compared to a reference population. Data on 
psychosocial problems were normally distributed. On most domains caregivers 
of children and adolescents aged 6-16 years with asthma reported more overall 
psychosocial problems in their children compared to the reference group. 
Adolescents with asthma themselves did not report more overall psychosocial 
problems than the reference group. In contrast, they even reported fewer 
problems with peer relationships and reported higher scores on prosocial 
behavior. According to caregivers, 43% of asthmatic children aged 6-10 years 
had major (28%) or minor (15%) psychosocial problems. Caregivers of asthmatic 
adolescents aged 11-16 years reported similar numbers, whereas in the general 
population, 10% of the children have minor psychosocial problems and 10% 
have major psychosocial problems [24].  
Asthma-related QoL-scores were not normally distributed. Median 
overall asthma-related QoL score of adolescents in this population was 6.48 and 
median scores for the sub-domains were 6.30 (Symptoms), 6.20 (Activities), and 
7.0 (Emotions; Table 2), indicating that adolescents in this populations 
experienced few problems in their asthma-related QoL. Reports of caregivers of 
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children with asthma on their own asthma-related QoL also approached 
maximum scores (Table 2). 
 
Table 1  
Percentages of major and minor psychosocial problems in three different age-groups 
of children and adolescents with asthma 
    
 n Minor 
psycho-
social 
problems 
Major 
psycho-
social 
problems 
  
Caregiver-reported psychosocial problems (SDQ)of their child aged 6-10 years 
  Emotional symptoms a 181 15.5% 26.5% 
  Conduct problems a  181 17.7% 24.3% 
  Hyperactivity a  181 19.9% 24.9% 
  Peer problems a  181 12.7% 14.9% 
  Prosocial 181 8.8% 11.6% 
  Total problems a  181 14.9% 27.6% 
  
Caregiver-reported psychosocial problems (SDQ) of their child aged 11-16 years 
  Emotional symptoms a b 151 7.9% 29.1% 
  Conduct problems a  151 17.2% 21.2% 
  Hyperactivity a 151 20.5% 15.9% 
  Peer problems 151 10.6% 13.9% 
  Prosocial 151 12.6% 15.2% 
  Total problems a  151 13.9% 25.8% 
  
Self-reported psychosocial problems (SDQ) of adolescents aged 11-16 years  
 Emotional symptoms 149 14.1% 10.1% 
 Conduct problems 149 6.7% 5.4% 
 Hyperactivity 149 8.1% 13.4% 
 Peer problems a  149 6.7% 4.7% 
 Prosocial a  149 3.4% 2.0% 
 Total problems 149 10.1% 10.1% 
  
a  Significant difference (p ≤ .01) between mean scores of research population and 
mean scores from reference population based on t tests. 
b Numbers of adolescents and caregivers included were sometimes below numbers 
mentioned above due to missing values. 
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Figure 1   
Percentage major psychosocial problems in three different age groups compared to 
the reference population 
 
 
 
 
Table 2  
Descriptive data for asthma-related quality of life scores  
 
    
 n Range Median 
  
Asthma-related QoL of caregivers (PACQLQ) of children aged 6-10 years 
 Activities 177 3.00 – 7.00 6.75 
 Emotions 170 3.56 – 7.00  6.56 
 Overall QoL 176 3.38 – 7.00 6.54 
  
Asthma-related QoL of caregivers (PACQLQ) of children aged 11-16 years 
 Activities 151 4.00 – 7.00 7.00 
 Emotions 149 3.33 – 7.00 6.67 
 Overall QoL 152 3.54 – 7.00 6.69 
  
Self-reported asthma-related QoL of adolescents (PAQLQ) aged 11-16 years 
 Activities 143 2.00 – 7.00 6.20 
 Emotions 151 2.50 – 7.00 7.00 
 Symptoms 151 2.50 – 7.00 6.30 
 Overall QoL 151 2.39 – 7.00 6.48 
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Correlation between psychosocial problems and asthma-related QoL 
In adolescents self-reported psychosocial problems and asthma-related QoL 
were negatively correlated (r = -0.34, p <0.01; see Table 3): more psychosocial 
problems, and especially emotional symptoms, were related to lower asthma-
related QoL. Caregivers who reported more psychosocial problems in their 
children aged 6-16 years experienced lower asthma-related QoL (r = -0.36, p 
<0.01; Table 4), had more limitations in their own activities (r = -0.28, p <0.01), 
and worried more about their child’s asthma (r = -0.37, p <0.01). 
 
Identification of significant psychosocial problems on the asthma-related 
QoL assessments 
Table 5 shows the percentage of children with major psychosocial problems 
based on an optimal versus suboptimal asthma-related QoL-score of both 
caregivers and adolescents. In over one out of seven children (15.9%) with an 
optimal caregiver’s asthma-related QoL score, major psychosocial problems in 
the children were reported by caregivers. Of the adolescents with an optimal 
asthma-related QoL-score, 10% still reported major psychosocial problems.  
 
Table 3   
Spearman correlations between asthma-related quality of life (Asthma-related QoL) 
and self-rated psychosocial problems in adolescents aged 11-16 years  
 
     
 Self-reported asthma-related QoL of adolescents 
(PAQLQ) (age 11-16) 
 Overall 
(n=148) 
Emotions 
(n=148) 
Activities 
(n=140) 
Symptoms 
(n=148) 
  
Self-reported psychosocial problems (SDQ) 
 Total problems -0.34** -0.31** -0.33** -0.25** 
 Emotional symptoms -0.44** -0.44** -0.42** -0.34** 
 Conduct problems -0.05 -0.01 -0.08 -0.02 
 Hyper-activity -0.21** -0.20* -0.22** -0.16 
 Peer problems -0.13 -0.06 -0.14 -0.08 
 Pro-social -0.01 -0.03  0.01 -0.01 
   
* p ≤ .05, ** p ≤ .01 
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Table 4  
Spearman correlations between asthma-related quality of life (Asthma-related QoL) 
of caregivers and caregiver-rated psychosocial problems in their children with asthma 
aged 6-16 years  
 
    
 Asthma-related QoL of caregivers (PACQLQ) 
 Overall 
(n=325) 
Emotions 
(n=316) 
Activities 
(n=325) 
  
Caregiver-reported psychosocial  
problems (SDQ) of their child 
 Total problems -0.36** -0.37** -0.28** 
 Emotional symptoms -0.38** -0.38** -0.33** 
 Conduct problems -0.25** -0.28** -0.19** 
 Hyper-activity -0.22** -0.24** -0.15** 
 Peer problems -0.19** -0.19** -0.14* 
 Pro-social -0.02  0.03 -0.08 
  
* p ≤ .05, ** p ≤ .01 
 
 
Table 5   
Percentage of major psychosocial problems in different asthma-related QoL 
categories 
 
   
 % adolescent- reported 
major psychosocial 
problems (SDQ total) 
% caregiver- reported 
major psychosocial 
problems (SDQ total) 
   
   
   
Suboptimal asthma-related  
QoL of adolescents (PAQLQ < 7) 
10.6% (n=142) 26.2% (n=141) 
Optimal asthma-related  
QoL of adolescents (PAQLQ = 7) 
10,0 % (n=10) 10,0% (n=10) 
Suboptimal asthma-related 
caregivers QoL  (PACQLQ < 7) 
10.7% (n=112) 30.1% (n=256) 
Optimal asthma-related  
caregivers QoL  (PACQLQ = 7) 
10.8% (n=37) 15.9 % (n=69) 
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 Discussion 
This is the first multicenter study comparing general measurements of 
psychosocial problems assessed with a short but validated screening tool and 
asthma-related QoL of both children and caregivers in pediatric outpatient 
asthma clinics in a substantial sample. In addition, it is the first study on 
psychosocial problems and asthma-related QoL, in which all patients had 
asthma diagnosed by doctors.  
This study has two relevant findings. First, caregivers of children and 
adolescents with asthma reported high rates of major psychosocial problems in 
their children. Over 40% of the children and adolescents aged 6- 16 years with 
asthma had major or minor psychosocial problems according to their caregivers. 
This means that psychosocial problems are about twice as prevalent as in the 
normal population and related to emotions, conduct, hyperactivity, and problems 
in peer relationships. Adolescents themselves did not report these problems, and 
even reported fewer problems with peers and more prosocial behavior than the 
reference group.  
The second major finding is that an optimal or suboptimal asthma-
related QoL does not rule out major psychosocial problems. Despite the fact that 
in a large part of our population, major psychosocial problems were reported by 
caregivers, median asthma-related QoL was rather good. One out of ten 
adolescents with an optimal asthma-related QoL score reported major 
psychosocial problems in about 16% of the children. This shows that even major 
psychosocial problems in children and adolescents with asthma are not 
necessarily reflected by a much lower asthma-related QoL. Overall self-reported 
psychosocial problems of adolescents with asthma correlated only weakly 
(explained variance <16%), with aspects of asthma-related QoL. Such a 
relationship was also found in the asthma-related QoL of caregivers. More 
caregiver-reported psychosocial problems in their child were related to slightly 
more limitations in the activities of caregivers and slightly more worries about 
their child’s asthma. This finding shows that there is some relationship between 
asthma-related QoL and psychosocial problems in general but that these two 
concepts are clearly not interchangeable. 
One of the reasons why we found high asthma-related QoL scores could 
be that the PAQLQ provides short-term information (about the past week). 
Because asthma is a highly variable and unpredictable disease, it is possible 
that the perception of asthma-related QoL of the past week does not correlate 
well with asthma-related QoL over a longer period of time. If patients do not 
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experience asthma-related symptoms, limitations, and negative emotions in the 
past week, asthma-related QoL may mask the way asthma negatively affects 
their QoL over a longer period of time. Another explanation might be that we only 
included patients who attended the outpatient clinics on the basis of 
nonemergency scheduled visits. This could mean that these patients had more 
asthma control at the time of the study. On the other hand, this reflects the daily 
life situation: the vast majority of asthma patients visiting their physician will do 
so on scheduled visits.  
Because of the cross-sectional nature of the study, no statements about 
causality of these effects can be made. In this study we did not include teachers’ 
perception of psychosocial problems. Adding this informant to future studies 
might add valuable information about whether psychosocial problems are also 
observed outside the family context. The same goes for self-report asthma-
related QoL and psychosocial problems in children aged 6-10 years. Because 
psychosocial problems in children with asthma negatively affect adherence to 
treatment [9-12], early detection and treatment of psychosocial problems may 
improve adherence and, subsequently, asthma control. However, randomized 
controlled trials are needed to evaluate efficacy of screening for and treating of 
psychosocial problems in pediatric asthma care. 
We conclude that assessment of asthma-related QoL (based on the PA(C)QLQ) 
is insufficient to provide a description of a child’s overall health status. Based on 
our findings we recommend the addition of a psychosocial screenings instrument 
in routine pediatric asthma care. 
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Abstract 
Background: Many adolescents have poor asthma control and are at high risk 
for psychosocial problems. However, structured assessment of asthma control or 
psychosocial problems is still not implemented in routine asthma care. 
Pediatricians typically rely on their clinical view and physiological measurements. 
To date, it is unknown whether clinical and patient reported outcomes are 
interrelated. Furthermore, there is no consensus on who should be the 
informant; the adolescent or his caregiver. 
Study aim(s): This study aimed to assess the relationship between patient and 
caregiver reported outcomes (Asthma Control Questionnaire and Strengths and 
Difficulties Questionnaire (SDQ)) and physiological parameters (FEV1 and 
Fractional exhaled Nitric Oxide) in adolescents (aged 11-16) with asthma.  
Methods: A multicenter observational study was performed in four Dutch 
pediatric outpatient departments. Association between asthma control, 
physiological parameters, and results of psychosocial questionnaires completed 
by both adolescent and caregiver was analyzed. 
Results: Forty-eight adolescents and their caregivers participated in this study. 
Asthma was uncontrolled in about 30%. Asthma control was not associated with 
age, gender, FEV1, FeNO, or psychosocial problems. Agreement between 
adolescents and caregivers about how well asthma was controlled was 
moderate (κ = 0.577, p < 0.01).  
Discussion: Asthma control, physiological parameters and psychosocial 
problems are different domains of health status. It could be suggested to use 
validated patient and caregiver reported outcomes in routine adolescent asthma 
care. 
Conclusion: Patient and caregiver reported outcomes on asthma control and 
the presence of psychosocial problems add valuable, unique information to 
physiological parameters in adolescent asthma management. 
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Introduction 
Asthma is the most common chronic illness in childhood [1]. Traditionally, 
asthma management focused on conventional physiological parameters such as 
forced expiratory volume in 1 sec (FEV1). Modern asthma management 
however, has shifted towards achieving optimal asthma control. Patients with 
well-controlled asthma are defined by the international guidelines issued by the 
Global Initiative for Asthma (GINA) as patients who can avoid troublesome 
symptoms during days and nights, use little or no reliever medication, have 
productive, physically active lives, have (near) normal lung function and who can 
avoid serious attacks [2]. Despite the availability of effective therapies asthma 
control is generally low and many children and adolescents continue to have 
symptoms, experience lifestyle restrictions, and require emergency care [3].  
Several factors may interfere with asthma control. Besides airways 
obstruction, airway inflammation is one of these factors. Fractional exhaled Nitric 
Oxide (FeNO) as a measurement of airway inflammation seems to be associated 
with disease control in children and adults [4]. However, studies combining the 
measurement of airway inflammation and airways obstruction in relation to 
asthma control are rare in childhood and results are conflicting [5-9]. 
Psychosocial problems may also interfere with asthma control, and 
children and adolescents with asthma were found to be at a higher risk with 
regard to psychosocial problems [10-12]. We recently observed that over 43% of 
the parents of children with asthma in a pediatric outpatient department report 
clinically significant psychosocial problems in their child [13]. Psychosocial 
problems may contribute to poor asthma control in various ways, including 
behavioural pathways (through diminished adherence to treatment), 
psychological pathways (e.g. symptom perception) and biological pathways 
(neural and immunological) [14-20]. These mechanisms are complex, not 
understood very well and are therefore the focus of extensive research.  
 Although the main treatment goal in the care for patients with asthma is 
the achievement of good asthma control, its systematic measurement is still not 
implemented in clinical care on a large scale. Many physicians solely rely on the 
combination of physiological measurements (such as FEV1% and FeNO) and 
their clinical view, the latter mainly based on the patient’s history. However, 
clinicians, caregivers and patients tend to overestimate asthma control [3, 21-
23]. Both patients and physicians often consider asthma to be controlled, 
although this may not be the case according to current guidelines [24]. Patients 
seem to think that their asthma is controlled even better than physicians when 
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they rate their overall asthma control on an ordinal scale from 1 (very poor) to 5 
(very good) and not on a validated questionnaire [24]. Therefore, implementing 
the systematic use of Asthma Control Questionnaires (ACQs) in clinical asthma 
care could be an important improvement. 
 In the care for adolescents with asthma another question is yet 
unanswered: which informant provides the most valuable information about 
asthma control; adolescents themselves or their caregivers? Very little is known 
about the agreement between adolescent and caregiver responses to questions 
about asthma-related items [25, 26]. To our knowledge, there have been no 
studies comparing asthma control reported by caregivers and by adolescents, 
based on an ACQ. The same applies for measuring psychosocial health in 
adolescents with asthma. 
Comprehensive knowledge of the various factors contributing to asthma 
control and how to measure these in clinical care is essential to reduce the 
burden of asthma in the pediatric population.  
This study has two aims: (1) To analyze the relationship between 
asthma control and physiological measurements and psychosocial problems, 
and (2) to assess the agreement between caregivers and adolescents on both 
asthma control and reporting of psychosocial problems. We hypothesized that 
asthma control, physiological parameters and psychosocial problems as 
reported by the adolescent and caregivers can be partly related to each other. 
On the other hand we believe that they all provide unique and additional 
information to the clinical view of the physician and are therefore important 
factors to assess in clinical asthma care.  
 
Materials and methods 
Participants 
This study was part of a larger-scale study on asthma-related quality of life and 
psychosocial problems, in which participants were recruited from four pediatric 
outpatient clinics in the Netherlands (University Lung Centre Dekkerswald, 
Groesbeek; Canisius Wilhelmina Hospital, Nijmegen; Rijnstate Hospital, Arnhem; 
and Máxima Medical Center, Veldhoven) [13]. Between September 2007 and 
November 2008 all patients and their caregiver(s) visiting the outpatient clinic for 
regular control visits , and who fulfilled the inclusion criteria were invited to 
participate in this study. The inclusion criteria were: children and adolescents 
aged 6-16 years with asthma diagnosed by a pediatrician, informed consent of 
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legal caregivers and adolescents and ability to understand and read the Dutch 
language.  
For the present study inclusion criteria were refined to: adolescents 
between the age of 11 and 16 years who were diagnosed with asthma by a 
pediatrician, informed consent of legal caregivers and adolescents, the ability to 
understand and read the Dutch language, complete data on the questionnaires 
reported by adolescents and their caregivers and measurements of FeNO or 
FEV1% on the same day.  
In the original study 156 adolescents between 11 and 16 years of age 
participated. One hundred eight adolescents were excluded from the current 
study mainly due to missing physiological measurements on the same day. 
Eventually 48 adolescents were included in the current study. One-way analysis 
of variance revealed there were no significant differences between these two 
groups with respect to age, asthma control and psychosocial problems. 
 
Measures 
Asthma control  
Asthma control in adolescents was assessed by using the six-item original Dutch 
version of the Asthma Control Questionnaire (ACQ) [27, 28]. The ACQ, which 
was developed by Juniper and colleagues, is a reliable and validated instrument 
to measure asthma control. The ACQ has strong measurement properties and 
was validated for use in children 6-16 years [29]. Patients between 11 and 16 
years of age and their caregivers were asked to recall their respiratory health 
status (or the respiratory health status of their child) during the previous week. 
Scores on each question range from 0 (well controlled) to 6 (extremely poorly 
controlled). All six questions were equally weighted and therefore the ACQ score 
is the mean of all responses. Patients were considered to be well controlled 
when the ACQ score was ≤0.75, partly controlled when the ACQ score was 
between 0.75 and 1.5, and uncontrolled when ACQ score was ≥1.5 [29, 30]. 
 
Physiological parameters (Airways obstruction and airway inflammation) 
Airways obstruction was assessed using the Forced Expiratory Volume in 1 sec 
(FEV1) during the visit to the pediatrician. Spirometry was conducted according 
to ATS/ERS guidelines and measurements were expressed as percent predicted 
(FEV1%) [31]. Measurements of FeNO were used as a marker of eosinophilic 
inflammation, expressed in parts per billion (ppb). FeNO was obtained as 
described previously and applied as a continuous variable in the data analyses 
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[32]. Spirometry and FeNO were measured with the same equipment and were 
calibrated according to the same guidelines and protocol in all centers. 
 
Psychosocial problems 
Psychosocial problems of children were assessed with the Dutch version of the 
Strengths and Difficulties Questionnaire (SDQ) [33]. The SDQ is used as a valid 
instrument to assess a wide range of psychosocial problems, including emotional 
symptoms, behavioral problems, inattention and hyperactivity, peer problems 
and prosocial behavior [34, 35]. The questionnaire consists of 25 questions. The 
SDQ has been recommended as a screening tool in pediatric care to identify and 
refer children at risk for major psychosocial problems to child mental health 
services in an appropriate way [36]. Its scores vary between 0 and 40 points, 
and the normal range in the general population is between 0-10 points for overall 
problems reported by caregivers and 0-13 points for overall problems reported 
by adolescents. The reference data and cut-off scores were based on a general 
population study of 1,288 Dutch adolescents (age 11-16) and 285 caregivers 
[37]. Psychometric properties of the SDQ are comparable to those of the 
Achenbach System of Empirically Based Assessment [33, 38-40]. Caregivers 
and adolescents were asked to fill out the SDQ and report about the last six 
months. The questionnaires were retrieved from the following website; 
http://www.sdqinfo.com/. 
 
Procedure 
After visiting their pediatrician, patients and caregivers filled out the paper-pencil 
versions of the questionnaires without any help. This study was approved by the 
medical ethics committee of the Radboud University Nijmegen Medical Center 
and the local medical ethics committees of participating hospitals. Written 
informed consent was obtained from caregivers and adolescents.  
 
Statistical analysis  
Descriptive statistics were used for this observational study. One-way analyses 
of variance tests were used to assess potential gender differences. Non-
parametric tests were used because not all variables were normally distributed. 
Spearman’s rank correlation coefficients (Spearman’s ρ) were calculated to 
study the correlations between the variables. The κ statistics was used to assess 
agreement between patients and caregivers on the asthma control score and the 
psychosocial problem score. The level of significance was set at 5%. All 
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analyses were carried out with the statistical software package SPSS version 
16.0.  
 
Results 
Demographic Characteristics 
The mean age for the 48 adolescents (29 males) participating in this study was 
13.3 years (SD: 1.5; range: 11-16). Asthma was not well controlled (ACQ > 0.75) 
according to adolescents and caregivers in 35% and 29%, respectively. None of 
these patients used oral steroids. Forty-six of 48 adolescents used ICS. In 24 
patients LABA medication was added. Seventeen of the participating 
adolescents were prescribed anti-allergic medication and five patients used 
LTRA besides their ICS or LABA. A more detailed description of the patient 
characteristics and descriptive of relevant variables is presented in Table 1. 
 
Correlations between asthma control, physiological parameters and 
psychosocial problems  
Asthma control reported both by adolescents and by caregivers was not 
significantly correlated with any of the following variables: age, gender, airways 
obstruction (FEV1), airway inflammation (FeNO) or the presence of psychosocial 
problems (Table 2). There was no significant correlation between FEV1 and 
FeNO (Spearman’s ρ = 0.087, p = 0.56). 
 
Agreement between reports of adolescents and caregivers on asthma 
control and psychosocial problems  
Table 3 shows the crosstabulations for agreement between reports of 
adolescents and those of caregivers on asthma control, respectively. Agreement 
between adolescents and caregivers on asthma control was moderate (κ = 
0.577; p < 0.01): in 79% (n=38) of cases, caregivers and adolescents rated the 
same degree of asthma control. Five adolescents (10.4%) rated their own 
asthma control as better controlled than their caregivers and vice versa.  
Less agreement between caregivers and adolescents was observed in 
reporting psychosocial problems (κ = 0.211; p < 0.05). Table 4 shows that in 
66.7 % (n=32) of cases, caregivers and adolescents rated psychosocial 
problems similarly. In 13 cases (27.1%), caregivers reported more (and more 
severe) psychosocial problems than the adolescents. In only three case (6.3%) 
adolescents reported more psychosocial problems compared to the reports of 
their caregivers.  
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Table 1 
Patient characteristics (n = 48) 
 
  
Variable N (%) 
  
Gender 29 (60.4%) males; 19 (39.6%) females  
      
 Mean SD Median Min. Max. 
      
Age 13.27 1.47 14 11 16 
FeNO 25.43 27.74 12 5 123 
FEV1% 93.92 13.29 95.5 54 120 
Psychosocial problems  
    (caregiver-reported) 
9.17 6.07 7.5 0 30 
Psychosocial problems  
    (adolescent-reported) 
8.31 4.91 8 1 21 
Asthma control (caregiver-reported) 0.60 0.79 0.25 0 3.5 
Asthma control (adolescent-reported) 0.75 0.82 0.58 0 3.33 
  
    
 Well  
controlled 
(%)  
(ACQ ≤ 0.75)  
Partly  
controlled 
(%) 
(0.75 < ACQ < 
1.5) 
Un 
controlled 
(%) 
(ACQ ≥ 1.5) 
    
Asthma control (caregiver-reported) 34 (70.8%) 6 (12.5%) 8 (16.7%) 
Asthma control (adolescent-reported) 31 (64.6%) 10 (20.8%) 7 (14.6%) 
    
 No 
problems 
(%)  
Minor 
problems  
(%) 
Major 
problems  
(%) 
    
Psychosocial problems (caregiver-
reported) 
31 (64.6%) 8 (16.7%) 9 (18.8%) 
Psychosocial problems (adolescent-
reported) 
41 (85.4%) 3 (6.2%) 4 (8.3%) 
    
FeNO = Fractional exhaled Nitric Oxide (ppb); FEV1% = Forced Expiratory Volume in 1 second 
(percentage predicted) SD = Standard Deviation; Min. = minimum; Max. = maximum. 
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Table 2  
Spearman’s rho correlations between asthma control and the independent variables 
age, FEV1%, FeNO, and psychosocial problems; a one-way analysis of variance 
between asthma control and gender 
 
 
Independent variable 
Asthma control  
(caregiver-
reported) 
Asthma control 
(adolescent-
reported) 
   
FEV1% 0.148(NS) 0.237(NS) 
FeNO 0.185(NS) 0.064(NS) 
Psychosocial problems (caregiver-reported)  0.019(NS) -0.105(NS) 
Psychosocial problems (adolescent-reported)  0.123(NS) 0.058(NS) 
Gendera 1.749(NS) 3.774(NS) 
Age -0.015(NS) -0.018(NS) 
   
a F-values are given 
FeNO = Fractional exhaled Nitric Oxide (ppb); FEV1% = Forced Expiratory Volume in 1 second 
(percentage predicted), NS = Not Significant 
 
 
Table 3 
Cross tabulation between asthma control reported by adolescents and asthma 
control reported by caregivers 
 
 Asthma control reported by adolescents 
 Well-
controlled 
Partly-
controlled 
Uncontrolled Total 
Asthma control reported by  
caregivers 
   
Well-controlled 29 3 2 34 
Partly-controlled 2 4 0 6 
Uncontrolled 0 3 5 8 
Total 31 10 7 48 
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Table 4 
Cross tabulation between self-reported psychosocial problems of adolescents and 
psychosocial problems reported by their caregivers 
 
 Psychosocial problems reported by adolescents 
 No 
problems 
Minor 
problems 
Major 
problems 
Total 
Psychosocial problems reported 
by caregivers 
    
No problems 30 1 0 31 
Minor problems 6 0 2 8 
Major problems 5 2 2 9 
Total 41 3 4 48 
 
 
Discussion 
This study addressed the relationship between self- reported and caregiver-
reported asthma control on the one hand, and physiological parameters (FEV1% 
and FeNO) and psychosocial wellbeing (reported by adolescents and their 
caregivers) on the other hand in asthmatic adolescents. This has not been 
studied before, and there were some major relevant findings.  
First, in agreement with previous research, we could not demonstrate 
any significant correlation between asthma control and the degree of airways 
obstruction or FeNO, nor a significant correlation between the two physiological 
parameters FEV1% and FeNO. Unfortunately we did not have any data on FEV1 
reversibility after short acting beta2 agonist and its correlation with FeNO, 
asthma control or psychosocial problems. We did find that in more than 29% of 
the adolescents their asthma was not well-controlled. Based on only FEV1% 
and/or FeNO, patients could have been considered well controlled during their 
health visit while in fact they report poor asthma control on a validated 
questionnaire. As mentioned in the introduction, clinicians, patients and 
caregivers tend to overestimate asthma control when measurement of asthma 
control is not based on a validated questionnaire [3, 21, 22]. Therefore in order 
to identify adolescents with un- or partly controlled asthma in an adequate way, 
physiological measurements and the clinical opinion of the physician should be 
combined with the results of a validated asthma-control questionnaire. This 
recommendation is supported by a recent article of Koolen et al. in which they 
recommend the use of a web-based validated questionnaire to assess asthma 
control in clinical practice [41]. 
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The second finding is that there is moderate agreement between adolescents 
and their caregivers on how they report on an asthma control questionnaire. For 
clinical care this indicates that adolescents from the age of 11 seem capable of 
providing reliable information. Clinicians do not have to rely solely on the report 
of caregivers, but can use the information from the adolescent to promote 
shared-decision making. By paying attention to reports of the adolescents 
themselves, physicians can enhance adequate self-management. The use of the 
asthma control questionnaires can therefore help adolescents to achieve good 
symptom perception and it could be a useful tool to teach them when their 
asthma is not well controlled and what they can do about this. 
We found no significant correlation between psychosocial problems and 
asthma control. Previous research showed that patients with asthma tend to 
have more psychosocial problems [12]. Psychosocial problems can negatively 
interfere with adherence to inhaled steroids, asthma control and more health 
care usage [15-17, 42]. Although we did find elevated scores for psychosocial 
problems (reports of caregivers were almost doubled compared to a normative 
sample), we did not find these problems when we asked the adolescents 
themselves. Adolescence is a specific time period in which children grow into 
adulthood and adolescents want to be as ‘normal’ as possible. Being part of a 
peer group is a very important topic in adolescence. Especially in a chronically ill 
population in which adolescents already have medical problems which 
differentiate them from healthy peers, underestimation of psychosocial problems 
as reported by the adolescent may explain the discrepancy between caregivers 
and adolescents in this study. We therefore suggest to integrate reports from 
both adolescents and caregivers on psychosocial wellbeing of the child in routine 
asthma care. If only the adolescents with asthma themselves were asked how 
they feel, those patients at risk for major psychosocial problems are likely to be 
missed.  
One of the reasons why we did not find any correlation between 
psychosocial problems and asthma control can be the difference in time intervals 
in which the two questionnaires gather information about symptoms: The ACQ 
only addresses symptoms during the last week, whereas the SDQ asks for 
symptoms of the past 6 months. It is possible that in the past week asthma 
control was rather good, compared to that in previous weeks. We therefore 
cannot exclude an overall overestimation of the degree of asthma control. For 
this reason it is advisable to assess asthma control on a more regular basis or to 
ask patients at their health visit whether the last week was representative for the 
period since their last visit. To avoid recall-bias the first option will probably be 
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better but has the disadvantage that many adolescents do not want to spend too 
much time on assessing their asthma control regularly. Specific interventions 
adjusted for adolescents, such as using modern communication techniques, may 
solve this problem. 
One other reason why no significant correlations were found could be 
the relative small sample size of this study. Because no pilot study was 
performed it was not feasible to conduct a power calculation before the start of 
the study. However, we reasoned that, if we could not demonstrate any 
statistically significant correlations between these variables in a study population 
of this size, any possible correlations are unlikely to be strong and relevant for 
daily practice. Similarly, for clinical practice this implicates that the various 
parameters are therefore not interchangeable because they all measure different 
aspects of overall health of these adolescents with asthma. A basic power 
analysis at the start of this study would have given us information about the 
sample sizes needed to avoid a type II error. However, it would not give any 
information about the clinical relevance of the findings. For that reason, a post 
hoc power analysis was performed in which the difference in FEV1% which could 
have been found in the two groups (34 adolescents with well-controlled asthma 
and 14 patients with un- or partly controlled asthma) was calculated. This 
calculation demonstrated that the power of the present study was sufficient to 
detect a difference of FEV1 of 11% (which is also clinically relevant) with a 
power of 80% (α = 0.05 and β = 0.2). We recommend for future studies to 
expand the research population in order to do post analyses on potential gender 
or age-related differences.  
A second limitation of this study is the fact that there is information 
lacking about the degree of atopy of our patients. Although we had no indication 
that in the present group of participants a disproportional percentage of non-
allergic patients were included, a large percentage of non-allergic adolescents 
could have masked the potential relation between asthma control and FeNO. For 
future studies we advise to also assess and include the degree of atopy of the 
participants. 
The high percentage of adolescents who received LABA (50%) may 
have influenced the way asthma activity in the lungs was masked. A treatment 
with LABA can have an effect on symptom perception, FEV1% predicted and 
both patient and caregiver-reported asthma control. Therefore the percentage of 
adolescents with good reported asthma control might have been overestimated 
in this study. In a larger scale study the effect of medication or asthma control on 
the relationship between the various variables can be studied.  
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Conclusion 
This study demonstrates once again that asthma is a complex disease, and that 
merely physiological parameters are insufficient to provide a picture of overall 
physical and mental wellbeing of the adolescent with asthma. The variables 
studied (FEV1%, FeNO, asthma control, and psychosocial problems) all measure 
different domains of health status that are relevant for the patient and his asthma 
management. These factors are therefore not interchangeable; they all provide 
unique and valuable information about a child’s overall health status. Future 
research should focus on the interrelationship between these factors 
longitudinally in a larger group and on how measuring these factors can improve 
the assessment of the health status in adolescent asthma care. Adding the 
assessment of asthma control and psychosocial problems (using standardized 
and validated questionnaires) to routine asthma care procedures can improve 
our understanding of this complex disease. It will help us to create individually 
tailored interventions, to optimize adherence to treatment and asthma control 
and ultimately it may reduce the burden of asthma in adolescents with asthma.  
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Abstract 
Background: Cystic fibrosis (CF) poses a heavy burden on patients and their 
families, not only because of the physical manifestations of the disease, but also 
because of complex and time-consuming daily treatments required to manage a 
disease which still shortens lifespan. Previous literature shows that patients with 
CF and their caregivers have elevated levels of depression and anxiety. These 
problems affect health in general but have also been shown to negatively 
influence adherence and thereby worsening physical outcomes. Current studies 
are rare and inconsistent in terms of prevalence estimates and few studies have 
examined other important psychosocial health problems or risk factors, besides 
anxiety and depression. This study aimed to remediate these gaps in knowledge.  
Methods: This cross-sectional study recruited adolescents (aged 12-17), young 
adults (aged 18-35), and caregivers (of children aged 1-17) from all seven cystic 
fibrosis centers in the Netherlands. Participants completed standardized 
screening measures of anxiety, depression, psychosocial problems, illness 
cognitions, treatment adherence, CF-specific health related quality of life and 
parenting stress.  
Results: 383 patients and 266 caregivers participated. Twenty percent of the 
young adults and 17% of adolescents with CF reported elevated 
symptomatology. Approximately one third of caregivers reported elevated 
psychosocial health problems in their child or adolescent and 28% of all 
caregivers reported elevated levels of psychosocial health problems themselves. 
Overall, adults with CF reported more psychosocial health problems than 
adolescents. Self- and caregiver-rated reports of good treatment dropped from 
64% to rates below 20% from childhood to adulthood.  
Conclusion: Elevated levels of psychosocial problems are common in both 
young patients with CF as well as in their caregivers and self- or caregiver 
reported treatment adherence is poor. Assessing psychosocial health problems 
and risk factors in the care for patients with CF (and their caregivers) is important 
in all age groups and needs further investigations.  
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Introduction 
Cystic fibrosis (CF) is the most common hereditary disease found among 
Caucasian populations, currently affecting almost 1400 patients in the 
Netherlands [1]. CF is a severe disease with a progressive course affecting 
many organs, especially the lungs, pancreas and digestive systems. Patients 
with CF have a reduced life-expectancy, despite advances in care and treatment 
modalities [2]. It also poses a heavy burden on patients and their caregivers; not 
only because of the frequency and severity of physical symptoms and limitations, 
but also because of its complex and time-consuming daily treatment regimen [3-
8]. Poor treatment adherence is commonly reported, with average rates of 
adherence generally below 50% for children and adults across treatments [4, 9, 
10]. Prior studies have shown that adherence is related to patient age, 
socioeconomic status and symptoms of depression and anxiety [11-17].  
Previous research has shown that patients with chronic illnesses and 
their caregivers are at risk for developing psychosocial health problems [18-20]. 
This also seems to be true for patients with CF and their caregivers. However, 
the literature is inconsistent about the prevalence and severity of these 
symptoms (such as anxiety and depression) [5, 14, 21-33], given that they differ 
between countries, ages, and assessment methods. One common limitation of 
prior research is collapsing data across ages, without taking into account 
important developmental differences between age groups.  
In addition, previous studies have typically limited their assessment to 
standardized measures of anxiety, depression and occasionally, health-related 
quality of life (HRQOL). Few studies have measured important risk factors, such 
as underlying illness cognitions (which can be the starting point for a cognitive 
behavioral based treatment), parenting stress, medical crises (e.g., new CF-
related diabetes diagnosis) or self-reported treatment adherence [34, 35].  
Based on the present literature, we hypothesized that a wide variety of 
psychosocial health problems would be common among children and 
adolescents with CF and their caregivers and that, given the progressive nature 
of CF, these issues would increase in young adults. The aim of this study was to 
systematically evaluate the psychosocial health of both young patients with CF 
and their caregivers, as well as young adults. Thus, the main research objective 
was to describe the frequency and severity of a wide range of psychosocial 
health problems and risk factors in both patients and caregivers. A secondary 
objective was to identify differences in these variables by age and gender.    
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This study was part of a large scale, international epidemiological study (The 
International Depression/anxiety Epidemiological Study (TIDES), started in 
2007), which measured levels of anxiety and depression in both patients with 
cystic fibrosis and their caregivers (http://www.tides-cf.org/). Part of the Dutch 
data in this paper was collected as part of this international effort. The added 
value of the present study was to provide a more comprehensive assessment of 
other psychosocial health problems (e.g., HRQOL) and to identify key factors, 
such as parenting stress and adherence, in relation to psychological symptoms 
of anxiety and depression. 
 
Materials and methods 
Participants 
This cross-sectional study recruited children, adolescents, and young adults with 
CF, as well as parent caregivers at all seven CF centers in the Netherlands, 
excepting children and parents from one center in the centre of the Netherlands. 
In this center, most children already participated in another study which made it 
impossible to participate in the current study. Between May 2010 and June 2011, 
all patients and their caregiver(s) who met the inclusion criteria were invited to 
participate in the study. Patients ages 12 to 17 and 18 through 35 years were 
included, as well as caregivers of children with CF ages 1-17. Exclusion criteria 
included: patients who underwent an organ transplantation, patients or 
caregivers who had insufficient comprehension of the Dutch language, patients in 
whom CF was recently diagnosed (<one year) and patients > 35 years. 
Procedure 
The study protocol was approved by the Ethics Committee at the Nijmegen 
University Medical Centre St. Radboud and the local institutional review boards 
of the six other participating CF centers. Participants completed the paper-and-
pencil questionnaires at the beginning of a routine, stable visit in the CF-center 
or at home after receiving the questionnaires by mail. Written informed consent 
was obtained from patients, caregivers and adolescents. Completion of the 
questionnaires took approximately 20 minutes. Medical data were obtained by a 
staff member at the CF center.  
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Measures 
Patient and caregiver depression (CES-D) 
The Dutch version of the Center for Epidemiological Studies Depression Scale 
(CES-D) was used to assess depressive symptoms in patients (ages 12 and 
older) and caregivers over the past 7 days. The CES-D consists of 20 items, with 
scores ranging from 0 to 60. A cut-off score of ≥ 16 was used to identify 
participants with clinically significant levels of depressive symptoms [36]. 
 
Patient anxiety and depression (HADS) 
The Dutch version of the Hospital Anxiety and Depression Scale (HADS) was 
used to assess symptoms of anxiety (seven items) and depression (seven items) 
in patients (ages 12 and older) and caregivers. A cut-off score of ≥ 11 was used 
to identify participants with clinically significant levels of anxious or depressive 
symptoms. A cut-off on a scale score of ≥ 8 was used to assess borderline levels 
of anxious or depressive symptoms [37, 38].  
 
Psychosocial problems of young patients (SDQ) 
Psychosocial problems of children (ages 3-18 years) over the past 6 months 
were assessed with the Dutch version of the Strengths and Difficulties 
Questionnaire (SDQ) [39]. The SDQ is a well-validated instrument designed to 
measure a wide range of psychosocial health problems, including emotional 
symptoms, conduct problems, hyperactivity–inattention, peer problems, and 
prosocial behavior [40-43]. The questionnaire consists of 25 questions, with 
scores ranging from 0 and 40, with higher scores indicating more serious 
problems. For the self-reported scores of adolescents ages 12-18, a cut-off 
score of ≥ 14 was used to identify participants with borderline levels of 
psychosocial problems and ≥ 17 for clinically significant psychosocial problems. 
For the caregiver-reported scores on children ages 3-18, cut-off scores were ≥ 
11 and ≥ 14, respectively, for borderline levels and clinically elevated 
psychosocial problems [44].  
 
CF-specific health-related quality of life (CFQ-R)  
The Cystic Fibrosis Questionnaire – Revised version (CFQ-R) was used to 
assess CF-specific health-related quality of life (HRQOL). The CFQ-R is the 
most widely used disease-specific measure for CF and has demonstrated good 
reliability, validity and response to treatment [45, 46]. The Dutch translation of 
the Teen/Adult version consists of 50 items and was used for patients from the 
age of 14 and older. Caregivers of children ages 6-13 years old completed the 
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CFQ-R Parent version with 44 items. Young patients (ages 12-13 years) old 
completed the CFQ-R Child version with 35 items. Scores were standardized 
according to the manual on a 0 to 100-point scale, with higher scores 
representing better quality of life. There are no cut-off scores available, so 
therefore this score was used as a continuous variable.  
 
Self- or caregiver-reported treatment adherence (MMAS-4) 
The Morisky Medication Adherence Scale-4 items (MMAS-4) was used to 
assess self-reported and caregiver-reported adherence to treatment. Its scores 
vary between 0 to 4, with higher scores reflecting worse adherence. A score of 0 
was classified as good adherence and a score above 0 as poor adherence [47]. 
Patients answering ‘‘no’’ to all these questions received a total score of 0 with 
their adherence classified as good, whereas those answering “yes” to one or 
more questions had their adherence classified as poor.  
 
Parenting Stress (NOSIK) 
The short version of the Nijmeegse Ouderlijke Stress Index (NOSIK) was used to 
assess parenting stress in caregivers of children with CF between 1 and 18 
years of age. This questionnaire is a Dutch version derived from the Parenting 
Stress Index (PSI) and consist of 25 items [48, 49]. The total score ranges from 
25 to 150. A cut-off score of ≥ 64 was used to identify clinically elevated stress 
and ≥ 54 to identify borderline elevations in male caregivers. A cut-off score of ≥ 
74 represented clinically elevated scores and ≥ 62 represented borderline levels 
for female caregivers. Cut off scores were based on the Dutch manual.  
 
Illness cognitions (ZCL) 
Illness cognitions were assessed in patients with CF (ages 14 to 35 years) and 
caregivers of patients with CF (ages 1-18) using the Dutch version of the Illness 
Cognitions Questionnaire (ZCL: ‘ziekte cognitie lijst’) [50]. This questionnaire 
consists of 18 items across three scales (helplessness, acceptance and 
perceived benefits) and was adapted for caregivers. The total subscale score 
ranges from 6 to 24. One example of an item in the disease-benefits subscale is: 
‘My illness has taught me what is important in life’. No cut-off scores are 
available, so this score was used as a continuous variable, with higher scores 
reflecting more helplessness, more acceptance or more disease benefits. 
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Medical and sociodemographic data 
Sociodemographic data (e.g. living status, age, sex) were collected and 
additional medical data (e.g. FEV1% predicted) were obtained from the medical 
records and filled in by the nurse.  
 
Statistical analysis  
First, descriptive statistics were used to describe means, standard deviations 
and medians (in non-normally distributed data) for the different psychosocial 
health problems and risk factors. Second, prevalence rates of elevated scores 
were calculated for anxiety, depression, parenting stress, psychosocial problems 
in general and treatment adherence, using the cut-off scores documented above. 
Third, group comparisons were performed using non-parametric tests 
(independent samples Mann-Whitney U tests) because much of the data was not 
normally distributed. These statistical tests were used to assess potential gender 
and age group differences. All analyses were carried out with the statistical 
software package SPSS version 16.0, with the level of significance set at p<.05. 
 
Results 
Demographic characteristics of the sample (Table 1) 
A total of 706 patients and 324 caregivers met the inclusion criteria and were 
approached to participate in the study. A total of 515 patients and 266 caregivers 
completed the questionnaires, representing a response rate of 73% and 82% 
respectively. Ultimately, only young adults below the age of 36 were included in 
the analyses, yielding 383 patients (92 adolescents ages 12 to 18 and 291 
young adults ages 18 to 35). Among adolescents, 85% were living with two 
caregivers, and 15% were living with a single parent. Among young adults, 30% 
were married or living with a partner. Table 1 shows the demographic 
characteristic of the participants. 
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Table 1 
Baseline characteristics of the study population 
 
 
Psychosocial health and treatment adherence in adolescents 
Self-report (Tables 4 & 5):  
Among adolescents, psychosocial problems were reported by 17% of patients at 
the borderline or clinical level on the SDQ. A relatively small percentage of 
adolescents reported elevated symptoms of anxiety (6%) or depression (5%) on 
the HADS, with 11% reporting elevations in depression on the CES-D. In 
contrast, “good” adherence was reported by only 18% of teens (Table 4). 
Average CFQ-R scores ranged from a low of 67 on Vitality to a high of 87 on 
Body Image (see Table 5). Adolescent girls versus boys reported more 
helplessness (p= .014), less acceptance (p= .012), more depressive symptoms 
on the CES-D (p= .005), and more emotional problems on the CFQ-R (p= .010) 
(gender differences are not reported in these tables). 
 
Caregiver-report (Table 2): 
Thirty percent of caregivers of adolescents with CF reported psychosocial 
problems in their children (12% borderline, 18% clinically elevated) on the SDQ, 
compared to 10% borderline and 10% clinically elevated scores in the general 
Dutch population [44]. Caregivers reported good adherence in only 21% of 
adolescents (Table 2). No gender differences were found in rates of 
psychosocial problems or treatment adherence as reported by caregivers 
(gender differences are not reported in these tables). 
Variable 
Children 
Caregiver-
reported  
Adolescents  
Self-
reported 
Young adults  
Self- 
reported 
Caregivers  
Caregiver-
reported 
     
Age (years) N 177 92 291 263 
 Range  1-11 12-17 18-35 24-57 
 Mean (SD) 6,14 (3,21) 14,62 (1,67) 24,20 (5,15) 40,47 (5,87) 
 Median 6,00 15,00 23,00 40,00 
Gender N  177 92 290 266 
 Male N (%) 94 (53,1%) 51 (55,4%) 155 (53,3%) 61(22,9%) 
 Female N (%) 83 (46,9%) 41 (44,6%) 135 (46,6%) 205 (77,1%) 
FEV1% predicted 112 91 290 - 
 Range 42-141 28-134 14-120 - 
 Mean (SD) 92,45 (18,29) 83,85 (21,88) 65,20 (24,58) - 
 Median 93,00 86,10 64,00 - 
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Psychosocial health and treatment adherence in young adults 
(Tables 4 & 5) 
More than 20% of young adults with CF (ages 18-35) reported clinically elevated 
levels of depressive symptoms on the CES-D. Anxious symptoms at the 
borderline or clinical levels were reported by 12.7% of adults on the HADS, with 
8% reporting borderline or clinically elevated depressive symptoms on the 
HADS. Poor adherence was reported by 80.6% of all adult patients (Table 4). On 
the CFQ-R, average scores ranged from a low of 57 on the Health Perceptions 
scale to a high of 87 on Eating Disturbances (Table 5). Females vs. males 
reported significantly more anxious symptoms on the HADS (p= .006), more 
depressive symptoms on the CES-D (p< .001), and lower HRQOL scores on the 
following subscales: Physical Functioning (p< .001), Social Functioning (p< 
.001), Treatment Burden (p= .021), Respiratory Symptoms (p< .001), Role 
Functioning (p= .020), Vitality (p< .001), and Health Perceptions (p= .004). In 
contrast, females reported more disease benefits on the Illness Cognitions 
scales than males (p< .001) and they were more satisfied with their Body Image 
than males (p< .001). (Gender differences are not reported in these tables). 
 
Comparisons of adolescents vs. young adults (Tables 4 & 5) 
No significant differences between the reports of adolescents and young adults 
with CF were found on the following (sub)scales: anxiety and depression on the 
HADS, treatment adherence and the following CFQ-R scales: Eating 
Disturbances, Social Functioning, Body Image, Role Functioning and Digestive 
Symptoms. On all other measures, adults reported significantly more 
psychosocial health problems than adolescents, such as more depression on the 
CES-D (p= .014) and lower HRQOL-scores on several CFQ-R scales. In terms 
of illness cognitions, adults reported significantly more helplessness, less 
acceptance but also more disease benefits. 
 
Comparisons of caregiver scores of children vs. adolescents (Table 2) 
No significant differences were found in the psychosocial problems reported by 
parents of young children compared to those reported by parents of adolescents 
on the SDQ (p= .204). However, parents of younger children reported better 
adherence than parents of adolescents (p< .000).  
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Psychosocial health of caregivers (Table 6) 
More than 28% of caregivers of children ages 1-17 reported elevated levels of 
parenting stress (8% borderline, 20% clinically elevated). In addition, almost 20% 
of caregivers reported clinical levels of depressive symptoms on the CES-D; 
28% of parents reported elevated levels of anxiety on the HADS (16% 
borderline, 12% clinically elevated). Comparisons of parents of younger children 
versus parents of adolescents revealed no significant differences on any 
psychosocial variables except the subscale acceptance on the Illness Cognition 
Questionnaire. Parents of adolescents reported less acceptance than parents of 
younger children. Further, no significant differences were found when comparing 
female and male caregivers, except on the disease benefits and helplessness 
subscales, with female caregivers reporting more helplessness but also more 
disease benefits than male caregivers (gender differences are not reported in 
these tables). 
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Table 2 
Caregiver-reported psychosocial health problems and treatment adherence in 
children and adolescents with CF 
# Independent samples Mann Whitney U test between scores of caregivers of young 
children compared to caregivers of adolescents; p-values are given 
* p<0.05 
 
Table 3 
Caregiver-reported quality of life scores of young children aged 1-11 with CF 
    
Variable Young children 
(1-11) 
Adolescents 
(12-18) 
p# 
    
    
Psychosocial problems (SDQ) N 137 87 0,204 
 Median 8,00 7,00  
 Mean (SD) 9,19 (5,93) 8,26 (5,91)  
 Normal N (%) 87 (63,5%) 61 (70,1%)  
 Borderline N (%) 23 (16,8%) 10 (11,5%)  
 Clinical N (%) 27 (19,7%) 16 (18,4%)  
Treatment adherence (MMAS) N 170 85 0,000* 
 Median 0,00 2,00  
 Mean (SD) 0,55 (0,84) 1,66 (1,20)  
 Good adherence N (%) 108 (63,5%) 18 (21,2%)  
 Poor adherence N (%) 62 (36,5%) 67 (78,8%)  
     
Variable N Mean SD Median 
     
     
CF-related quality of life (CFQ-R)      
 Physical functioning 91 86,27 15,98 92,59 
 Vitality 91 73,11  14,79 73,33 
 Emotional functioning 92 84,11  15,12 86,67 
 Eating disturbances 92 61,05  30,19 50,00 
 Health perceptions 92 74,52  20,68 77,78 
 Body image 92 81,04  21,13 88,89 
 Role-school functioning 91 68,38  27,53 77,78 
 Weight 92 67,03  36,48 66,67 
 Respiratory symptoms 92 84,00  16,07 88,89 
 Digestive symptoms 92 71,01  18,49 77,78 
 Treatment burden 92 67,03  22,73 66,67 
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Table 4 
Self-reported psychosocial health of adolescents and young adults with CF  
 
#  Independent samples Mann Whitney U test between scores of adolescent patients 
compared to adult patients; p-values are given 
* p<0.05 
      
Variable Adolescents 
(12-17)  
Young adults  
(18-35) 
p# 
    
Anxiety (HADS) N 92 291 0,064 
 Median 2,00 3,00  
 Mean (SD) 3,09 (2,77) 3,93 (3,54)  
 Normal N (%) 86 (93,5%) 254 (87,3%)  
 Borderline N (%) 4 (4,3%) 21 (7,2%)  
 Clinical N (%) 2 (2,2%) 16 (5,5%)  
Depression (HADS) N 92 291 0,424 
 Median 2,00 2,00  
 Mean (SD) 2,46 (2,62) 2,77 (2,96)  
 Normal N (%) 87 (94,6%) 269 (92,4%)  
 Borderline N (%) 4 (4,3%) 14 (4,8%)  
 Clinical N (%) 1 (1,1%) 8 (2,7%)  
Depression (CES-D) N 92 290 0,014* 
 Median 4,00 6,00  
 Mean (SD) 6,28 (6,95) 8,83 (9,01)  
 Normal N (%) 82 (89,1%) 231 (79,7%)  
 Clinical N (%) 10 (10,9%) 59 (20,3%)  
Psychosocial problems (SDQ) N 90 - - 
 Median 8,00 -  
 Mean (SD) 8,93 (4,79) -  
 Normal N (%) 75 (83,3%) -  
 Borderline N (%) 8 (8,9%) -  
 Clinical N (%) 7 (7,8%) -  
Treatment adherence (MMAS) N 89 289 0,270 
 Median 2,00 2,00  
 Mean (SD) 1,52 (1,00) 1,70 (1,21)  
 Good adherence N (%) 16 (18,0%) 56 (19,4%)  
 Poor adherence N (%) 73 (82,0%) 233 (80,6%)  
Helplessness (ZCL) N 63 291 0,026* 
 Median 8,00 9,00  
 Mean (SD) 8,59 (2,81) 9,77 (3,74)  
Acceptance (ZCL) N 63 291 0,004* 
 Median 21,00 19,00  
 Mean (SD) 19,71 (4,16) 18,46 (3,68)  
Disease benefits (ZCL) N 63 291 0,001* 
 Median 14,00 16,00  
 Mean (SD) 13,86 (4,44) 16,05 (4,99)  
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Table 5 
Self-reported quality of life scores of adolescents and young adults with CF 
#  Independent samples Mann Whitney U test between scores of adolescent patients 
compared to young adult patients; p-values are given 
* p<0.05 
 
 
      
Variable N Mean SD Median p# 
      
CF-related quality of life (CFQ-R) adolescents (12-17) 
       
 Physical functioning 92 82,72 20,37 91,67 0,001* 
 Vitality 63 67,46 17,88 66,67 0,001* 
 Emotional functioning 92 81,09 15,57 83,33 0,019* 
 Eating disturbances 92 85,51 21,90 100,00 0,426 
 Health perceptions 63 73,02 22,38 77,78 0,000* 
 Social functioning 90 78,19  16,07 78,89 0,072 
 Body image 91 87,36 19,26 100,00 0,083 
 Role-school functioning 62 81,95 15,96 83,33 0,062 
 Weight 63 83,60 25,31 100,00 0,013* 
 Respiratory symptoms 92 75,48 17,45 83,33 0,000* 
 Digestive symptoms 92 75,48 21,76 77,78 0,735 
 Treatment burden 92 73,67 19,12 66,67 0,002* 
 
CF-related quality of life (CFQ-R) young adults (18-35) 
       
 Physical functioning 291 73,84 24,18 79,17 0,001* 
 Vitality 291 59,08 18,14 58,33 0,001* 
 Emotional functioning 291 75,97 18,13 80,00 0,019* 
 Eating disturbances 290 87,55 19,15 100,00 0,426 
 Health perceptions 291 57,05 25,52 55,56 0,000* 
 Social functioning 291 74,82  16,43 77,78 0,072 
 Body image 291 83,81 20,51 88,89 0,083 
 Role-school functioning 290 75,23 21,83 83,33 0,062 
 Weight 291 72,74 32,12 66,67 0,013* 
 Respiratory symptoms 291 66,38 17,70 66,67 0,000* 
 Digestive symptoms 291 76,21 17,28 77,78 0,735 
 Treatment burden 289 66,21 20,28 66,67 0,002* 
 Physical functioning 291 73,84 24,18 79,17 0,001* 
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Table 6 
Self-reported psychosocial health of caregivers of young patients (aged 1-17) with CF 
#  Independent samples Mann Whitney U test between scores of caregivers of young 
children and caregivers of adolescents; p-values are given 
* p<0.05 
 
     
Variable 
Caregivers of  
all children 
and 
adolescents  
aged 1-17 
years 
Caregivers of  
young 
children  
aged 1-11 
years  
Caregivers of 
adolescents  
aged 12-18 
years 
#p  
     
Anxiety (HADS) N 263 175 88 0,727 
 Mean (SD) 5,46 (3,95) 5,49 (4,16) 5,40 (3,50)  
 Median 5,00 5,00 4,50  
 Normal (N (%)) 189 (71,9%) 125 (71,4%) 64 (72,7%)  
 Borderline (N (%)) 43 (16,3%) 27 (15,4%) 16 (18,2%)  
 Clinical (N (%)) 31 (11,8%) 23 (13,1%) 8 (9,1%)  
Depression (CES-D) N  264 176 88 0,075 
 Mean (SD) 8,42 (8,59) 7,95 (8,75) 9,34 (8,22)  
 Median  6,00 5,00 8,00  
 Normal (N (%)) 213 (80,7%) 144 (81,8%) 69 (78,4%)  
 Clinical (N (%)) 51 (19,3%) 32 (18,2%) 19 (21,6%)  
Parenting stress (NOSIK) N  264 176 89 0,903 
 Mean (SD) 51,14 (23,55) 50,70 (22,50) 52,01 (25,63)  
 Median 44,00 45,00 43,00  
 Normal (N (%)) 191 (72,1%) 130 (73,9%) 61 (68,5%)  
 Borderline (N (%)) 20 (7,5%) 13 (7,4%) 7 (7,9%)  
 Clinical (N (%)) 54 (20,4%) 33 (18,8%) 21 (23,6%)  
Helplessness (ZCL) N  264 176 88  
 Mean (SD) 9,20 (2,69) 9,09 (2,72) 9,43 (2,65) 0,193 
 Median 9,00 9,00 9,00  
Acceptance (ZCL) N 264 176 88  
 Mean (SD) 19,04 (3,42) 19,33 (3,44) 18,47 (3,31) 0,022* 
 Median 19,00 20,00 18,00  
Disease benefits (ZCL) N 264 176 88  
 Mean (SD) 17,31 (4,48) 17,60 (4,54) 16,74 (4,33) 0,082 
 Median 18,00 18,00 17,00  
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Discussion 
In this large, multicentre study we assessed a wide range of important 
psychosocial health problems and risk factors in patients with CF and their 
caregivers. The major findings, study strengths and limitations, 
recommendations for future research, and the clinical implications will be 
discussed.  
 
Principal findings 
Fortunately, the majority of young patients with CF and their caregivers reported 
normal levels of psychosocial health. This fits with prior studies that have 
indicated that most patients with CF and parents adapt surprisingly well to the 
daily demands of their illness [21, 30]. However, these results supported our 
hypothesis that a substantial proportion of participants would report elevations in 
both risk factors and psychological distress on a wide range of measures, also 
consistent with prior studies [21-23, 26-28, 51]. These psychosocial problems 
have been found to affect health in general, but are also likely to negatively 
influence disease management (e.g., attending clinic visits) and adherence, 
which was dramatically low in our study, especially among adolescent and young 
adult patients (more than 80% reported their adherence was poor). Previous 
research has shown that elevated symptoms of depression in children and 
adolescents with CF are associated with worse adherence to airway clearance 
treatments [14] and this relationship between depression and adherence has 
also been reported in other chronic conditions such as asthma [52] or diabetes 
[53]. The relationship between anxiety and adherence is more complex and may 
be curvilinear; some level of anxiety is important to increase motivation, but too 
much anxiety can be paralyzing [16, 54]. Further research is needed to 
understand these complex, dynamic processes. 
Increasing age was associated with increased symptoms of depression 
and decreased adherence and HRQOL. This may be explained in several ways, 
including the inevitable progression of the disease and the onset of new 
conditions (e.g., CF-related diabetes), which increase the frequency and severity 
of symptoms and the need to take new medications and treatments [55]. In fact, 
in the international TIDES data, a new CF-related diagnosis of diabetes and 
other medical crises were significantly associated with higher depression and 
anxiety scores, whereas current lung function and BMI were not [56]. Thus, it 
makes sense that young adults with CF reported more depression, more 
helplessness, less acceptance and worse quality of life than adolescents. This 
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finding is in agreement with previous literature [26, 28]. Another reason why we 
found relatively low rates of psychosocial health problems reported by 
adolescents themselves, might be the fact that adolescents differ from adults in 
terms of their cognitive and emotional development. They tend to deny their 
disease, express a sense of invulnerability, and underreport psychosocial 
problems [57, 58]. Critically, this is the developmental period during which 
numerous studies report a decline in lung function, a decrease in adherence, a 
female preference for thinness, and an increase in IV-treated exacerbations [55, 
59, 60]. So, it may be particularly important to intervene with this age group to 
prevent the well-documented slide in daily functioning, disease management, 
and health outcomes. Comparing caregiver-reported adherence in young 
children (63% reported good adherence) versus caregiver-reported adherence in 
adolescents (21% reported good adherence) illustrates the change. Adolescents 
themselves only reported that 18% had good adherence. This finding is in 
agreement with a recent study by Masterson et al. in which it was shown that 
treatment adherence drops with increasing age, especially in adolescence [61]. 
From a developmental perspective, this is not surprising given that there is also 
a shift in treatment responsibilities and supervision from parent to teen [62]. Role 
confusion about self-management during this period and movements toward 
greater autonomy and rebellious behavior can also negatively affect adherence 
[61, 63].  
We also found some interesting gender differences. Women reported 
more symptoms of anxiety and depression than men, which has been 
documented robustly in the epidemiological literature on healthy populations 
[51]. Our results also converge with published data showing that females with CF 
report more disease-related symptoms, have more rapid declines in lung 
function, greater morbidity and earlier mortality, and report worse health-related 
quality of life than males [26, 64, 65]. The only scale on which females reported 
greater HRQOL satisfaction than males was the CFQ-R Body Image. This may 
reflect strong societal pressures across Europe and the US for women to be thin 
and maintain a thinner body image [46, 60].  
Our results highlight the importance of screening of a wide variety of 
psychosocial health problems and risk factors in patients over different age 
groups and offering them both emotional support and cognitive-behavioral 
interventions that are personalized to their life needs [66]. A lense that accounts 
for both the developmental and gender differences we see in our patients is 
necessary if we are to develop effective interventions for this population [66].  
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In addition, almost one third of all caregivers reported elevated levels of 
parenting stress, 19% reported clinically elevated levels of depression, and 28% 
reported elevated levels of anxiety on at least borderline level. Similar results 
have been reported in studies with mainly smaller samples [21, 67, 68]. Children 
of caregivers who are depressed have more difficulty adhering to the daily CF-
regimen [14, 69]. It has also been shown that parental stress, poor parental 
coping and negative family functioning is associated with worse health outcomes 
in children with CF [70, 71]. White et al. concluded that children with CF from 
more cohesive families had better adherence [16]. 
 
Study strengths, limitations and future research 
The strengths of this study included its large sample of patients with CF and 
parent caregivers, the use of standardized disease-specific measures, besides 
the use of more generic instruments, and assessment of a broad range of 
important psychosocial health problems and risk factors. These data may also 
be used in the future to evaluate the health outcomes of patients and their 
caregivers who scored in the elevated range. Longitudinal data on these 
variables could also answer questions related to the stability of symptoms and 
the variables which predict their maintenance.  
One question that remains is which depression screening tool to use in 
patients with chronic conditions. In the current study, the HADS-Depression 
measure appeared to underestimate symptoms of depression when compared 
with the CES-D and did not include all of the elements in the DSM-IV diagnostic 
criteria. On the other hand, the CES-D might give an overestimation of actual 
levels of depressive symptoms because somatic symptoms of the disease (for 
example lack of appetite) are confused with depressive symptoms. Furthermore 
it is debatable whether some other instruments we used in our study (for 
example the Illness Cognition Questionnaire or the NOSIK) can already be 
implemented into clinical care because they lack appropriate norms or cut-off 
scores or are not psychometrically tested in all different age groups. We 
recommend a consensus conference to determine the state of the evidence, the 
best choice for screeners, and issues related to referrals to psychologists or 
social workers on CF teams. 
In this study we excluded patients with CF above the age of 35. This 
group of patients (the so-called ‘long term survivors’) is growing and represents a 
special, heterogeneous population within the overall CF-population which 
deserves specialized attention in future studies [72]. 
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Finally, adherence was assessed using self-report by either the patient or 
caregiver [47]. Although this is an inexpensive and efficient method, it has been 
shown to be inflated due to recall and social desirability biases, in comparison to 
other methods (e.g., diary, electronic) [4, 73]. Thus, it is possible that adherence 
was even lower in this sample than reported.  
 
Consequences for clinical care 
Currently, clinical guidelines for patients with CF are usually limited to the 
medical aspects of cystic fibrosis and tend to neglect the accompanying 
psychosocial components [74-78]. As a result, there is no consensus on how to 
assess the psychosocial health of patients and their direct relatives and how to 
cope with these problems in this population in clinical care. Extending knowledge 
about these psychosocial health problems and risk factors might lead to 
adequate and evidence-based medical and psychosocial interventions targeting 
these problems and lead to better health outcomes. 
Although a few studies highlight the importance of systematic screening 
on psychosocial health problems and risk factors, psychosocial screening has 
still not been implemented on a large scale in clinical care for patients with CF 
[21, 28]. Screening for, and discussing potential psychosocial health problems 
and risk factors with patients and their caregivers can help doctors and nurses 
understand which barriers patients and caregivers face in everyday life. It can 
promote a more open and effective patient-doctor communication and moreover 
it can help identify those patients and caregivers in need of referral to specialized 
mental health specialists [79].  
For clinical care our recommendation is therefore in line with previous 
recommendations of our German, American and Belgian colleagues [21, 26-28]: 
Psychosocial health problems and risk factors should be assessed routinely, in 
both patients with CF and their caregivers in clinical care. Based on the 
individual profile, medical and psychosocial treatment should be adapted and 
tailored to patients’ need. Especially in this relatively young population it is 
important to screen on a regular basis and to take potential gender and age 
differences into account. Then certain psychosocial health problems or risk 
factors can be detected in time and additional psychosocial or specialized mental 
care can prevent the worsening of problems. In order to give patients with CF the 
full care they deserve mental health care providers should be part of each CF 
team.  
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Conclusion 
In summary, this study shows that elevated levels of psychosocial health 
problems are common in both young children, adolescents and young adults 
with CF and their parent caregivers. Adherence was reported as quite low by 
both self- and parent-report, and decreased in adolescence. Annual screening of 
psychosocial health problems and risk factors, with referrals for those who score 
in the elevated range is recommended.  
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Abstract 
Background: The Cystic Fibrosis Questionnaire (CFQ) is widely used in 
research as an instrument to measure quality of life in patients with cystic fibrosis 
(CF). In routine patient care however, measuring quality of life is still not 
implemented in guidelines. One of the reasons might be the lack of consensus 
on how to interpret CFQ scores of an individual patient, because appropriate 
reference data are lacking. The question which scores reflect normal functioning 
and which scores reflect clinically relevant problems is still unanswered. 
Moreover, there is no knowledge about how healthy children and adolescents 
report on their quality of life (on the CFQ). With regard to quality of life the effect 
of normal development should be taken into account, especially in childhood and 
adolescence. Therefore, it is important to gain more knowledge about how 
healthy children and adolescents report on their quality of life and if there are any 
difference in a healthy populations based on age or gender. Without these data 
we cannot adequately interpret the CFQ as a tool in clinical care to provide 
patient-tailored care. Therefore this study collected data of the CFQ in healthy 
children and adolescents with the aim to refer health status of CF youngsters to 
that of healthy peers.  
Methods: The CFQ was completed by 478 healthy Dutch children and 
adolescents (aged 6-20) in a cross-sectional study. 
Results: The majority of healthy children (over 65%) did not reach maximum 
scores on most domains of the CFQ. Median CFQ-scores of healthy children 
and adolescents ranged from 67 to 100 (on a scale of 0-100) on the different 
CFQ-domains. Significant differences in quality of life exist among healthy 
children and adolescents, and these depend on age and gender.  
Conclusions: Reference data of quality of life scores from a healthy population 
are essential for adequate interpretation of quality of life in young patients with 
CF. Clinicians should be aware that the perception of health-related quality of life 
is not as disease-specific as one might think and also relies on factors such as 
age, normal maturation and gender. 
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Background 
Cystic fibrosis (CF) is the most common autosomal-recessive disease in the 
white population [1]. CF is, despite advances in care and treatment modalities, 
still a life threatening disease, involving especially the pulmonary and 
gastrointestinal organs. CF poses a heavy burden on patients and their families 
involving daily complex and time-consuming treatments with medication and 
demands of a healthy life style with sufficient nutrition and exercise [2]. 
Fortunately, life expectancy of patients with CF has improved dramatically in the 
recent years due to early diagnosis and better treatment options [3]. With this 
increasing life expectancy, patients with CF face new issues such as disease 
self management, development towards personal autonomy and identity, 
questions concerning intimate relationships and family planning. It is now 
recognized that traditional measurements of the physiological status (e.g. lung 
function and body mass index) are inadequate to cover all aspects of the impact 
of CF on daily life and on the broader issues mentioned above [4]. Within this 
context, measuring health-related quality of life has received growing attention in 
clinical care especially in pediatric and adolescent care [5-7]. Disease specific 
instruments are preferred above general instruments to measure health-related 
quality of life in patients with CF because they are designed to assess the 
symptoms and areas of functioning that are most important for CF [4]. Although 
several studies highlight the importance of incorporating these patient reported 
outcomes in routine care, assessing health-related quality of life is not yet 
implemented in clinical guidelines. This is probably partly due to the lack of 
appropriate reference values. 
The Cystic Fibrosis Questionnaire (CFQ) was developed in 1997 as a 
CF specific questionnaire to measure various domains of health-related quality 
of life of children, adolescents and adults [8]. This instrument is now available in 
25 languages and it is the most widely known instrument to measure a broad 
range of health-related quality of life domains in CF, in research and in clinical 
care. Health-related quality of life is not stable in time, but varies due to different 
factors such as life events, maturation, and changes in environment, treatment, 
disease, and coping abilities. The CFQ is the only disease specific questionnaire 
for patients with CF with several age-appropriate versions, which make it 
possible to follow patients with CF throughout their life span. 
To date, however, there is no consensus on how to interpret CFQ 
scores of an individual patient with CF for clinical purposes, as no formal 
empirically derived reference data are available. There is some evidence about 
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the minimally clinically important difference for the CFQ, but in this research 
normal maturation in a healthy population was not taken into account [9]. In the 
Netherlands, only two small studies provide preliminary reference data for a 
small sample of Dutch CF-patients [10, 11]. In the first study psychometric 
characteristics of the Dutch CFQ were assessed in 84 adolescents and adults 
with CF aged 14-46 years. In the second study 68 children with CF (mean age 
11.3 years) participated. Internal consistency was acceptable for most domains 
of the CFQ (α= 0.43-0.92) and test-retest reliability was high for all domain 
scores (0.72-0.98). However, it is unknown which score range reflects normal 
functioning and which score range reflects clinically relevant problems. Normality 
cannot be defined by absence of complaints or functional impairment, because 
even healthy subjects may experience symptoms such as fatigue or suffer from 
anxiety or depressed feelings from time to time. With regard to quality of life the 
effect of normal development has to be taken into account. For example, 
decreased mood and worries about body image is common with increasing age, 
especially in adolescence. Therefore, changes over time in quality of life may be 
due to progression of the disease but may also be due to normal maturation. 
Therefore, it is important to gain more knowledge about how healthy children 
and adolescents report on their quality of life, and if there are any differences 
based on age or gender in a healthy population. Without these data we cannot 
adequately interpret the CFQ as a tool in clinical care to provide patient-tailored 
care. The aim of this study was therefore to collect data on the CFQ in a healthy 
population of children and adolescents and to increase knowledge about this 
important patient reported outcome instrument in the care for patients with cystic 
fibrosis. We hypothesized that even healthy children would not gain maximum 
scores on a disease-specific health-related quality of life instrument. 
 
Methods 
Participants 
In 2008, children and adolescents who met the inclusion criteria were invited to 
participate in this study. Inclusion criteria were: no chronic illness, not being 
under treatment of a medical specialist, age between 6 and 20 years, and the 
capability to understand and read the Dutch language. Children were recruited 
from primary and secondary schools in the Eastern region of the Netherlands. All 
primary and secondary schools in the city Nijmegen (42) were invited to 
participate. Six schools agreed to participate and in these schools classes were 
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selected at random. In secondary school classes were selected from low to high 
education levels. 
 
Measures 
The Cystic Fibrosis Questionnaire (CFQ) is a widely used disease specific 
questionnaire which measures different domains of health-related quality of life 
[12-15]. The CFQ was originally developed in France and designed for CF-care 
and research goals [8]. Psychometric properties of the Dutch version of the CFQ 
were good according to Klijn et al.[10]. For the purpose of the present study 
three Dutch versions were used:  
- CFQ 6-11: interviewer administered version for children between 6 and 
11 years old consisting of 35 items divided into 8 domains (physical 
functioning, emotional functioning, social functioning, body image, 
eating disturbances, treatment burden, respiratory symptoms, digestive 
symptoms). 
- CFQ 12-13: self-administered version for children between 12 and 13 
years old consisting of the same items and domains of the 6-11 version. 
- CFQ 14+: self-administered version for adolescents and adults 
consisting of 50 items divided into 12 domains: the eight domains 
mentioned above and an additional four domains (role functioning, 
vitality, health perception and weight).  
Response choices included ratings on a 4-point Likert scale. These scores are 
standardized and range from 0 to 100 on every domain with higher scores 
corresponding to better health-related quality of life. For the purpose of this study 
the domain ‘treatment burden’ with only disease specific questions about 
medical treatment for CF was omitted. We chose to use the ‘old’ version of the 
CFQ instead of the new CFQ-Revised, because the new CFQ-Revised was not 
psychometrically tested in the Netherlands and there are only small textual 
changes compared to the ‘old’ version [10]. The three versions of the Dutch CFQ 
are added as additional files 1, 2 and 3. 
 
Procedure 
Three primary schools and three secondary schools in the Eastern region of the 
Netherlands took part in this study. Formal approval from the local medical ethics 
committee (CMO Arnhem-Nijmegen) was obtained. Written informed consent 
was obtained according to the principles of the local ethical committee. Legal 
caregivers of children under 16 were asked permission as well as adolescents 
above 12 years old. Participating children and adolescents filled out the paper 
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and pencil version of the CFQ individually during a lesson in school. Children 
between 6 and 11 had individually interviewer administered questionnaires 
completed according to the manual. 
 
Analyses  
Mean, median, standard deviation (SD) and range were computed for each 
domain of the CFQ in this reference population. Kolmogorov-Smirnov tests were 
used to test whether the CFQ domain scores showed a normal distribution. 
Analyses were separated for the three age-versions (children aged 6-11, 
children aged 12-13, and adolescents 14 -20 years old). The Mann-Whitney test 
was used to assess potential differences between gender and different age-
groups. Data were analyzed with SPSS version 14.0. 
 
Results 
Participants 
478 schoolchildren and adolescents participated in this study (table 1). Children 
and adolescents were derived from a representative sample of all types of 
education, ranging from low to high education levels. 
 
Table 1 
Sociodemographic characteristics of the sample 
 
    
Variable Total 
(n=478)  
n (%) 
Boys  
(n=181)  
n (%) 
Girls  
(n=297)  
n (%) 
    
Age (years)    
 Mean ± S.D.  
(range) 
14.52 ±3.16  
(6-20) 
13.72 ±3.09  
(6-20) 
15.00 ±3.10  
(6-20) 
Age category (years)    
 Young children (aged 6-11 years) 60 (12.6%) 31 (52%) 29 (48%) 
 Elder children (aged 12-13 years) 120 (25.1%) 58 (48%) 62 (52%) 
 Adolescents (aged 14-20 years) 298 (62.3%) 92 (31%) 206 (69%) 
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CFQ-scores of healthy children and adolescents 
Table 2 shows descriptive characteristics for the CFQ domains in the three age 
groups. Median scores ranged from as low as 67 (‘Vitality’ in adolescents and 
‘Digestive symptoms’ in young children aged 6-11 years) to maximum scores of 
100 (‘Body image’ in children aged 6-13 years ‘Eating disturbances’, ‘Role 
functioning’, and ‘Weight’ in adolescents). The Kolmogorov-Smirnov test 
demonstrated that all domain scores on the different CFQ-domains were not 
equally distributed (all domains p<0.05). In the age group 6-11 years no gender 
differences were found. In the children aged 12 and 13 years old differences 
were found between boys and girls on the domains ‘Emotional functioning’ and 
‘Digestive symptoms’, where girls reported more problems than boys, but there 
was major overlap (Emotional functioning median score female = 79 and male = 
83, p=0.005; Digestive symptoms median score female = 67 and male = 100, 
p=0.025). In the adolescent group, male adolescents reported better quality of 
life status on the following domains: ‘Physical functioning’, ‘Health perception’, 
‘Eating disturbances’ and ‘Emotional functioning’ compared to female 
adolescents (Physical functioning median score female = 92 and male = 96, 
p=0.000; Health perception median score female = 78 and male = 89, p<0.001; 
Eating disturbances median score female = 100 and male = 100, p=0.007; 
Emotional functioning median score female = 80 and male = 87, p=0.003). 
These data illustrate the heterogeneity between the different domains of the 
CFQ in a healthy population. 
 Figure 1, 2 and 3 demonstrate the percentage of healthy children for 
each age group who do not reach maximum scores on the different domains of 
the CFQ. There is not one domain of the CFQ in which all healthy children reach 
maximum scores. 
 Figures 4, 5 and 6 illustrate the trend for median scores of the different 
CFQ domains for the three age groups. These figures demonstrate that CFQ-
scores are different for the subsequent age groups. Some symptoms are more 
frequent in younger healthy children than in healthy adolescents (e.g. digestive 
symptoms) and some domains are decreasing when children grow older (e.g. 
adolescents report more problems on the domain ‘Body image’ than younger 
children). 
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Table 2 
Descriptive analyses (mean, SD, range, median and % maximum scores) of CFQ 
domain scores in healthy children (n=478) 
 
 
      
Variable Mean SD Range Median n maximum 
score  
(% maximum 
scores) 
    
Healthy young children (aged 6-11) (n=60) 
 Age 8.93 1.58    
 Physical functioning 89.07 14.27 22-100 94 19 (31.7) 
 Emotional functioning 83.27 12.09 54-100 88 5 (8.3) 
 Eating disturbances 90.83 11.31 56-100 95 30 (50) 
 Social functioning 89.65 12.91 48-100 95 23 (16.7) 
 Body image 95.78 8.37 67-100 100 44 (73.3) 
 Respiratory symptoms 88.70 11.55 50-100 92 15 (25) 
 Digestive symptoms 80.13 20.49 33-100 67 28 (46.7) 
    
Healthy elder children (aged 12-13) (n=120) 
 Age 12.30 0.93    
 Physical functioning 88.41 13.25 17-100 92 47 (39.2) 
 Emotional functioning 79.89 14.52 17-100 83 8 (6.7) 
 Eating disturbances 85.57 16.74 33-100 89 47 (39.2) 
 Social functioning 84.95 12.97 38-100 86 27 (22.5) 
 Body image 93.20 11.93 44-100 100 79 (65.8) 
 Respiratory symptoms 90.68 10.23 33-100 92 35 (29.2) 
 Digestive symptoms 82.37 18.70 33-100 84 60 (50) 
    
Healthy adolescents (aged 14-20) (n=298) 
 Age 16.53 1.67    
 Physical functioning 90.04 11.66 38-100 92 84 (28.2) 
 Vitality 63.33 13.80 33-100 67 1 (0.3) 
 Emotional functioning 78.20 14.37 7-100 80 15 (5) 
 Eating disturbances 93.52 12.03 11-100 100 193 (64.8) 
 Health perceptions 80.78 16.74 33-100 84 74 (24.8) 
 Social functioning 90.26 9.14 33-100 94 73 (24.5) 
 Body image 84.59 17.77 22-100 89 126 (42.3) 
 Role functioning 93.81 7.94 67-100 100 157 (52.7) 
 Weight 93.42 19.47 0-100 100 260 (87.2) 
 Respiratory symptoms 92.21 11.34 33-100 94 131 (44) 
 Digestive symptoms 89.98 13.82 0-100 89 144 (48.3) 
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Fig. 1 
Percentage of healthy children aged 6-11 years NOT reaching maximum scores on 
the different CFQ domains (n=60) 
 
Fig. 2 
Percentage of healthy children aged 12-13 years NOT reaching maximum scores on 
the different CFQ domains (n=120) 
 
Fig. 3 
Percentage of healthy adolescents aged 14-20 years NOT reaching maximum scores 
on the different CFQ domains (n=298) 
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a 
b 
c 
Fig. 4 Median scores for the three age groups on three domains of the CFQ (physical 
functioning, emotional functioning and social functioning) 
 
 
 
 
 
 
 
 
 
 
 
 
a Differences between physical functioning are not significant in the three age-groups  
b Difference between emotional functioning is significant between healthy young children aged 6-11 years and 
healthy adolescents (p<0.05, Mann-Withney) 
c Difference between social functioning is significant between healthy children aged 6-11 years and healthy 
children aged 12-13 years (p<0.01, Mann-Whitney), and between healthy young children aged 12-13 years 
and healthy adolescents (p<0.01, Mann-Whitney) 
 
Fig. 5 
Median scores for the three age groups on two domains of the CFQ (eating 
disturbances and body image) 
 
 
 
 
 
 
 
 
 
 
 
 
a Difference between body image is significant between healthy young children aged 6-11 years and healthy 
adolescents (p<0.01, Mann-Whitney), and between healthy young children aged 12-13 years and adolescents 
(p<0.01, Mann-Whitney) 
b Difference between eating disturbance is significant between healthy young children aged 6-11 years and 
healthy adolescents (p<0.05, Mann-Whitney), and between healthy young children aged 12-13 years and 
adolescents (p<0.01, Mann-Whitney) 
a 
b 
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Fig. 6 
Median scores for the three age groups on two domains of the CFQ (respiratory 
symptoms and digestive symptoms) 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Difference between respiratory symptoms is significant between healthy young children aged 6-11 years and 
healthy adolescents (p<0.01, Mann-Whitney), and between healthy young children aged 12-13 years and 
adolescents (p<0.01, Mann-Whitney) 
b Difference between digestive symptoms is significant between healthy young children aged 6-11 years and 
healthy adolescents (p<0.01, Mann-Whitney), and between healthy young children aged 12-13 years and 
adolescents (p<0.01, Mann-Whitney) 
 
Discussion  
Principal findings 
This study has four major outcomes. The first conclusion is that the majority of 
healthy children do not reach maximum scores on many domains of the CFQ. 
The percentage of healthy children and adolescents reaching maximum scores 
on the different CFQ-domains was remarkably low with an average of 34.8% 
over the different domains. For example, in the domain ‘Vitality’’ 99.7 percent of 
all healthy adolescents did experience feelings of tiredness and exhaustion to 
some degree. This finding is in agreement with the statement that normality 
cannot be defined as the absence of symptoms or functional impairment. 
The second major finding is the heterogeneity of scores between 
different CFQ-domains in healthy subjects. Median scores on the different CFQ-
domains varied between 67 and 100. For example, digestive symptoms (e.g. 
abdominal pain, flatulence, and diarrhea) are apparently quite common in young 
healthy children (median score = 67 on domain ‘Digestive symptoms’ in children 
aged 6-11 years old). In contrast, eating disturbances did not occur very often in 
this healthy age group (median score 95).  
a 
b 
Chapter 6 
136 
 
The third finding is that median scores on different domains of the CFQ differed 
according to age. As mentioned above, digestive symptoms occurred frequently 
in healthy young children aged 6-11 years old (median score 67), in contrast to 
the relative absence of digestive symptoms in the age group of healthy 
adolescents, in which digestive symptoms were quite rare (median score 89). 
Body image becomes more problematic when children grow into adolescence. 
This finding is in agreement with previous research in which most general quality 
of life scales (e.g. emotional functioning, physical and psychological wellbeing 
and self-perception) decrease from childhood into adolescence [16, 17]. A 
community based study showed that abdominal pain is more frequently reported 
in childhood than in adolescence [18]. 
The last major finding is that there were some sex-related differences. In 
6-11 year old healthy children there were no differences in any domain of the 
CFQ between boys and girls. In children aged 12-13 years old, girls reported 
more problems with emotional functioning and digestive symptoms, but there 
was major overlap. In the age-group 14-20 years, boys reported better quality of 
life on the domains: ‘Physical functioning’, ‘Health perception’, ‘Eating 
disturbances’ and ‘Emotional functioning’. But also in these domains there was 
considerable overlap in scores. These findings are in agreement with 
observations that in general, female adolescents have a poorer perception of 
their own health and report more somatic problems than their male counterparts 
[17,18]. These data indicate that it is important to take into account gender in the 
evaluation of health-related quality of life. 
 
Methodological considerations and implications for future research 
The major strength of our study is that, to our knowledge, this is the first study in 
which data of a large group of healthy children and adolescents was used to 
expand knowledge on a disease specific instrument for CF. These data help to 
improve the interpretation of health-related quality of life assessment in CF using 
the CFQ. However, some methodological issues need further comment. In the 
adolescent group we had a disproportional high rate of females in our study-
sample, due to the particular schools which participated. This may have 
influenced our results, in some way. The difference in the domain eating 
disturbances between young children and adolescents may be even bigger. The 
difference between emotional functioning of young children aged 12-13 years 
and adolescents might be smaller in reality.  
It is impossible to determine whether differences in CFQ scores 
between the three age groups are due to true age differences or whether 
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differences in CFQ scores are caused by the fact that different, age-specific 
questionnaires and procedures were employed for each age group. In the 
youngest age group the CFQ was administered individually with an interviewer, 
whereas the older children and adolescents filled out the CFQ in the classroom 
without individual help. Because only Dutch children and adolescents were 
included, it is unknown whether our results are also representative for other 
countries. Future research should collect reference data from healthy adults and 
from a large clinical population of CF patients in all age groups in different 
countries. A longitudinal study would be needed to assess how health-related 
quality of life evolves over time in individuals.  
Obviously, the CFQ cannot be used as a quality of life measure for 
healthy children because it does not cover all aspects of quality of life in healthy 
children. It is especially designed for the evaluation of health-related quality of 
life of patients with CF. Therefore, the primary objective of this study is to 
optimize the interpretation of CFQ-scores in young patients with CF. The CFQ 
allows specific issues to be identified, addressed and monitored over time. 
However comparison against ‘norms’ is not always wanted. This new data allows 
us to see whether we are concerned about a CFQ score which is inherently 
‘normal’ or not for the CF child’s age and gender, but it must also be related to 
whether it is perceived as a problem regardless of whether it relates to the 
influence of the CF on the child or not.  
 
Consequences for patient care 
This study demonstrates that the majority of healthy children and adolescents do 
not gain maximum scores on a disease specific health-related quality of life 
instrument and that there are many differences between the outcomes on the 
different domains and age groups. This is important information if we want to 
interpret the health-related quality of life for individual patients based on the CFQ 
for treatment purposes. In healthy adolescents aged 14-20 most subjects scored 
on the domain ‘Vitality’ under 70 (median: 67), indicating that many healthy 
adolescents report feelings of tiredness, lack of energy or exhaustion. Therefore, 
a ‘Vitality’ score of 70 in an adolescent with CF does not automatically indicate a 
relation to his or her disease, but it can also be related to other factors NOT 
related to CF. Similarly, in children with CF, a suboptimal CFQ-score in the 
domain ‘Digestive symptoms’, does not always implicate that these symptoms 
are due to their disease because recurrent abdominal pain is a common 
complaint in normal childhood and in many cases an underlying cause is not 
found [19]. However, a score of 70 in a young boy (aged 7 years) with CF on the 
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domain ‘Body image’ is low compared to age-matched healthy controls, and 
deserves more CF-specific attention. This study indicates that for the clinical 
interpretation of health-related quality of life of an individual patient with CF it is 
essential to pay attention to contextual non-disease specific factors such as age, 
maturation and gender. Incorporating disease specific questionnaires that 
assess different domains of quality of life in routine CF care may improve our 
understanding of the impact of CF on daily life [7]. A better understanding of this 
impact can facilitate communication between health care providers and patients. 
In addition, more patient-tailored treatments may be developed. As previous 
research has shown, better communication can improve treatment adherence 
[20-22]. Improving treatment adherence can improve quality of life in a majority 
of CF-patients. 
 
Conclusion 
The results of the present study provide us with a tool to optimize the 
interpretation of CFQ-scores in young patients with CF. Clinicians should be 
aware that the perception of health-related quality of life is not as disease-
specific as one might think and also relies on factors such as age, maturation 
and gender. Health-related quality of life scores based on the CFQ of individuals 
with CF should be interpreted within the context of normal development. A 
careful interpretation of health-related quality of life helps to improve patient-
tailored treatment. 
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General discussion 
 
In December 2004, Atul Gawande (a famous surgeon and writer) wrote a 
beautiful article in The New Yorker entitled ‘The better doctor’, in which he 
discussed standards of medical care [1]. He devoted a substantial part of his 
article to the care of patients with cystic fibrosis. He mentioned the Minnesota 
Cystic Fibrosis Center as probably the best center for patients with CF. Visiting 
this center, Atul Gawande was expecting to find a breakthrough drug, specific 
guidelines or information which would explain the differences in outcome 
between this center and other centers that were not doing nearly as well. He did 
not find any of these differences. What he did find out, however, was the 
remarkable way in which patients were treated and taken care of by Dr. Warren 
Warwick, the longtime manager of the CF program in Minnesota. The one thing 
that sets this doctor apart, according to Atul Gawande, was that this doctor 
regards each patient as an individual. This is in essence the theme of this thesis.  
Not one patient with asthma or CF is the same. So whether it concerns 
patients with CF or asthma, it is essential to pay attention to the individual 
psychosocial characteristics (in addition to the more medical or physical 
characteristics) in all three boxes of the research model presented in the general 
introduction. Tailoring treatment to these unique characteristics will help 
healthcare providers to motivate patients and their caregivers in optimizing their 
self-management and ultimately health outcomes in general. 
 
The general aim of the research presented in this thesis was to gain a better 
understanding about the various psychosocial parameters which are relevant to 
assess in the care of young patients with asthma and cystic fibrosis. In this 
section the results of the studies described in this thesis will be put into 
perspective with regard to the general aim and the existing literature on asthma 
and CF. This general discussion will start with a brief paragraph about the main 
findings of our studies. Next, we will put these findings in a clinical perspective. 
Subsequently, we will discuss methodological considerations and continue with a 
discussion about future research objectives. Finally, we will summarize the 
clinical implications of the studies. This chapter ends with a view on future 
perspectives and opportunities. 
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Main research findings 
In the Chapter 2 we have shown that, in accordance with our research model, 
both the psychological characteristics of the affected children and their 
caregivers indeed contribute to the course and possibly also to the onset of 
asthma. More recent studies confirm these findings [2-4]. 
 
In agreement with current literature and concordant with our hypothesis we have 
reported in Chapter 3 that psychosocial problems in general do occur very often 
in young patients with asthma [5, 6]. However, these problems are hard to 
assess with a disease-specific health related quality of life instrument. This 
chapter shows why it is important to not only view children with an illness from a 
disease-perspective, but also from a more general developmental perspective. 
Moreover, this chapter illustrates why it is important to integrate the views of 
family caregivers with those of their adolescent children. We will elaborate on 
this theme slightly more in the section about consequences for clinical care.  
 
When considering our research model, we have shown in Chapter 4 that it is 
undesirable to focus on one overall outcome (such as asthma control or 
spirometry) with respect to the outcome measurements (Box 3). We advise to 
integrate outcome measurements on all three domains of Box 3 (physical, 
psychological and social) with objectives and subjective measurements (such as 
PRO's), because they provide unique information, add specific knowledge to the 
integral health outcome and are therefore essential for the provision of 
personalized medicine. This is in agreement with recent findings that it is 
important in asthma management to combine different outcomes [7-9]. 
 
In Chapter  5 we have focused on the psychosocial health of young patients with 
CF and their family caregivers and found similar results compared to previous 
chapters on asthma: patients and caregivers are at risk regarding the 
development of a wide variety of psychosocial health problems and risk factors. 
The assessment of these important factors from our research model deserves 
systematic attention in clinical care. In our introductory chapter we mentioned 
why it is important to consider a developmental perspective.  
 
This developmental perspective is reflected in our closing Chapter 6, in which we 
have shown that even healthy peers do not obtain maximum scores on a 
questionnaire to measure different aspects of health-related quality of life 
specifically designed for CF. The most important finding of this study is that in 
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the assessment of psychosocial issues in a chronic ill population it is important to 
take general factors such as age, gender and normal maturation into account 
besides disease-specific considerations. This is also reflected in our research 
model in which disease-related risk factor and disease-related mediating factors 
are combined with more general stressors and mediating factors which both 
account for the diverse health outcomes in Box 3. 
 
Main findings in clinical perspective 
The major findings of our studies support earlier findings that psychosocial 
factors are relevant to assess when treatment of young patients with asthma or 
CF is aimed at an improvement of health on all three domains of our research 
model (physical, psychological and social). Fortunately, clinicians are nowadays 
more aware of the fact that patients do not only experience physical symptoms, 
limitations and complaints. They increasingly realize that the psychosocial 
wellbeing and illness beliefs of patients with chronic illnesses and barriers to 
adhere to their treatment are also important factors to take into account in 
providing optimal care for this population. In this respect psychosocial health 
should be a treatment goal in itself, besides the physical health of patients. 
Moreover, we have shown that a psychosocial assessment can also be an 
important tool to identify unique risk factors (Box 1) or mediating factors (Box 2) 
in an individual patient. Considering these unique individual characteristics may 
improve patient-tailored care and/or self-management for better overall (physical, 
mental and social) outcomes. Due to this growing knowledge of the intriguing 
interplay between the mind and the body, psychosocial issues have attracted a 
growing interest in research. For example, quality of life instruments are used 
often as a primary outcome in many medical intervention studies [10, 11]. In the 
past decades a large number of new questionnaires (measuring a wide variety of 
psychosocial issues or concepts) were designed and tested for validity and 
reliability, with the ultimate goal to not only be used for research purposes, but 
also in clinical care [12]. However, these standardized patient-reported outcomes 
(PRO’s) have not been implemented yet until now on a large scale in clinical 
care. The degree to which psychosocial topics are discussed in medical 
consultations usually depends on the individual health care provider’s 
knowledge, skills, time, motivation and ability to discuss these themes, and to 
tailor treatment plans to individual strengths, weaknesses and characteristics. 
Hypothetically, there are different reasons why the structured assessment of 
’PRO's have not been implemented yet in clinical care on a large scale: 
- Lack of time or resources to set up a screening method. 
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- Lack of knowledge about the questionnaires to be used. 
- Lack of appropriate cut-off scores or reference values.  
- Doctors’ opinions that assessing mental and social issues is outside the 
scope of their ‘medical’ responsibility. 
- Lack of confidence in health care providers on how to discuss potential 
problems or risk factors. 
- Lack of adequate ways to refer people to specialized mental health 
workers. 
 
However, this thesis shows that psychosocial problems and risk factors can be 
assessed in daily clinical practice and that these assessments add valuable 
information to the more medical information. Based on the findings in our thesis, 
we believe that if PRO’s are used more systematically in clinical care, they will 
help health care providers to tailor specific interventions based on patient’s or 
family’s needs. In the studies described in this thesis we have shown that young 
patients with chronic respiratory diseases are at risk of experiencing 
psychosocial problems to a high degree. These problems or risk factors can lead 
to worse health outcomes and, even worse, appear to be easily neglected in 
medical care [13].  
 
One of the reasons why many interventions intended to improve adherence and 
self-management have marginal effects on health outcome measurements is 
probably related to the fact that ‘general’ interventions do not attack the unique 
pitfalls for the individual patient and his family. I will provide some examples from 
clinical experience: For some patients and/or family caregivers a written action 
plan is a good intervention for promoting adherence, especially, when for 
example, caregivers are divorced, or find it difficult to remember all the provided 
medical advice. For other families a written plan of action does not automatically 
improve adherence, especially when dysfunctional cognitions regarding possible 
side-effects of medications hamper the long-term use of corticosteroids. 
Recently, data from a large study in the Netherlands (PIAMA study) showed that 
high parental concerns about, for example, medication dependence and adverse 
effects or a reduced effectiveness with long-term medication use were 
associated with a higher risk of uncontrolled asthma at the age of 8 [14]. 
Challenging people to change these dysfunctional cognitions into helpful 
cognitions and worry less is a more promising tool for improving adherence 
compared to a written plan of action in this particular case. This is also true for 
children with psychosocial problems: if caregivers report oppositional defiant 
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behavior in their child with asthma, training them to use effective parent 
management techniques may be a better solution for improving adherence for 
this family, especially when this oppositional behavior interferes negatively with 
taking medications on a regular basis. A young girl with CF and a comorbid low 
body-image will have more troubles gaining weight. Interventions to promote 
nutritional intake must take this problem into account. When the dietician only 
educates the girl about the good effects of gaining weight on her CF, without 
paying attention to her dysfunctional cognitions regarding her weight, the 
interventions of this dietician will probably not lead to better health outcomes in 
the face of an increased weight. These examples show the importance of 
assessing the various factors of Box 1, 2 and 3 of our research model and 
considering them in clinical care. 
 
Methodological considerations 
Although the results of our studies add important information to the available 
literature, our results still warrant careful consideration. Most importantly, the 
descriptive studies in this thesis all had a cross-sectional design. Because there 
are no longitudinal data, we can only make conclusions about how factors are 
interrelated at a certain time. Based on these and previous results, we expect 
that these parameters will also influence each other reciprocally over time [15-
18], but data (except for chapter 1) in this thesis are not able to underpin this 
theory. Besides the design of our studies two other aspects deserve more 
attention: the generalizability of the results and the limitations of the 
questionnaires we used in our studies.    
  
Generalizability of study samples 
The studies described in this thesis concerned data of different samples of 
young patients with chronic pulmonary diseases that were collected in the 
context of our research objectives. Because only patients with asthma referred to 
pediatricians and pediatric pulmonologists (in secondary and tertiary care) were 
included in our studies, we do not know whether our results also apply to young 
patients with asthma in primary care. 
Although the inclusion rate was high, we cannot exclude the role of 
selection bias. In theory, it is conceivable that patients and/or caregivers with 
more severe psychosocial problems did not want to participate in the studies 
because it was a too great burden. However, we know from clinical experience 
that in particular caregivers with a great burden are usually more than willing to 
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participate in this study, especially because they underpin the importance of 
psychosocial research in this population.  
Another important aspect regarding the generalizibility is the age range of our 
included patients and caregivers. As shown in our research model and 
introduction, it is important to take differences into account in developmental 
phases. For example, we discussed a study in the third chapter in which we 
included adolescents from the age of 11. Based on the findings in this study we 
cannot draw any conclusions about how younger children would rate their 
asthma-related quality of life or their psychosocial well-being in general. 
However, previous research has shown that even children from the age of 5 
years old are capable of providing reliable information about their asthma-related 
quality of life on a pictorial version of the Pediatric Asthma Quality of Life 
Questionnaire [19]. In the nearby future many more of these instruments will 
probably be developed to assess different important psychosocial factors in this 
relatively young age-group. 
Family caregivers participating in our studies were mostly female. This is 
not surprising, given the fact that mothers still tend to be the primary caregiver in 
most families and accompany their child with hospital visits more frequently than 
fathers. However, and this also applies to female caregivers, the commitment of 
fathers to their children (and of course to their own psychosocial well-being), 
influences the development of the child in very many important and different 
ways [20-23]. For example, the National Literacy Trust showed in 2001 that, 
regardless of the quality of the mother-child relationship, the closer children were 
to their fathers, the happier, more satisfied and less distressed they reported to 
be later on in life [24]. Fortunately, the emotional well-being of the paternal 
caregivers of chronically ill children has received more attention in recent years 
[25, 26]. Broger stated in her article of 2011 that it is important to provide 
appropriate psychosocial resources with a family-centered focus to fathers of 
chronic ill children. It can promote the effective coping of fathers to increase the 
level of involvement in the child's life, an important determinant in the 
development of a child. So providing appropriate psychosocial and medical care 
for a child is only possible if we include the entire family, and not only focus on 
the mothers and their children [24]. Fathers might provide different, unique 
information which can be of added value to tailor the treatment to specific needs 
of families with a chronic ill child. Unfortunately, because of a lack of financial 
resources we were not able to include both caregivers in our studies. 
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Although we included participants from more than one centre and from different 
cities in the Eastern and Southern part of the Netherlands, it is plausible that the 
percentage of participants with asthma and a non-Caucasian ethnic origin are 
underrepresented in our study, because the majority of non-Caucasian ethnic 
groups live in the western part of the Netherlands. Van Dellen et al. showed that 
ethnicity as well as an insufficient comprehension of the Dutch language are 
independent risk factors for uncontrolled asthma [27]. Ethnicity or language 
comprehension may be regarded as personal factors from Box 1 of our research 
model. 
 
Limitations of questionnaires 
In our studies we used several instruments to measure different factors of our 
research model. As stated before, all these instruments have their own strengths 
and limitations: norm groups were lacking for some instruments (for example, the 
Illness Cognition Questionnaire or the Asthma-related Quality of Life 
Questionnaire for patients and caregivers) or the norm groups were not 
completely appropriate for this population. We, for example, used the NOSIK as 
a measurement of parenting stress in caregivers of patients between the age of 
1 and 18 years. However, cut-off scores derived from the manual of the NOSIK 
were assessed in a smaller age range. Another example: norm scores of the 
SDQ were derived from the study of Goedhart and it is a matter of debate 
whether these norms are appropriate because there was a high rate of non-
responders in the sample of caregivers [28]. Despite these limitations, we used 
this instrument in our studies because it is a brief instrument that can screen on 
a wide variety of psychosocial problems, it is easily accessible and free of 
charge compared to for example, the famous questionnaires of the Achenbach 
System of Empirically Based Assessment (ASEBA) [29]. 
 
Future research 
Based on the results of the studies described in this thesis and the 
methodological considerations stated in the previous paragraph, we will highlight 
five recommendations for future studies:  
 
1. Longitudinal design  
The studies presented in this thesis provide new insights into a number of small 
(but important) pieces of a major puzzle. Large, prospective studies that 
integrate these factors are greatly required to analyze potential causal 
relationships and learn more about how these factors influence each other 
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reciprocally over time. More knowledge about the complex interaction between a 
broad spectrum of psychosocial and physical factors is essential to reduce the 
burden of asthma and cystic fibrosis in the future. 
 
2. Expanding the research population 
Based on the limitations of generalizibility that were mentioned in a previous 
paragraph, it would be more than interesting to broaden the research population 
in future studies and add patients in primary care, both male and female 
caregivers, siblings, younger children and adult patients. The data in this thesis 
are based on a research population from the eastern part of the Netherlands (for 
the asthma studies). From previous research we know that there may be 
important differences between different states, countries or different parts of the 
world. A cross-region or cross-country comparison can make it very worthwhile 
to study potential differences in how psychosocial factors influence disease 
outcomes. Aspects of how care is organized, but also cultural, developmental or 
religious aspects, will most probably have an important effect on how people 
cope with their own illness or the illness of a family member (Box 2 in our 
research model). Aspects such as accessibility, satisfaction with care, financial 
burden (due to differences in how care is financed) or different beliefs about the 
treatment and origin of asthma or CF may differ between different regions. 
Therefore, comparing information from different countries may give us advanced 
insights on how to improve health care systems and improve the treatment for 
individual patients.  
This intriguing interplay between psychosocial factors and overall health 
does most probably not only apply to the two chronic pulmonary diseases 
asthma and CF, but also (to some extent) to other chronic pediatric illnesses 
such as diabetes, rheumatoid arthritis or dermatological diseases in childhood. 
Combining scientific evidence and clinical experiences in a wide range of chronic 
pediatric illnesses may accelerate future developments in this field. 
 
3. Increasing the validity of psychosocial screening instruments 
Based on the limitations of the questionnaires we used, as described in the 
paragraph above, it is essential to expand our knowledge on reference data of 
patients, caregivers and healthy peers and studying appropriate cut-off scores if 
we want to use patient reported outcomes in clinical care to their full potential. 
For example, the CFQ-R and the PA(C)QLQ are two very promising tools in 
assessing various health related quality of life domains in patients with CF or 
asthma. However, there are no appropriate cut-off scores at present. Therefore 
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we do not know which score ranges are indicative for ‘at risk’ (and therefore 
require special attention) or are in the ‘normal range’.  
 
4. Combining questionnaires to identify the most powerful items 
As stated before, it is not feasible to ask patients and caregivers to fill out 
hundreds of different questionnaires, as many questionnaires have a 
considerable overlap and are (therefore) time consuming. For example, the 
PAQLQ and the ACQ both include items on symptoms of how asthma is 
controlled. On the other hand, our studies have shown that it is important to 
screen on a broad spectrum of aspects and that the assessment of disease 
specific health-related quality of life is insufficient to provide an overall view of 
important other ‘more general’ psychosocial factors. In order to overcome this 
problem, future research should focus on the development and testing of a 
screening battery in which items of several instruments are combined and 
overlap is avoided. This instrument should be as brief as possible, but still 
requires sufficient items to warrant adequate reliability. Peters et al. (2009) have 
done an incredible job in developing such a screening instrument for the adult 
patient with COPD. This instrument, referred to as the Nijmegen Clinical 
Screening Instrument, may be an example of what is needed in the pediatric and 
adolescent asthma and CF care [30]. 
 
5. Feasibility & effect studies 
Before the implementation of psychosocial assessment based on the patient- or 
caregiver-reported outcomes in clinical care, research must establish that these 
types of assessments are feasible and effective. A good example of such a 
feasibility study has been published by Kazak et al. in 2011. She showed that a 
psychosocial screening tool was feasible in the care for young patients with 
cancer in clinical care and that it was associated with more documentation of 
psychosocial risk factors in medical records [31]. In 2007, Goldbeck investigated 
the feasibility of monitoring the quality of life in a clinical setting of 108 
adolescent and adult outpatients with CF. The quality of life was repeatedly 
assessed parallel to each pulmonary function test (2–16 assessments per 
patient within 18 months). He showed that the acceptance of the method was 
good, according to the feedback from patients and staff, and only one patient 
refused to repeat the assessment [15]. These findings are in agreement with the 
conclusion of the study of Detmar in 2003, in which she concluded that the use 
of patient reported outcome is feasible in clinical care and that it facilitates 
patient-physician communication. She states that ‘It seems likely that effective 
Chapter 7 
154 
 
communication will lead to increased recognition of patients’ problems, which in 
their turn, will result in appropriate medical actions (e.g. referrals, medication 
prescriptions)’. This may ultimately lead to an improvement in all three domains 
of Box 3 in our research model [32]. In a multicenter randomized controlled trial 
de Wit et al. showed that the monitoring and discussion of health-related quality 
of life in adolescents with type 1 diabetes during medical consultations had 
positive effects on the psychosocial well-being of most patients 12 months later. 
They also showed that adolescents in the intervention group were more satisfied 
with care [33]. 
The samples mentioned above show that evidence is available and that 
it is increasing. Nevertheless, the total evidence that the use of patient-reported 
outcomes and assessment of relevant psychosocial factors is feasible in clinical 
care and can have positive effects on themes such as patient satisfaction, 
patient-doctor communication (Box 2), or even health outcomes (Box 3), is still 
limited and requires further research [34]. 
 
Clinical implications 
Based on the findings in our studies we advise to take the following six 
recommendations into account in the clinical care for young patients with CF 
and/or asthma: 
 
1. Systematic screening of relevant psychosocial issues by using patient 
reported outcomes 
The standardized screening of a wide range of psychosocial factors, which are 
important background (Box 1), mediating (Box 2) or outcome measurements 
(Box 3) should be incorporated into clinical guidelines and requires systematic 
attention in clinical care, alongside the use of more 'traditional' physiological 
based parameters such as spirometry, physical exams, blood tests, X-rays or the 
medical (interval) history. Patients with a beautiful FEV1, however with an 
uncontrolled asthma, or who are suffering from severe depressive symptoms 
may run a greater risk to experience more serious health outcomes in the nearby 
future than patients with some small obstructions in their airways, but with a 
good asthma control and no other psychosocial health problems or risk factors. 
The use of patient-reported outcomes provides valuable information, not only for 
measuring health outcomes (Box 3), but also for offering tailor-made treatment 
on the basis of individual characteristics from Box 1 or 2 of our research model. 
Patient-reported outcomes are not only relevant for psychosocial issues, but also 
for example on how patients and caregivers assess their more physical health 
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status (for example in the case of asthma control, physical complaints or the 
identification of exacerbations).  
 
2. Repetition of assessments 
Repeated assessments offer the possibility to follow a patient and/or his 
caregivers over a longer period. Positive or negative changes in various 
psychosocial parameters can be detected in time and could be tackled by 
adequate interventions. Some parameters are prone to more rapid changes than 
others. For clinical care this means that some assessments, for example on how 
asthma is controlled, should be assessed more often compared to health beliefs 
about medication that are unlikely to change each month. An additional reason 
why, especially in pediatric care, psychosocial assessments should be repeated 
is the fact that children develop very fast and that every age has its own tasks 
and challenges. Moreover, asthma and CF are sensitive to rapid change in 
disease activity in this particular period, because of physical and psychosocial 
changes in adolescence. The disease management of young children and 
adolescents will change rapidly over time. For example, a young girl who takes 
her medication very regularly can change into a non-adherent adolescent within 
a very short period, because she does not like being different anymore, rebels 
against the rules of her caregivers in her battle for independence or is afraid she 
will gain too much weight in a period in which her body image is very important 
for her overall self-esteem. Therefore, psychosocial assessments are dynamic 
processes that have to be followed up on a regular basis, especially in a young 
population. 
 
3. Assessments should be adapted to specific developmental ages 
Our third recommendation is also based on our research model as well as on the 
results we found in several chapters. As discussed in the introduction and 
already mentioned in the above paragraph, young children are not merely small 
adults: a 3-year old boy has completely different tasks than a boy of 6. It is 
impossible to ask a two-year old child about his asthma control, in contrast to an 
adolescent of 11, who is usually very capable of providing reliable information 
from his point of view about how well his asthma is controlled. Not only the way 
in which children are able to provide adequate feedback about how they feel or 
think about specific subjects change over time, but also the specific tasks they 
have to face regarding their developmental age and self-management. For 
example, younger (pre-school) children very often have sleeping problems, 
which may be a cause of parenting stress, in contrast to children of school age, 
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who have sleeping problems less frequently, but who may experience more 
social and internalizing problems [35]. A two-year old has few self-management 
tasks regarding his disease, in contrast to an adolescent, who is increasingly 
responsible for his own treatment and should be able to adequately interpret 
signs of an upcoming exacerbation. For these reasons the items in a 
psychosocial assessment must be adapted to specific developmental ages. The 
same obviously applies to the parental tasks for caregivers and the potential 
psychosocial barriers they face when their child is younger compared to a later 
age. Disease-specific management tasks differ according to the developmental 
phase of their children, but also according to the more general tasks children and 
their caregivers face in everyday lives. 
 
4. The information from multiple informants should be integrated 
(caregivers, patients and clinicians) 
In contrast to the care of adults with chronic illnesses, caregivers are both 
important informants and health care receivers in the care of young patients with 
chronic illnesses. As shown in all three boxes in our research model, a system- 
oriented perspective is therefore important over all ages. In agreement with 
previous research, we showed that not only patients are vulnerable to 
developing psychosocial problems, but caregivers are also at risk of developing 
psychosocial problems [36, 37]. It is important to integrate perceptions of both 
children and their caregivers: neglecting the needs or beliefs of caregivers will 
eventually lead to non-tailored care, which may affect various outcomes. For 
example, incorrect beliefs of caregivers regarding the need or possible side-
effects of inhaled corticosteroids are an important cause of non-adherence in 
children [38]. On the other hand, when pediatricians focus only on the caregiver 
and ignore the view of children, they may miss significant opportunities to teach 
children to cope with their disease independently. Most of the disease 
management occurs at home and teaching children adequate symptom 
perception and what they have to do when they experience symptoms, 
disturbing feelings or distress is the first step in teaching them to cope with their 
illness in daily life.  
Another reason why it is important to consider the psychosocial health of 
caregivers is that previous research has shown that children of parents with 
mental health problems are more likely to develop psychosocial problems 
themselves [39, 40] . In conclusion, the system-oriented view incorporating the 
primary caregivers is essential in pediatric and adolescent respiratory care. We 
therefore advocate that both pediatric patients with chronic pulmonary diseases 
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as well as their primary caregivers are to be involved in psychosocial 
assessments. 
 
5. Using a combination of generic and disease-specific questionnaires 
As shown in chapter 3 and chapter 6, disease specific questionnaires focus on 
disease-specific items relevant for the particular disease, and usually neglect 
more general psychosocial health problems or risk factors. These instruments 
can be of significant value in clinical care. However valuable information is 
added when generic items are used alongside disease-specific questions or 
results are placed in a broader perspective than merely from a disease point of 
view. Besides having a medical illness, all patients may experience comorbid 
problems (in psychological, physical or social domains) which are initially not 
associated with their illness, but which may ultimately affect disease outcome on 
all three domains of health. For example, a child with CF who is being bullied at 
his football team may lose its self-esteem and stops playing football. In the 
beginning there may not even be a relation between the bullying and the child 
having CF, but in the end the bullying may result in problems adhering to a 
healthy, sporty lifestyle. In chapter 3 and 4 we used a questionnaire to measure 
the asthma-related quality of life. Although most of these scores were relatively 
good (adequate cut-off scores are lacking), caregivers reported more 
psychosocial problems in general in their child on another less disease-specific 
questionnaire. Clinicians who only use this asthma-specific questionnaire may 
miss more general psychosocial health problems or risk factors in their patients. 
A combination of generic and disease-specific questions could optimize the 
interpretation of psychosocial assessments. 
 
6. Interdisciplinary approach / Referral of patients and caregivers at risk 
Merely screening does not suffice to solve the problems which may arise in 
assessments. Screening may be the starting point for a conversation with 
patients or caregivers about which problems they face in everyday life. It can 
facilitate effective coping strategies such as the problem-solving strategies of 
patients and their relatives. It may also facilitate the communication between 
health care providers and receivers as a tool to promote patient-tailored care and 
shared-decision making. However, a doctor is not specifically trained for the 
treatment of severe or persistent mental health problems. Patients and 
caregivers who are at risk of developing severe psychosocial problems should 
be referred to specialized mental health workers for adequate diagnostic 
procedures and treatment, who are experienced in dealing with chronic 
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pulmonary diseases. Therefore a medical psychologist should be part of each 
multidisciplinary team for young patients with chronic pulmonary diseases. Nobili 
et al. have done an incredible job in describing the guiding principles for 
psychosocial professionals on how to manage relevant psychological aspects 
within a CF team from an interdisciplinary approach [41]. Such a framework can 
be of use for other chronic respiratory diseases. 
 
Future perspective and opportunities 
In recent decades health care has greatly advanced from a physician-managed 
care model to a more patient-partnership model [42]. In the 21st century, shared 
decision-making will be promoted even more as an important tool to improve 
patient involvement and self-management, in particular of chronic ill patients and 
their relatives. The evidence-based contributions of clinicians to treatment plans 
will have to consider the patient’s preferences and the physician’s abilities to 
tailor treatment to the specific needs of the individual patient and his family. 
Asthma education tailored to individual patient requires optimized partnerships in 
asthma self-management [43]. One major development of recent years and a 
promising tool for promoting this active involvement of the patient is the great 
amount of new information and the many communication technology 
applications. E-health applications have the possibility to positively enhance the 
role patients and their caregivers play in the management of their chronic illness. 
This is especially the case with asthma and CF, where patients have to adhere 
to a daily complex treatment and their self-management is of great importance, 
E-health may be a promising tool. A recent Cochrane review of McLean et al. 
showed that telehealthcare interventions appear to have the potential to reduce 
the risk of admission to hospital, in particular for patients with severe asthma 
[44]. Petrie et al. showed that a text message program designed to modify the 
beliefs of patients regarding their illness and treatment improves the self-
reported adherence to asthma prevention medication [45]. Another study by 
Chan et al. showed that an internet-based home monitoring and education of 
children with asthma was comparable to an ideal office-based care in a one year 
prospective study [46]. There are many more studies which have already proved 
the effectiveness of such interventions in an asthmatic population [47-50]. E-
health applications are also attracting a growing attention in the field of CF, 
although effect studies are still scarce, [51-53]. This is not surprising in view of 
the fact that this is a group of relative young patients and caregivers, in which the 
use of new information and communication technology is highly incorporated in 
the daily lives of many children and adolescents living in the Western world. 
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Regarding the subject of this thesis, psychosocial screening through ICT 
applications could have some major advantages in comparison with old- 
fashioned paper and pencil assessments [54]: they can provide visual feedback, 
they are less prone to errors, analyses and results can be automatically 
generated, which makes the assessment less time-consuming and they could be 
cost-effective. Moreover, they can be available 24/7, overcome physical 
distances, are accessible everywhere with an internet connection and are 
environmental friendly.  
 
Conclusions  
In agreement with the summary and discussion, the main conclusion of this 
thesis can be formulated as follows: A broad spectrum of psychosocial factors of 
patients with asthma or CF and their caregivers deserves systematic attention in 
clinical care. These factors can be assessed by using validated patient- and/or 
caregiver-reported outcomes, which should be incorporated in standard 
protocols and implemented systematically in clinical procedures. 
 
We started this thesis with the story of Eric and Jane, two patients both with a 
chronic pulmonary disease. At the beginning of this general discussion we 
shared our hypothesis that health care for children with chronic respiratory 
disorders will improve when each child is regarded as an individual. We hope 
that psychosocial assessment will be a standard part of care for all patients with 
chronic lung diseases in the nearby future and that it will contribute to improved 
integral health outcomes. We believe this could lead to a happy ending in the 
closing chapters of the stories of Jane and Eric: 
 
 
 
 
 
 
 
 
 
 
 
 
 
After completing the psychosocial assessment and the discussion with her 
parents, Jane is referred for specialized psychological help. With the 
assistance of a pediatric psychologist she learns to break the vicious circle of 
fear and avoidance by applying several techniques based on a cognitive 
behavioral therapy (such as relaxation, identifying and changing dysfunctional 
thinking and exposure). 
After a few months Jane’s mother reports a major change in Jane’s behavior, 
it feels like having her ‘old’ daughter back. Jane is active again. She enjoys 
going to school again and playing with her friends. She takes her asthma 
medications more regularly and her asthma is better under control.  
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After completing the psychosocial assessment, the pediatric pulmonologist 
discusses the results with Eric and his caregivers. Besides the oppositional 
defiant behavior of Eric, his father reports elevated levels of anxious 
symptoms and parenting stress. In this conversation, Eric’s father tells that he 
has troubles combining his work load with taking care of his family and coping 
with the chronic disease of his eldest son. Eric and his parents are referred 
for specialized psychological help.  
A few months later the father of Eric tells the pediatric pulmonologist that he is 
feeling much better. He changed his working hours and learned new ways to 
cope with his daily hassles and worries. Eric is also doing much better: he 
spends more time with his father, while discussions and arguments about 
daily regimes (such as bedtimes, taking medications and doing homework) 
take place less frequently.  
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Summary 
 
In this thesis we studied psychosocial aspects relevant for pediatric management 
of asthma and cystic fibrosis. The first part of the thesis reported on psychosocial 
aspects of asthma and the second part focused on cystic fibrosis. 
 
In Chapter 2 we systematically reviewed the literature on all studies available at 
that time that investigated the longitudinal relationships between the 
psychological characteristics of children and adolescents suffering from asthma 
and those of their caregivers, and the onset and course of the asthma. Relevant 
studies were identified using Medline, PubMed, and PsychINFO between 1970 
and September 2009. Twenty studies matching inclusion criteria were reviewed. 
Six studies focused on child-specific psychological characteristics in relation to 
the onset and course of asthma. No compelling evidence was found for an 
association with asthma onset, but there was some evidence that the child’s 
psychological characteristics can contribute to the subsequent course of asthma. 
Fourteen studies considered the effects of the psychological characteristics of 
the caregivers. Eleven studies established significant relationships between the 
psychological problems of caregivers and the subsequent onset and unfavorable 
course of the asthma in the child. We concluded that both the psychological 
characteristics of the affected children and their caregivers appear to contribute 
to the course and possibly also to the onset of the condition in pediatric asthma.  
 
The study presented in Chapter 3 explored whether an asthma-related quality of 
life instrument was able to identify children with asthma who are at risk of 
developing serious mental health problems. In a multicentre study psychosocial 
problems (Strengths and Difficulties Questionnaire) and asthma-related QoL 
(Pediatric Asthma (Caregivers) Quality of Life Questionnaire) were established in 
children and adolescents with asthma, aged 6-16 years, and their caregivers. In 
total 339 children and adolescents (response rate 95%) from four pediatric 
outpatient clinics in the Netherlands with doctor-diagnosed asthma participated. 
Of the caregivers, 43% reported major or minor psychosocial problems in their 
child or adolescent, which is twice as much than in the reference group, whereas 
the percentage of adolescents reporting psychosocial problems was comparable 
to a reference population. Adolescents and caregivers reported few impairments 
in asthma-related QoL (median score between 6.2 and 7.0). However, an 
optimal asthma-related QoL did not rule out major psychosocial problems: 10% 
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of the adolescents with an optimal asthma-related QoL score reported major 
psychosocial problems. And major psychosocial problems were reported in one 
out of seven children with an optimal caregiver’s asthma-related QoL score. We 
concluded that the prevalence of psychosocial problems in children and 
adolescents with asthma is considerable. The assessment of asthma-related 
QoL in itself is insufficient to identify those children with major psychosocial 
problems. We recommend the implementation of psychosocial screening, 
besides assessment of asthma-related QoL, in routine pediatric asthma care, to 
improve patient-tailored care and asthma management.  
 
In Chapter 4 we studied the relationship between the patient- and caregiver-
reported outcomes (Asthma Control Questionnaire (ACQ) and Strengths and 
Difficulties Questionnaire (SDQ)) and physiological parameters (FEV1 and 
Fractional exhaled Nitric Oxide) in adolescents with asthma. The second aim in 
this chapter was to study the concordance between adolescents and caregivers 
regarding the reports of asthma control and psychosocial problems. A 
multicentre observational study was performed, in which adolescents between 
the age of 11 and 16 with doctors’ diagnosed asthma were recruited in four 
Dutch pediatric outpatient departments. 48 adolescents and their caregivers 
participated in this study. Asthma was uncontrolled in about 30%. Asthma control 
was not associated with age, gender, FEV1, FeNO, or psychosocial problems 
(SDQ-score). Agreement between adolescents and caregivers about how well 
asthma was controlled was moderate (κ = 0.577, p<0.01). Based on these 
results we suggest to use validated patient- and caregiver-reported outcomes 
(such as the asthma control questionnaire and psychosocial screening 
instruments) in routine adolescent asthma care. 
 
In Chapter 5 we discussed the psychosocial health of young patients with cystic 
fibrosis and their caregivers. In this cross-sectional study adolescents (aged 12-
17), young adults (aged 18-35), and caregivers (of children aged 1-17) from all 
seven cystic fibrosis centers in the Netherlands were recruited. Participants 
completed a battery of questionnaires concerning anxiety (Hospital Anxiety and 
Depression Scale (HADS)), depression (HADS/ Centre for Epidemiological 
Studies - Depression (CES-D)), psychosocial health in general (Strengths and 
Difficulties Questionnaire (SDQ)), illness cognitions (Ziektecognitielijst 'Illness 
Cognition Questionnaire' (ZCL)), treatment adherence (Morisky Medication 
Adherence Scale (MMAS-4)), CF-specific quality of life (Cystic Fibrosis 
Questionnaire- Revised (CFQ-R)) and parenting stress (Nijmeegse Ouderlijke 
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Stress Index - short version 'Parenting Stress Index' (NOSIK)). 383 patients and 
266 caregivers participated. Twenty percent of the young adults and 17 percent 
of the adolescents reported clinical or elevated levels of psychosocial health 
problems. Approximately one third of all caregivers reported psychosocial health 
problems in their child on at least borderline level and 28% of all participating 
caregivers reported having elevated levels of psychosocial health problems 
themselves. Adult patients reported overall more psychosocial health problems 
and risk factors (such as more depression, more helplessness, less acceptance 
and lower quality of life scores) than their younger counterparts. Self- and 
caregiver-reported treatment adherence dropped from childhood to adulthood to 
rates of poor adherence up to more than 80%. Therefore, in conclusion, we 
showed that elevated levels of psychosocial health problems are common in 
both young patients with CF as well as in their caregivers and self- or caregiver-
reported treatment adherence is poor. Assessing psychosocial health problems 
and risk factors in the care for patients with CF (and their caregivers) is therefore 
important over different age groups and requires further investigations.  
 
In Chapter 6 we collected data of a CF-specific health related quality of life 
instrument (Cystic Fibrosis Questionnaire (CFQ)) in healthy children and 
adolescents, with the aim to refer health status of CF youngsters to that of 
healthy peers. The CFQ was completed by 478 healthy Dutch children and 
adolescents (aged 6-20) in a cross-sectional study. We found that the majority of 
healthy children (over 65%) did not reach maximum scores on most domains of 
the CFQ. Median CFQ scores of healthy children and adolescents ranged from 
67 to 100 (on a scale of 0-100) on the different CFQ domains. Significant 
differences in health-related quality of life were reported among healthy children 
and adolescents, and these depended on age and gender. We concluded that 
reference data of quality of life scores from a healthy population are essential for 
an adequate interpretation of quality of life in young patients with CF. Clinicians 
should be aware that the perception of health-related quality of life is not as 
disease-specific as one may think and that it also relies on factors such as age, 
normal maturation and gender. 
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In dit proefschrift staan een aantal studies centraal waarin diverse psychosociale 
aspecten onderzocht werden die relevant zijn voor de behandeling van kinderen 
en jongeren met astma en cystic fibrosis (CF). Het eerste deel van het 
proefschrift (hoofdstuk 2 t/m 4) richt zich op astma en het tweede deel 
(hoofdstuk 5 en 6) op CF. 
 
Hoofdstuk 1,  de algemene inleiding, geeft  een kort overzicht van de huidige 
inzichten binnen de pediatrische psychologie en astma en CF in het bijzonder. 
Een onderzoeksmodel wordt gepresenteerd en de achtergrond en vraagstelling 
van dit proefschrift alsmede de opbouw van de verschillende hoofdstukken wordt 
toegelicht. 
 
In hoofdstuk 2 hebben we systematisch alle beschikbare literatuur beschreven 
waarin een longitudinale relatie tussen enerzijds de psychosociale gezondheid 
van kinderen, adolescenten en hun ouders, en anderzijds het ontstaan en/of het 
beloop van astma bij het kind centraal stond. Relevante studies, gepubliceerd 
tussen 1970 en september 2009, werden geïdentificeerd met behulp van 
Medline, PubMed, en PsychINFO. Twintig studies voldeden aan de 
inclusiecriteria en werden beoordeeld. Zes studies richtten zich op de relatie 
tussen psychologische kenmerken van het kind en het ontstaan en/of beloop van 
astma. Er werd geen overtuigend bewijs gevonden dat psychosociale 
gezondheid van het kind geassocieerd was met het ontstaan van astma. Echter, 
er was enig bewijs dat psychosociale problemen van het kind kunnen bijdragen 
aan een ongunstiger beloop van het astma bij die kinderen die reeds bekend 
waren met astma. Veertien onderzoeken focusten op de relatie tussen de 
psychosociale gezondheid van ouders  en het ontstaan en/of het beloop van 
astma bij hun kinderen. Elf studies vonden significante relaties tussen de 
psychische problemen van ouders en het daaropvolgende ontstaan en 
ongunstige beloop van astma bij het kind. Wij concludeerden dat zowel de 
psychosociale gezondheid van de kinderen zelf als ook de psychosociale 
gezondheid van hun ouders blijken bij te dragen aan het beloop en mogelijk ook 
aan het ontstaan van astma in de kinderleeftijd. 
 
In hoofdstuk 3 is beschreven of een astmagerelateerd kwaliteit van leven 
instrument in staat is om kinderen met astma te identificeren die risico lopen op 
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het ontwikkelen van ernstige psychische problemen. In een multicenter studie 
werden psychosociale gezondheid (Strengths and Difficulties Questionnaire) en 
astmagerelateerde kwaliteit van leven (Pediatric Astma (Caregivers) Quality of 
Life Questionnaire) in kaart gebracht bij kinderen en adolescenten met astma in 
de leeftijd van 6-16 jaar, en hun verzorgers. In totaal hebben 339 kinderen en 
adolescenten met astma (respons 95%) van vier pediatrische poliklinieken in 
Nederland deelgenomen. Drie en veertig procent van hun ouders rapporteerde 
ernstige of matige psychosociale problemen bij hun kind of adolescent. Dit is 
twee keer zo veel als in een normale populatie, terwijl het percentage jongeren 
dat zelf deze psychosociale problemen rapporteerde vergelijkbaar was met een 
referentiepopulatie. Adolescenten en hun ouders rapporteerden slechts enkele 
beperkingen in astma-gerelateerde kwaliteit van leven (mediane score tussen 
6,2 en 7,0, bij een maximaal-score van 7). Echter, een optimale astma-
gerelateerde kwaliteit van leven sloot klinisch significante psychosociale 
problemen niet uit: 10% van de adolescenten met een optimale astma-
gerelateerde kwaliteit van leven score rapporteerde ernstige psychosociale 
problemen. Klinisch significante psychosociale problemen werden gerapporteerd 
bij een op de zeven kinderen waarvan de ouder een optimale score had op de 
astma-gerelateerde kwaliteit van leven vragenlijst. We concludeerden dat de 
prevalentie van psychosociale problemen bij kinderen en adolescenten met 
astma aanzienlijk is. De beoordeling van de astma-gerelateerde kwaliteit van 
leven op zichzelf is onvoldoende om die kinderen te identificeren met ernstige 
generieke psychosociale problemen. Uit eerder onderzoek is bekend dat 
psychosociale problemen een negatieve invloed kunnen hebben op het beloop 
van astma. Tijdige herkenning van deze problematiek is een eerste stap om dit 
negatieve effect op het ziektebeloop tegen te gaan. Wij adviseren de 
implementatie van screening op algemene psychosociale problematiek, naast de 
beoordeling van astma-gerelateerde kwaliteit van leven, in de gebruikelijke zorg 
voor kinderen en jongeren met astma, om zodoende de zorg voor deze groep 
jongeren te verbeteren en mogelijk ook hun astma beter te reguleren.  
 
In hoofdstuk 4 bestudeerden we de relatie tussen diverse 
gezondheidsuitkomsten die gerapporteerd werden door jonge patiënten en hun 
ouders (Asthma Control Questionnaire (ACQ) en Strengths and Difficulties 
Questionnaire (SDQ)) en fysiologische parameters (FEV1 en FeNO) bij 
adolescenten met astma. Het tweede doel van deze studie was om de 
overeenstemming tussen adolescenten en verzorgers met betrekking tot astma 
controle en psychosociale problemen te bestuderen. Een multicenter 
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observationele studie werd uitgevoerd, waarbij jongeren tussen de leeftijd van 11 
en 16 met astma werden geworven in vier Nederlandse kinderpoliklinieken. 48 
jongeren en hun ouders namen deel aan deze studie. Astma was  
ongecontroleerd in ongeveer 30%. Astmacontrole bleek niet geassocieerd met 
leeftijd, geslacht, FEV1, FeNO, of psychosociale problemen (SDQ-score). De 
overeenkomst tussen adolescenten en verzorgers over hoe goed de astma was 
gecontroleerd was matig (κ = 0,577, p <0,01). Deze resultaten laten zien dat 
kinderen met een goede longfunctie en een normale FeNO waarde toch een 
beperkte astmacontrole kunnen rapporteren. Op basis van deze resultaten raden 
wij aan gevalideerde patiënt en ouder-gerapporteerde gezondheidsuitkomsten 
(zoals de astma controle vragenlijst en psychosociale screening instrumenten) te 
gebruiken in de dagelijkse zorg voor adolescenten met astma. 
 
In hoofdstuk 5 staat de psychosociale gezondheid van jonge patiënten met 
cystic fibrosis (CF) en hun ouders centraal. In deze cross-sectionele studie zijn 
adolescenten (leeftijd 12-17), jongvolwassenen (leeftijd 18-35), en ouders (van 
kinderen in de leeftijd 1-17) van alle zeven CF-centra in Nederland geworven. 
Deelnemers vulden een batterij vragenlijsten in met betrekking tot angst 
(Hospital Anxiety and Depression Scale (HADS)), depressie (HADS / Centrum 
voor Epidemiologische Studies - Depressie (CES-D)), psychosociale gezondheid 
in het algemeen (Strengths and Difficulties Questionnaire (SDQ)), ziekte 
cognities (Ziektecognitielijst 'Ziekte Cognitie Vragenlijst' (ZCL)), therapietrouw 
(Morisky Medication Adherence Scale (MMAS-4)), CF-specifieke kwaliteit van 
leven (Cystic Fibrosis Questionnaire-Revised (CFQ-R)) en ouderlijke stress 
(Nijmeegse Ouderlijke Stress Index - korte versie 'Parenting Stress Index' 
(Nosik)). 383 patiënten en 266 ouders hebben deelgenomen. Twintig procent 
van de jongvolwassenen en 17 procent van de jongeren met CF rapporteerden 
ernstige of matig ernstige psychosociale gezondheidsproblemen. Ongeveer een 
derde van alle ouders rapporteerde psychosociale problemen bij hun kind op ten 
minste borderline-niveau en 28% van alle deelnemende ouders rapporteerde 
psychosociale problemen bij hen zelf. Volwassen patiënten rapporteerden in het 
algemeen meer psychosociale gezondheidsproblemen en risicofactoren (zoals 
meer depressieve symptomen, meer gevoelens van hulpeloosheid, minder 
acceptatie en een lagere kwaliteit van leven) dan jongere patiënten. 
Therapieontrouw (gerapporteerd door patiënten zelf en hun verzorgers) steeg 
van de kindertijd naar de volwassenheid tot meer dan 80%. Samenvattend 
kunnen we stellen dat psychosociale problemen vaak voorkomen bij zowel jonge 
patiënten met CF als ook bij hun verzorgers en dat zelf-of ouder-gerapporteerde 
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therapietrouw slecht is. Het is daarom belangrijk om in de zorg voor patiënten 
met CF (en hun verzorgers) psychosociale gezondheidsproblemen en 
risicofactoren in verschillende leeftijdsgroepen in kaart te brengen. Dit vereist 
nader onderzoek. 
 
In hoofdstuk 6 hebben we gegevens verzameld van een CF-specifieke 
gezondheidsgerelateerd kwaliteit van leven instrument (Cystic Fibrosis 
Questionnaire (CFQ)) bij gezonde kinderen en adolescenten, met als doel de 
gezondheidstoestand van CF jongeren te relateren aan die van gezonde 
leeftijdsgenoten. De CFQ werd ingevuld door 478 gezonde Nederlandse 
kinderen en adolescenten (leeftijd 6-20) in een cross-sectionele studie. We 
vonden dat het merendeel van de gezonde kinderen (meer dan 65%) geen 
maximale score behaalde op de meeste domeinen van de CFQ. Mediane CFQ 
scores van gezonde kinderen en adolescenten varieerden van 67 tot 100 (op 
een schaal van 0-100) op de verschillende CFQ domeinen. Significante 
verschillen in gezondheidsgerelateerde kwaliteit van leven werden gevonden bij 
gezonde kinderen en adolescenten en deze waren afhankelijk van leeftijd en 
geslacht. We concludeerden dat deze gegevens over de kwaliteit van leven 
scores van een gezonde populatie van essentieel belang zijn voor een adequate 
interpretatie van de kwaliteit van leven bij jonge patiënten met CF. Artsen 
moeten zich ervan bewust zijn dat de perceptie van gezondheidsgerelateerde 
kwaliteit van leven niet zo ziektespecifiek is als men zou kunnen denken en dat 
deze ook afhankelijk is van meer algemene factoren als leeftijd, normale 
ontwikkeling en geslacht. 
 
In de algemene discussie (hoofdstuk 7) worden de belangrijkste bevindingen van 
de verschillende studies in klinisch perspectief geplaatst en worden een aantal 
algemene methodologische overwegingen besproken. Tot slot volgen de  
aanbevelingen voor vervolgonderzoek en voor de klinische praktijk.  
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List of abbreviations 
 
ACQ Asthma Control Questionnaire 
AE  Allergen exposure 
AL Caregiver alcohol use 
BF  Breast feeding 
BM Baseline morbidity 
BSI Brief Symptom Inventory 
BSQ Behavior Screening Questionnaire 
BW   Birth weight 
CBCL Child Behavior Checklist 
CCEI Crown-Crisp Experiental Index 
CES-D Center for Epidemiological Studies Depression Scale 
CF Cystic Fibrosis  
CFQ Cystic Fibrosis Questionnaire  
CFQ-R Cystic Fibrosis Questionnaire-Revised 
CI Confidence interval 
ECBI Eyberg Child Behavior Inventory 
ED  Emergency department 
FeNO Fractional exhaled Nitric Oxide 
FEV1%  Forced Expiratory Volume in 1 second (percentage 
predicted) 
FHA  Family history of asthma 
GHQ General Health Questionnaire 
HADS Hospital Anxiety and Depression Scale 
HRI  History of respiratory infections 
ICD International Classification of Diseases 
ICS Inhaled glucocorticosteroids  
IgE Immunoglobulin E 
IL Interleukin 
INF Interferon 
MMAS Morisky Medication Adherence Scale 
MH Mental health 
NOSIK Nijmegen Ouderlijke Stress Index - kort 
OR Odds ratio 
PACE Psychosocial Assessment of Childhood Experiences 
PACQLQ Pediatric Asthma Caregivers Quality of Life Questionnaire  
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PAQLQ Pediatric Asthma Quality of Life Questionnaire  
Ppb   Parts per billion 
PP Parenting practices 
PRS Parenting Risk Scale 
PSS Perceived Stress Scale  
QoL Quality of life 
RR  Relative risk 
SC Spearman correlation 
SD Standard deviation 
SDQ Strengths and Difficulties Questionnaire 
SES Socio-economic status 
SPSS Statistical Package for the Social Sciences 
SS  Social support 
TNF-α Tumor necrosis factor-α 
UCLALSI-CV University of California Los Angeles Life Stress Interview – 
Child version 
ZCL Illness Cognition Questionnaire (‘Ziekte cognitie lijst’) 
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Dankwoord  
Op een druilerige zaterdagmiddag, een aantal maanden voordat ik dit 
proefschrift ga verdedigen in de aula van de Radboud Universiteit, ga ik nog 
even snel voor sluitingstijd de boekenwinkel in om sinterklaascadeautjes te 
kopen. Mijn ogen schieten heen en weer tussen de nieuw verschenen romans 
totdat mijn oog valt op de afdeling met reisboeken. Kleurige platen op de 
voorkant van mensen uit andere culturen met andere gebruiken trekken mijn 
aandacht. De afgelopen jaren heb ik het voorrecht gehad om naast mijn werk 
verschillende reizen te kunnen maken naar verre oorden. Zo terugdenkend aan 
deze mooie herinneringen valt mij ineens de samenhang op tussen het maken 
van een verre reis en het schrijven van een proefschrift. Tijdens het schrijven 
van een proefschrift doe je nieuwe indrukken op, kom je op plaatsen waar je 
nooit eerder van gehoord hebt, ontmoet je nieuwe mensen, leer je flexibel om te 
gaan met je vooraf bedachte reisschema en krijg je inzicht in je eigen kwaliteiten 
en valkuilen. Op reis gaan is anders dan op vakantie gaan. Een truckdriver in 
Zuid-Afrika zei eens ‘Is nie vakansie nie, is een avontier’. En ja, dat lijkt me wel 
een mooie metafoor. Een avontuur beleef je niet alleen maar doe je samen met 
bekenden en minder bekenden. Het met goed gevolg afsluiten van dit 
'wetenschappelijk avontuur' heb ik te danken aan vele mensen.  
 
Voorbereiding van de reis 
Een reis start vaak met ideeën en wegdromen, zo ook mijn promotie. Toen ik in 
2007 startte in het UMC St. Radboud stond promoveren zeker niet boven aan 
mijn wensenlijstje. Ik wilde graag ervaring op doen binnen de patiëntenzorg en 
me verder bekwamen binnen de pediatrische psychologie. De eerste paar 
maanden werkt ik ingewerkt door mijn voorganger, mevrouw Els Heitkamp. Els, 
jij leerde mij in die paar maanden de eerste kneepjes van het vak. Jouw 
enthousiasme en ervaring binnen de psychosociale zorg voor jonge patiëntjes  
met veelal chronische luchtwegaandoeningen, maakten dat ik me snel op mijn 
gemak voelde in Dekkerswald.  
 Mevrouw dr. Ineke Hulstijn-Dirkmaat, destijds sectieleider van de sectie 
kinderen en jeugdigen van de afdeling Medische Psychologie van het UMC St. 
Radboud, beste Ineke, jij hebt mij tijdens het eerste jaar in wekelijkse supervisie 
met raad en daad bijgestaan. Tijdens die gesprekken is de basis gelegd van dit 
promotieonderzoek. Onze hoofdvraag ‘welke psychosociale problemen zie je bij 
jonge patiëntjes met een longaandoening’ lag ten grondslag aan wat destijds 
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bedoeld was als een klein pilot onderzoek. Dit ‘kleine vragenlijstenonderzoekje’ 
groeide de afgelopen jaren uit tot dit proefschrift. Ineke en Els, bedankt voor 
jullie inspiratie! 
 
Reisleiders 
Een reis wordt pas interessant als ervaren mensen je kunnen vertellen welke 
paden je moet bewandelen. Als reisleiders begeleiden zij je over de hobbels die 
je tegenkomt onderweg. Zij kunnen datgene wat je ziet en hoort vertalen en in 
perspectief plaatsen. Mijn beide copromotoren mevrouw dr. Chris Verhaak 
(klinisch psycholoog en sectieleider van de sectie kinderen en jeugdigen van de 
afdeling Medische Psychologie) en dr. Peter Merkus (kinderlongarts en hoofd 
van de subafdeling Kinderpulmonologie)  hebben mij de afgelopen jaren aan de 
hand meegenomen en mij wegwijs gemaakt in de wereld die wetenschappelijk 
onderzoek doen heet. Bij Chris kon ik ten alle tijden binnenlopen met praktische 
vragen. Zij leerde mij om systematisch te werk te gaan en vanuit een theoretisch 
model te kijken naar mijn bevindingen. Peter, jij leerde mij om mijn ellenlange 
zinnen te vertalen naar compacte wetenschappelijke tekst en herschreef mijn 
teksten naar 50% van wat ik op papier had gezet. (Ik ben benieuwd hoe je dit 
dankwoord zou vertalen en hoeveel bomen dat gescheeld zou hebben!). Chris 
en Peter, bedankt voor jullie laagdrempelige hulp en begeleiding! Zonder jullie 
enthousiasme en ongeëvenaarde snelheid van werken was dit boekje er nooit 
geweest!  
 Naast mijn beide copromotoren ben ik begeleid door mijn twee 
promotoren prof. dr. Judith Prins en prof. dr. Ronald de Groot. Beste Judith, 
bedankt voor jouw 'helikopterview' en betrokkenheid bij het tot stand komen van 
dit proefschrift. Als afdelingshoofd heb je mij de kans gegeven om me naast mijn 
taken binnen de patiëntenzorg en het onderwijs te verdiepen in wetenschappelijk 
onderzoek. Het feit dat ik altijd zo bij je binnen kon wandelen, met name in de 
afrondende fase van mijn proefschrift gaf mij veel rust en vertrouwen dat ik mijn 
boekje mooi op tijd af kon ronden. Beste Ronald, bedankt voor jouw bijdrage 
tijdens de laatste loodjes van mijn promotie. Jouw enthousiasme en holistische 
visie sluiten mooi aan bij waar het in dit proefschrift om draait. 
 
Douane 
Ja, en dan is het zover. Alle hoofdstukken zijn geschreven en de meeste 
artikelen zijn gepubliceerd of 'under review': het manuscript is in grote lijnen af. 
Maar zoals je in de meeste verre landen niet binnenkomt zonder de nodige 
papieren en stempels, zo ook bij promoveren. Ik wil prof. dr. C. van Weel, 
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mevrouw prof. dr. M.A. Grootenhuis van het Emma Kinderziekenhuis/AMC in 
Amsterdam en mevrouw prof. dr. M.W.G. Nijhuis-van der Sanden bedanken voor 
hun snelle beoordeling van dit proefschrift. Beste Chris van Weel, als voorzitter 
van de manuscriptcommissie, had ik je graag bij mijn verdediging willen zien op 
26 maart. Helaas ben jij naar alle waarschijnlijkheid op dat moment als 
gasthoogleraar in Australië. Beste Ria Nijhuis en Martha Grootenhuis, ik zie er 
naar uit om op 26 maart met jullie van gedachten te wisselen over mijn 
wetenschappelijke bevindingen. 
 
Reisgidsen 
Mevrouw dr. Anja Vinck, lieve Anja, een aantal weken geleden vroeg ik je te 
solliciteren naar de functie van paranimf. Jouw kwaliteiten als paranimf kwamen 
in je sollicitatiebrief bijzonder goed naar voren: een multitasker, jouw 
relativeringsvermogen, organisatietalent en jouw (zoals je het zelf omschrijft) 
‘buitenproportioneel lange onderzoekservaring’. Je hebt me weten te overtuigen 
dat cognitief-gedragstherapeutische technieken zeer waardevol kunnen zijn bij 
de voorbereiding van een promotie. Ik heb bewondering voor jouw 
doorzettingsvermogen en de manier hoe jij werk en thuis de afgelopen jaren 
hebt weten te combineren! Na deze drukke jaren gaan we ons maar eens 
storten in een nieuw avontuur naast onze baan: het maken van leuke jurkjes, 
hippe tuniekjes en kekke rokjes voor onze meiden en kunnen we ons vast 
voorbereiden op de jaarlijkse verjaardagstraktaties rond 27 juli! 
 Mevrouw Coosje Sintnicolaas, lieve Coosje, spin in het web van de 
kinderlongziekten, rots in de branding voor vele ouders en patientjes, maar ook 
voor mij. De manier waarop jij jouw werk als verpleegkundig specialist vormgeeft 
met zo veel passie en respect is bewonderenswaardig en een waar voorbeeld 
voor hoe de zorg aan patiënten werkelijk 'patient-centered' kan zijn. Ik hoop dat 
we met dit boekje weer een kleine stap hebben gemaakt in de reis naar de 10 
groene bolletjes! 
 Lieve Anja en Coosje, ik hoefde niet lang na te denken over wie ik naast 
mij wilde hebben staan tijdens mijn verdediging. Gelukkig hoefde ik ook niet lang 
op jullie antwoord te wachten ;-) Dank! 
 
Reisgenoten 
Reizen doe je veelal niet alleen. In een groep beleef je dingen anders en kun je 
samen bij het kampvuur ’s avonds de mooiste verhalen en belevenissen delen.  
Mijn reisgenoten tijdens deze onderzoeksreis komen uit verschillende 
geledingen. Een aantal van hen waren direct betrokken bij dit onderzoek en een 
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aantal van hen waren indirect zeer belangrijk voor de nodige ontspanning of 
andere gesprekken tussendoor. Allereerst mijn dank aan Mees van 
Schravendijk. Na jouw stage ben je bij ons gebleven en hebben we samen de 
TIDES-studie in Nederland vormgegeven. Jouw zeer nauwkeurige werkhouding 
en inzet hebben er mede toe geleid dat dit manuscript nog mooi op tijd voor mijn 
verlof naar de manuscriptcommissie kon. Als alle drukte rondom dit proefschrift 
wat is afgezwakt kom ik graag een keer langs voor een rondleiding op jullie 
boerderij. Jannemarie de Ridder, Carla Reidsma, Daphne Deelen, Nicole ter 
Heide en Lidewij Zwart wil ik bedanken voor hun hulp bij de organisatie van de 
verschillende studies uit dit proefschrift en de hulp bij de data-invoer. 
 Dank aan alle onderzoekers, collega’s en leiding van de afdeling 
Medische Psychologie van het UMC St. Radboud en van het UCCZ 
Dekkerswald. Met een aantal van jullie heb ik wat intensievere contacten gehad 
dan met anderen. Aan de collega psychologen in Dekkerswald hierbij mijn 
oprechte excuses voor het feit dat ik keer op keer mijn belofte brak om nu toch 
echt eens vaker aan te sluiten bij de gezellige lunches in het oude restaurant van 
Dekkerswald. Wellicht dat ik na mijn promotie meer tijd over ga houden (of is dit 
de zoveelste loze belofte?). Speciale dank aan dr. Jan Vercoulen, klinisch 
psycholoog en sectieleider in Dekkerswald. Jan, jouw voorbereidend werk van 
de afgelopen jaren heeft de weg vrijgemaakt om ook aan de kinderkant de 
psychosociale zorg voor patiënten met longaandoeningen op de kaart te zetten. 
 De afdeling kinderlongziekten bestaat tegenwoordig uit een grote groep 
enthousiaste professionals die gezamenlijk de zorg voor kinderen met veelal 
chronische luchtwegaandoeningen vormgeven in de regio: het doktersduo op de 
begane grond Jan-Bart Yntema en Jolt Roukema, de collega’s vanuit het CWZ: 
Marianne Brouwer, Peter Gerrits en Petra Stevens en natuurlijk de dames op de 
berg: Cindy Hugen, Imke van Esschoten, Marian Bobbert, Sonja Willems en 
Maartje Salemans. Alle collega’s van het CF team van zowel de kinderkant als 
de volwassenenkant en alle andere collega's die zich dagelijks inspannen voor 
longpatiënten en hun gezin: dank voor alles! Ik hoop dat we de komende jaren 
alle kennis die we opgedaan hebben kunnen vertalen naar praktische 
zorginnovaties! Met al jullie liefde voor dit mooie vak heb ik daar het volste 
vertrouwen in! 
 Het secretariaat vanuit zowel Dekkerswald als het Radboud: Jolanda, 
Sandy, Evelien, Jet, Nancy, Joost, Helma en Jacintha. Wat moest ik zonder 
jullie? Jullie praktische ondersteuning, de gezellige praatjes tussendoor, de altijd 
gevulde droppot, de vele keren dat ik mee naar beneden mocht rijden de berg af 
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en al jullie hulp bij de verschillende facetten van dit onderzoek. Velen malen 
dank! 
 Collega’s van de kinderpsychologie: Sandra, Elske, Monique, Marchien, 
Mirjam, Jet, Marian, Kim, Esther, Jolanda, Ietske, Saskia, Emiel, Simone, 
(ex)stagiaires en alle oud-gedienden: wat hebben we toch een leuke club bij 
elkaar! Dank voor jullie interesse in dit onderzoek, de fijne lunches in de serre, 
de updates over de echt belangrijke zaken in het leven (wie is er uitgestemd bij 
BZV?) en jullie meeleven, meedenken en meehelpen van de afgelopen jaren! 
 Prof. dr. Alexandra Quittner, dear Alexandra, in the past few years we 
met a few times in the Netherlands and last time even in Elst! Your enthusiasm 
is contagious! As you know I am impressed by the way you put the psychosocial 
agenda of CF in the spotlights! I hope in the future we shall meet again in Miami! 
 En dan natuurlijk alle collega onderzoekers, nurse-practitioners, 
onderzoeksverpleegkundigen, artsen en co-auteurs uit andere ziekenhuizen in 
het land die aan een of meer publicaties hun bijdrage hebben geleverd. Zonder 
jullie inspanningen was het nooit mogelijk geweest om zoveel patiënten te 
includeren en onze artikelen gepubliceerd te krijgen. Dank aan jullie! 
 
Lokale bevolking 
Als psycholoog zijnde zal het niemand verbazen dat het leukste aan reizen voor 
mij naast de adembenemende natuur veelal de mensen zijn. Zij die je tegenkomt 
op je reis en je vertellen over hun eigen achtergrond en gebruiken, je meenemen 
in hun cultuur en je laten zien wat oprechte gastvrijheid is. Voor mij staan al deze 
mensen symbool voor de vele jonge patiënten, hun ouders en de gezonde 
vrijwilligers die hebben meegewerkt aan de verschillende studies uit dit 
proefschrift. Dit onderzoek is door hen en voor hen tot stand gekomen met als 
doel om de zorg voor deze kwetsbare groep te verbeteren en meer aandacht te 
hebben voor hun psychosociaal welbevinden.  Dus voor jullie allen: dank! 
 In mijn klinisch werk heb ik de afgelopen jaren tientallen kinderen en 
ouders voorbij zien komen die allen om verschillende redenen verwezen waren 
voor medisch-psychologische diagnostiek, begeleiding of behandeling. Jullie 
brachten allemaal jullie eigen ideeën, gebruiken, geschiedenis, normen en 
waarden mee de spreekkamer in en motiveerden mij om door te gaan met dit 
onderzoek. Jullie lieten mij zien hoe zeer het belangrijk is om elke patiënt te 
behandelen binnen zijn of haar eigen context. Dank voor al jullie verhalen! 
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Thuisfront 
En dan kom je na een tijd reizen weer terug op Schiphol aan. Door een horde 
mensen zie je je ouders staan en bedenk je je dat het mooiste van reizen 
wellicht het thuiskomen is. Je beseffen hoe goed je het hebt in ons mooie 
kikkerlandje. Een stabiele basis waar je ten alle tijden op terug kan vallen. En 
zoals Guus zo mooi zei: 'ik woon hier echt niet meer toch kom ik elke keer weer 
thuis'. Pap en mam, bedankt voor alles! Barbara, Sander en Bennie; na de 
aankomst op Schiphol staat Veghel (en tegenwoordig de boerderij in Uden) vaak 
bovenaan het wensenlijstje om op bezoek te gaan, waarna we via Eindhoven 
weer in Loenen belanden om daar mijn schoonfamilie te bezoeken (Bart, 
Christien, Petra, Jakko, Eva, Lars, Martine en Tjarco). Lieve opa en oma, toch 
nog een echte doctor in de familie! Aan jullie allen dank voor wat jullie voor mij 
betekenen en voor jullie hulp op alle mogelijke manieren de afgelopen jaren! 
Jullie laten me zien waar het echt om draait in het leven! 
 Na een drukke werkweek vol met patiëntenzorg, onderwijs en 
onderzoek staat het weekend veelal in het teken van ontspanning en zijn er vele 
vrienden die voor deze broodnodige ontspanning, plezier en tijdverdrijf zorgen. 
Van Groningen naar Maastricht, van Amsterdam via Utrecht naar het Oosten 
van het land, Van de Randstad naar Nijmegen en zelfs tot in België en Helmond. 
Oude studiegenoten, goede vrienden en vriendinnen, kennissen, buren, 
sportmaatjes in en buiten Elst city, de vele kilometers zijn het meer dan waard! 
 Lotte en Sofie; tijdens onze vakantie in Turkije in april 2012 hadden jullie 
het niet zo in de gaten, maar die tante van jullie was toen eigenlijk heel hard aan 
het werk. Met fototoestel in de aanslag aan het wachten op het perfecte plaatje 
voor de verfraaiing van dit boekje. En zie hier het resultaat; jullie staan er 
prachtig op. Meiden bedankt voor jullie fotogenieke bijdrage aan dit boekje! 
 
Vergeten 
Al die mensen die je op je reis ontmoet en waarbij je naderhand thuis net niet op 
de naam kan komen of zij die je je pas herinnert als je je fotoboek nog eens van 
zolder haalt. Die toevallige ontmoetingen langs de kant van de weg of op een 
verlaten station. Die glimlach van een onbekende die je dag weer goed maakte. 
Zo ook met het doen van wetenschappelijk onderzoek: zo veel mensen 
betrokken die allemaal in het klein of in het groot bijgedragen hebben aan het 
afmaken van dit boekje. Voor eenieder die een steentje heeft bijgedragen aan de 
totstandkoming van dit boekje en niet persoonlijk genoemd is: bedankt!  
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Sponsoring 
Ik las ergens de volgende spreuk en ook die is geheel van toepassing op het 
doen van wetenschappelijk onderzoek: ‘Voor je op reis gaat, overleg eerst 
hoeveel bagage en hoeveel geld je gaat meenemen. Berg daarna de helft van 
de bagage weer op en neem dubbel zoveel geld mee’. Dit proefschrift is mede 
tot stand gekomen door een financiële bijdrage van de Nederlandse CF 
Stichting, Chiesi Pharmaceuticals, Teva Nederland, GlaxoSmithKline, Abbott, de 
Radboud Universiteit Nijmegen en de afdeling Medische Psychologie van het 
UMC St. Radboud, waarvoor ik hen veel dank ben verschuldigd.  
 
Thuis zijn 
Lieve Jeroen, ruim tien jaar geleden kwam ik je tegen in het verre zuiden en het 
was meteen liefde op het eerste gezicht (althans van mij uit dan hè ;-) Gelukkig 
werd dat wederzijds tijdens één van de beroemde (of beruchte) ledenweekenden 
van Fyrfad! De afgelopen jaren hebben wij samen al zoveel mooie momenten 
beleefd: vele kilometers weg van huis maar ook heerlijk kneuterig samen thuis 
op de bank! Ik hoop dat er nog vele avonturen gaan volgen die we samen gaan 
beleven! Jij weet als geen ander hoe belangrijk je voor me bent en hoe 
ontzettend dankbaar ik ben voor hoe we het samen (en nu met Sanne) voor 
mekaar hebben. Jij bent mijn thuis! 
 Lieve Sanne, wat een prachtig meisje ben je toch! Ik hoop dat jij de 
nieuwsgierige blik die je nu hebt en die overweldigende glimlach van je vast 
weet te houden de komende jaren. Jouw komst was de beste motivatie om dit 
proefschrift af te ronden!  Met jou wandelen, spelen, kijken, verbazen en de 
wereld ontdekken is mijn nieuwe grootste hobby geworden! 
Lieve Jeroen en Sanne, ik ben blij met jullie!  
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Curriculum Vitae  
 
Marijke Maria Tibosch werd op 12 augustus 1982 geboren in ’s-Hertogenbosch 
als dochter van Wim en Marie-José Tibosch en zus van Barbara. Een paar jaar 
later was het gezin compleet met de geboorte van broer Bennie. In 2000 
behaalde zij haar VWO diploma in Veghel en verhuisde zij als zeventienjarige 
naar Maastricht. Daar begon zij met veel plezier aan de studie Geneeskunde 
aan de Universiteit Maastricht. Na het behalen van haar doctoraal (cum laude) in 
2004 heeft zij haar studieloopbaan verder voortgezet in Leiden. Daar studeerde 
zij Pedagogische Wetenschappen aan de Universiteit van Leiden. Zij behaalde 
in 2006 haar Master (eveneens cum laude). Haar wetenschappelijke en klinische 
stage liep zij in twee kinderrevalidatiecentra; Heliomare en Blixembosch. Na 
haar afstuderen startte zij als orthopedagoog bij revalidatiecentrum Leijpark in 
Tilburg en was zij nog 1 dag per week op haar voormalige stageplek in 
Eindhoven bij revalidatiecentrum Blixembosch werkzaam binnen de 
kinderrevalidatie. In januari 2007 kwam er een uitdagende functie vrij binnen de 
sectie kinderen en jeugdigen van de afdeling Medische Psychologie van het 
UMC St. Radboud. In 2008-2009 volgde zij de postdoctorale opleiding tot 
gezondheidszorgpsycholoog met als aandachtsgebied kinderen en jeugdigen. 
Gedetacheerd vanuit de afdeling Medische Psychologie werkt zij de afgelopen 
jaren met veel plezier binnen de patiëntenzorg voor kinderen met veelal 
chronische luchtwegaandoeningen. Een enthousiast multidisciplinair team werkt 
vanuit drie locaties (UMC St. Radboud, UCCZ Dekkerswald en Canisius 
Wilhelmina Ziekenhuis) aan het optimaliseren van de zorg voor kinderen met 
astmatische en allergische aandoeningen binnen het Regionaal Astma- en 
Allergiecentrum voor Kinderen (RAAcK). Binnen dit centrum wordt actief door 
meerdere disciplines samengewerkt. In 2011 heeft dit geleid tot de publicatie van 
het boek: ‘Leven met astma bij kinderen’ dat zij samen schreef met 
kinderlongarts en hoofd van de subafdeling kinderlongziekten dr. Peter Merkus. 
Daarnaast is zij als GZ-psycholoog vanuit de afdeling Medische Psychologie 
verbonden aan het CF centrum Oost-Nederland en in deze functie 
verantwoordelijk voor de psychosociale zorg aan kinderen en jongeren met 
cystic fibrosis en hun ouders. Naast haar taken binnen de patiëntenzorg geeft zij 
onderwijs aan studenten geneeskunde en tandheelkunde, begeleidde zij 
wetenschappelijke stages en doet zij wetenschappelijk onderzoek, waar dit 
proefschrift het resultaat van is. Marijke is al jaren gelukkig met Jeroen Jurriens 
waarmee zij in 2010 getrouwd is. Samen hebben zij een dochter Sanne (2012).  


